tab 3a tab a - alvarez and marsal · 2018-09-20 · li-31 this is exhibit "a" referred to...

Tab ATab 3A

LI-31

This is Exhibit "A"

referred to in the Affidavit of

DOUG QUAN

sworn September 10, 2018

Commissioner for Taking Affidavits (or as may be)

Martin Zuyu wn Hartister and Solicitor

Notary Public and Commissioner of Oaths in and for the Province of Ontario.

My commission is of tinlimitod duration.

Martin Zeyu Wu Banittef& Solicitor, Notary Public &lite 609, 33 city Centre. Diive Mississauga, ON'L5B•2N5 Tel: (905)-306 9000 Fax: (905) 306 9002

LI-31

This is Exhibit "A"


DOUG QUAN







LI-31

This is Exhibit "A"


DOUG QUAN







• •

~~~

i 1.1

. 4.4 ;? .:F, F. ,I .i i i IIII v i 9113E3E

ii itliat_311.$ :4Siti? '11V4F -, t "Fl:

I p ,, 1,,,L, ,,,r:;-Tif,;111

i

i 1.1

. 4.4 ;? .:F, F. ,I .i i i IIII v i 9113E3E

ii itliat_311.$ :4Siti? '11V4F -, t "Fl:

I p ,, 1,,,L, ,,,r:;-Tif,;111

i

1 irc ifikaE3kit:ikit_ii: 42ml 111(PiliiiiIIIIIPVIT . .'-!-''54

-

tot atom*

04

Tab 1E3Tab 3B

This is Exhibit "B"


DOUG QUAN



Martin 7.cytt Wit Banister and Solicitor

Notary Public and Commissioner °faiths in and for the Pmt•inco otOntario.

My commi.ssion is of unlimited duration.

Martin Zeyu Wu Barrister & Solicitor, Notary Public Suite 609, 33 City Centre Drive Mississauga, ON L5B 2N5 Tel: (905)306 9000 Fax: (905) 306 9002

This is Exhibit "B"


DOUG QUAN







This is Exhibit "B"


DOUG QUAN







hi: ;".q- hi: ;".q- hi: ;".q-

ig 74) 20i (_r-i 0 E-J PiVJ ig 74) 20i (_r-i 0 E-J PiVJ ig 74) 20i (_r-i 0 E-J PiVJ

Aug 24, 2018 at 5:07:37 PM Mississauga

"Clilltatil,J111_11L4e111.1 1 1.1.LitilgaMI$A1'

11111101. -AmNM Mil 1111MMill MIMS ••••

5,Y1%L.-d

Aug 24, 2018 at 5:07:37 PM Mississauga

111tVIM-ITI ) 171 - X-1171 . n I I, 1NT:02111i

1 C 4,:j 0:7 J--)M

r) J

°

1 C 4,:j 0:7 J--)M

r) J

°

•

. - • • - ... • ""

"". • • ' • - ••,- •

I

[[

•

. - • • - ... • ""

"". • • ' • - ••,- •

I

[[

Tab 3C

This is Exhibit "C"


DOUG QUAN


414


Martin Zeyu Wu Barrister and Solicitor

Notary Public and Commissioner of Oaths in and for the Pmvince of Ontario.

My commission is of unlimited duration.


This is Exhibit "C"


DOUG QUAN


414



Notary Public and Commissioner of Oaths in and for the Pmvince of Ontario.



This is Exhibit "C"


DOUG QUAN



414


Notary Public and Commis loner of Oaths in and for the Province of Ontario.



44S''

44S'' 4A

s"

444 444 _

°I)71fr

/-13,4qF

__

/-13,4qF

__

I

wt

I ts

4 1. 1

utzi.. 1 Zz d

gprrIRMAIFTTS

wt

I ts

4 1. 1

utzi.. 1 Zz d

gprrIRMAIFTTS

11 51

' 1%11;:l

7 4 11111 ff.

irrIrfirrorirr

/AM /AM 441

L

J J

0.601111111 MIEN ■/

Tab 3D

This is Exhibit "D"


DOUG QUAN



Martin Zcyu Wu Barrister and Solicitor

Notary Public and Commissioncrof Oaths in and for the Pinvince of Ontario:


Martin Zeyu Wu Barrister* Solicitor, Notary Public Suite 609, 33 City Centre Drive Mississauga, ON L5B 2N5 Tel: (905) 306 9000 Fax: (905) 306 9002

This is Exhibit "D"


DOUG QUAN







This is Exhibit "D"


DOUG QUAN







- - - - - -

- - - - - .- __.= ,, -

at : Mississauga

. • '—i;,..4.,-;;;., •,-. ",'. , ,rtz.-....k.,72.,' -.....

•. '..: , ,-; z_- ,. ,' , 4a ' ' N ' '$,..,, . :".", 7:4":1N I '• r"... ‘“`•.„,,,. .....:,. '"--,..... •-"

. .. , ,L-e..... ̀ ..r' ',- ,:_... j.. -1::,-,,, ... s,...- -,-,..,...-;?..,,-..... ,- ; .,. , ..--,-...• ..0,- -,• 7, ,,,-_-- r . .1_, . ._ .- ,,_- - ., ..,-,s- ,f , .-..,,,,01,-,,,, .,-.. ,. ,mot -1 '4•- i:/•-:. 7.—• . t :=

, • ' ,:: = './--:,-. `•::,..4,7e•- "" , :. _ "•-•-,, ..:--: ,L, .;:1 r ' :I•c.4, ' ' • : • '. , is. ).'.1 -.'•'_':,., .1 \-''.•-.7....''',1' 4 '"r1-'. I.., f t . . u : , ' • 1 ' i ' ‘: k :Z. _,,' . , ' .... • : t . .''': ,\No 1. ' . ' 'I"' ''•••':ef't.?' ...,, . , • V ' +. - ..r ' '4.1,.. . ; I'' ' ' . .• ' k . ' % , ' ..• ' ' '''''l " .;' 5 •5 .),:. ' ' - ,s•'''' - ‘11 ‘1 sl , N, ' N r L. , •

, 4.- • .. 'as .t , --- ., • , •••••• I • - _ • 1.) . 44s

."' • .: ' 5 .15 r " 4 ':...-- • - .', , . 1 1, , .04 ,.:,,, .,....:,... ... i

' -. '4'7'

at : Mississauga

. • '—i;,..4.,-;;;., •,-. ",'. , ,rtz.-....k.,72.,' -.....

•. '..: , ,-; z_- ,. ,' , 4a ' ' N ' '$,..,, . :".", 7:4":1N I '• r"... ‘“`•.„,,,. .....:,. '"--,..... •-"

. .. , ,L-e..... ̀ ..r' ',- ,:_... j.. -1::,-,,, ... s,...- -,-,..,...-;?..,,-..... ,- ; .,. , ..--,-...• ..0,- -,• 7, ,,,-_-- r . .1_, . ._ .- ,,_- - ., ..,-,s- ,f , .-..,,,,01,-,,,, .,-.. ,. ,mot -1 '4•- i:/•-:. 7.—• . t :=

, • ' ,:: = './--:,-. `•::,..4,7e•- "" , :. _ "•-•-,, ..:--: ,L, .;:1 r ' :I•c.4, ' ' • : • '. , is. ).'.1 -.'•'_':,., .1 \-''.•-.7....''',1' 4 '"r1-'. I.., f t . . u : , ' • 1 ' i ' ‘: k :Z. _,,' . , ' .... • : t . .''': ,\No 1. ' . ' 'I"' ''•••':ef't.?' ...,, . , • V ' +. - ..r ' '4.1,.. . ; I'' ' ' . .• ' k . ' % , ' ..• ' ' '''''l " .;' 5 •5 .),:. ' ' - ,s•'''' - ‘11 ‘1 sl , N, ' N r L. , •

, 4.- • .. 'as .t , --- ., • , •••••• I • - _ • 1.) . 44s

."' • .: ' 5 .15 r " 4 ':...-- • - .', , . 1 1, , .04 ,.:,,, .,....:,... ... i

' -. '4'7'

_

1

1 1

_ t

1

1 1

_ t

1

1 1

1

_

_ - _ - -

f

'41

177-

1,10, 0*, 5

114) el irk •

"att., • • • I

r

• .1;

• ,

•

• r. C. •

. • '` `

• *.,••• - •

" • •

. ,

• ••• • , 7

& • -

f

'41

177-

1,10, 0*, 5

114) el irk •

"att., • • • I

r

• .1;

• ,

•

• r. C. •

. • '` `

• *.,••• - •

" • •

. ,

• ••• • , 7

& • -

-7, 2 -',47 r-

e -7, 2 -',47 r-

e 71101(.i PJVJ -

•

me Ow. ro=-.. I

A

_•."- • • • 4 - " -

F. 2

42-

me Ow. ro=-.. I

A

_•."- • • • 4 - " -

F. 2

42- 42-

Tab 3E

This is Exhibit "E"


DOUG QUAN


3


Martin Zcyu Wit Barrister and Solicitor

Notary Public and Commissioner of Oaths in and for thc Province of•Onturio.

My commission is of tmlimited duration.

Martin Zeyu Wu Barrister & Solicitor, Notary Public Suite 609, 33 City Centre Drive Mississauga, I,5B 2N5 Tel: (905)306 9000 Fax: (905) 306 9002

This is Exhibit "E"


DOUG QUAN


3






This is Exhibit "E"


DOUG QUAN



3





G G

i

Sep 10, 2018 at 6:08:36 A Mississaug.

45.


45. 45.


Ri

I M1

•

146

111114

11111 .111.1.1iiptplog

— —

_

_

iiifk

-

I/6 I/6

Mg Mg A/CP

47

47

47

T 13 FTab 2F

This is Exhibit "F"


DOUG QUAN



Martin ZeyuWo Batista and Solicitor

Notary Public and Commissioner of Oaths in and for the Province °Mould°.


Martin Zeyu Wu Barrister & Solicitor, Notary Public Suite 609, 33 City Centre Drive Mississauga, ON L5B- 2N5 Tel: (905)306 9000 Fax: (905) 306 9002

This is Exhibit "F"


DOUG QUAN







This is Exhibit "F"


DOUG QUAN







MD Health Pharmacy Accreditation #300990 Audit & Exhibits 186 Main St South

Brampton, ON L6W 2E2

Exhibit 3: Prescription Hardcopies

o Patient Verbal Verification Dates listed In the table below

o Attached are 2 pages of the prescription hardcopies received from MD Health Pharmacy

Table 2 - Patient Verbal Verification Dates

1

2 854909

3 872651

4 I 870523

5 874103:

6 870522

7 '868150

8 860538

9 1 885015.

10 i870524

11, 854905

itrayr

e, Tic

0011A.

Nov 15, 2017

Nov 15, 2017

Mar 5,2018

1 Feb 20, 2018

Mar 08, 2018

Feb 20, 2018

Feb 09;2018 ,

Dec 18, 2018

Apr 3.1., 2018

Feb 20, 2018

Nov 15, 2017

e; April 20,2018 • May 2, 2018 • April 20, 2018 • May 2, 2018

• April .13, 2018

• May ; 2018

• April 20, 2018

• May 2, 2018

• April 20, 2018. • May2, 2018

• April 20, 2018 • May 2,2018 • April 20, 2018 • May 2, 2018

• April 20, 2018 • May 2, 2018

• April 20, 2018' • May 2, 2018

• April 20, 2018 • May ; 2018 • April 20, 2018 • May 2,: 2018

Phbne,Number not,in service

Phone Number not in service










•

ClaimSecure Inc. Confidential




o Patient Verbal Verification Dates listed In the table below



1

2 854909

3 872651

4 I 870523

5 874103:

6 870522

7 '868150

8 860538

9 1 885015.

10 i870524

11, 854905

itrayr

e, Tic

0011A.

Nov 15, 2017

Nov 15, 2017

Mar 5,2018

1 Feb 20, 2018

Mar 08, 2018

Feb 20, 2018

Feb 09;2018 ,

Dec 18, 2018

Apr 3.1., 2018

Feb 20, 2018

Nov 15, 2017

e; April 20,2018 • May 2, 2018 • April 20, 2018 • May 2, 2018

• April .13, 2018

• May ; 2018

• April 20, 2018

• May 2, 2018

• April 20, 2018. • May2, 2018

• April 20, 2018 • May 2,2018 • April 20, 2018 • May 2, 2018

• April 20, 2018 • May 2, 2018

• April 20, 2018' • May 2, 2018

• April 20, 2018 • May ; 2018 • April 20, 2018 • May 2,: 2018

Phbne,Number not,in service











•


ittrojet,




o Patient Verbal Verification Dates listed in the table below



1 854905

2 854909

3 872651

4 I 870523

5 874103:

6 870522

7 :868150

8 860538

9 l 885015.

10 870524

11, -854905

Nov 15, 2017

Nov 15, 2017 • •

Mar 5,2018

Feb 20, 2018

Mar 08, 2018 •

I Feb 20, 2018

Feb 09;2018 ,

Dec 18, 2018 •

• Apr 3.1., 2018

• • Feb 20, 2018 • •

Nov 15, 2017 •

April 20,2018 May 2, 2918 April 20, 2018 May 2, 2018

April 20, 208 May 2, 2018

April 20, 2018 May 2, 2018

April 20, 2018. May2, 2018

April 20, 2018 May 2, 2018 April 20, 2018 May 2, 2012

April 20, 2018 May 2, 2018

April 20, 2018' May 2, 2018

April 20, 2018 May 2, 2018

April 20, 2018 May 2, 2018

Phble,Nnmber not: in service










PhOne Number not in service


Rx:860538 Mon 18-Dec-201717:56

13.312.1 O GB

MD HEALTH PHARMACY 00001/0003

Rx:885015 Wed 11-Apr-2018 11:39

RX-37

•

Rx:854905 Wed 15-Nov-201712:12

Rx:868150 Fri 09-Feb-201815:44

CS: - 55:1111..1111.111111103 ip000 F

04117/2018 11:57AM FAX 9054567403 7 -

Rx:870522 Tue 20-Feb-201817:45 ' SS

11111111.11111111MNIIII 100 TAB EzetroliOmg Ezelirnibe ( Ezeir01) 10mg DIN: 02247521 196.37/100 Dr. Keshmirian, J 186 Main Street South Brampton ON Phone; (905) 456-7774 TAKE 1 TABLET EACH DAY Orig Rx:$5.51153 Auth:200 Ronn:0 Prev:20-Nov-17(855854) Ago:92 First 20-Nov-17(855853) Coat:198,37 Mkup155.00 Fee:11.99 Total:463.36 Pato.00 Disc1.73 Old Price:460.63 T.P.:455.63 ES1(151.32); C4(1313)(150.78); CSID13)(15355) kitergles

200 TAB Losec 20mg Omeprazoie Magnesium (LOSEC) 20mg Mfr, PMS DIN: 02190915 246.56/100 On Kant -1573oo Days: 100 Dr. Keshmitlan, J Doc# 01:67128 186 Main Street South No Script Image Brampton ON REFILL (14 date e Phone: (905) 456-7774 PR II, TAKE 1 TABLET TWICE DAILY Orig Re:854939 Auth:400 R7307.0 Prev:1544ov-17(864939) Ago 86 Plist:15-Nov1705400) Coat:493,12 Mkup:400.09 Feo:11.99 Total:905.11 Pat0.04 Disc:12.12 Old Price:897.99 T.P.:892.99 - ESI(450,89); OSIDE11(442.10) MORRO • Z•MInt•Clophteanolntn2 CLORODGREUESOUPRAZOICOMPR-DROJORG -Se -iPaleg 70n10 EaCtrALOPRAIS (b. QFt. Whitnalgem,cyp2_

-4riTi4P - PapUt Ulcer Agents

200 TAB Loses 20mg Omeprazole Magnesium (LOSEC) 20mg Mfr. PMS DIN: 02190915 246.56/100 On mend: -14730 Days: 100

Dr. Keshmirian, J Dou.e 01:67128 186 Main Street South NEW RX Brampton ON No Sc Phone: (905) 458-7774 REPRI

TAKE 1 TABLET TWICE DAILY Orig Rx:890536 AUth:400 Rem:200 (1) Cost:40112 Mkup:400.00 Foe:11.99 Tota1i905.11 Pat:6.00 '1315c:7.12 TP.:892 90 - 681(450;89). 010(18)(442.101 OR • 2.P1a4s Tkog ctoeitosneuasomaPIWOLai MIEPRA7.0111 OROMRo kw Unto eacrrst.opasis in on. no mop :motto OYP2... DUPM1P ttc.UlOer Agents

Counsel Dew: Phatmedel: 0 Yee 0 Patlent [Phone El Agent; U No 0 Had before. reason: Allergies Conditions

270 CAP Lyrica 150mg Pmgebslin 150mg Mfr PMS DIN: 02268460 145.76/60 on firma -311474 Days: 90

Brampton ON REFILL (29 d Phone: (905) 456-7774

186 Main Street South No Script Image Keshrhiriart, J Doc# 01:67128

TAKE 1 CAPSULE THREE TIMES DAIL DIRECTED . Orig Rx:8$4909 Auth:10110 Ram:270 (1) Prav:09•Feb•18(865113) Ago:61 First 15-Nov47(864909) Cost:665.92 Mkup:196.78 Fee:11.99 Total:864.69 Pab0.00 Diec:286,77 Old Moe:57742 T.P.:57742 - CS(577-92) DUP/THP - Antloonyulaant;

_ Allergies --Plato §

Rx:870524 Tue 20-Feb.2018 17:46

ESI: 32-312-0V PGX5 M13 CS; BX-37065- 100 TAB Crestor 40mg Rosuvastaiin Calcium 40mg DIN: 02247164 64_89/30 On nanu:-soiso Days: 100 Dr. Keshmirian, J 186 Main street South No

Dada :6712p0t1 tart

Pl3rone:t"

(905) ON

458-7774 REFILL (8 d

TAKEi TABLET EACH DAY AS DIREC ode fix:856956 AtIth:200 Pm:2041047(855856) Ago42 First:20-Nov-17(565856) Cose218,30 Mkup:180.00. Foe:11.99 Totel:408.29 Pab0.00 T.P.:383.50 • ES1(104.97);

Disc:24.79 CSIDEXt88.531

old Price:388.50

•.:Iums:±Iyhyperilolderrsles teadco•A Nuf Wass vrtoniunge (stem)

Zolmitriptan 2.5mg Mfr; AST 90 TAB Zomig 2.5mg

DIN: 02238660 90.73/6 on Nand: -89940 Days; 90 Dr. Keshmirian, J Dolt 01:67128 186 Main Street South NEW RX Brampton ON No Sod Phone: (905)45817774 PRI TAKE 1 TABLET AS DIRECTED WHE tfrED ONCE DAILY Orig Rx:854905 Auth:200 Ronr110 (11 Cost:1,360.95 MI:up:408.n Fee:11.99 Total:1.nrizs Pat:540 Mac:143.19 T.P.:1633.04 ES1(824 41); OS(Dt3)(809.03) ORG/DRG • 3-Cipratax 10mg SSBIS; SNR1515HT-10 Al3ORISTS, DRGIDRG -3•Clpraka 20m0 85RIS; SNR18/5HT-1D ACIONIST8 • Additional DUE issues - cheek profile

Counsel Date: Phannedst: 0 Yes ❑Patient °Phone 0 Agent 0 NO U Hod berm reason:

F.61: 32-31 -INNOVGXSPN974M8 CS: RX-3706

Mir MN On Hand:4371es Days: 100

Doc* 01:87128 No Script 'ma e

REFILL (8 da

Mir: MIN

Rx:860538 Mon 18-Dec-201717:56

13.312.1 O GB


Rx:885015 Wed 11-Apr-2018 11:39

RX-37

•

Rx:854905 Wed 15-Nov-201712:12

Rx:868150 Fri 09-Feb-201815:44

CS: - 55:1111..1111.111111103 ip000 F

04117/2018 11:57AM FAX 9054567403 7 -

Rx:870522 Tue 20-Feb-201817:45 ' SS

11111111.11111111MNIIII 100 TAB EzetroliOmg Ezelirnibe ( Ezeir01) 10mg DIN: 02247521 196.37/100 Dr. Keshmirian, J 186 Main Street South Brampton ON Phone; (905) 456-7774 TAKE 1 TABLET EACH DAY Orig Rx:$5.51153 Auth:200 Ronn:0 Prev:20-Nov-17(855854) Ago:92 First 20-Nov-17(855853) Coat:198,37 Mkup155.00 Fee:11.99 Total:463.36 Pato.00 Disc1.73 Old Price:460.63 T.P.:455.63 ES1(151.32); C4(1313)(150.78); CSID13)(15355) kitergles

200 TAB Losec 20mg Omeprazoie Magnesium (LOSEC) 20mg Mfr, PMS DIN: 02190915 246.56/100 On Kant -1573oo Days: 100 Dr. Keshmitlan, J Doc# 01:67128 186 Main Street South No Script Image Brampton ON REFILL (14 date e Phone: (905) 456-7774 PR II, TAKE 1 TABLET TWICE DAILY Orig Re:854939 Auth:400 R7307.0 Prev:1544ov-17(864939) Ago 86 Plist:15-Nov1705400) Coat:493,12 Mkup:400.09 Feo:11.99 Total:905.11 Pat0.04 Disc:12.12 Old Price:897.99 T.P.:892.99 - ESI(450,89); OSIDE11(442.10) MORRO • Z•MInt•Clophteanolntn2 CLORODGREUESOUPRAZOICOMPR-DROJORG -Se -iPaleg 70n10 EaCtrALOPRAIS (b. QFt. Whitnalgem,cyp2_

-4riTi4P - PapUt Ulcer Agents

200 TAB Loses 20mg Omeprazole Magnesium (LOSEC) 20mg Mfr. PMS DIN: 02190915 246.56/100 On mend: -14730 Days: 100

Dr. Keshmirian, J Dou.e 01:67128 186 Main Street South NEW RX Brampton ON No Sc Phone: (905) 458-7774 REPRI

TAKE 1 TABLET TWICE DAILY Orig Rx:890536 AUth:400 Rem:200 (1) Cost:40112 Mkup:400.00 Foe:11.99 Tota1i905.11 Pat:6.00 '1315c:7.12 TP.:892 90 - 681(450;89). 010(18)(442.101 OR • 2.P1a4s Tkog ctoeitosneuasomaPIWOLai MIEPRA7.0111 OROMRo kw Unto eacrrst.opasis in on. no mop :motto OYP2... DUPM1P ttc.UlOer Agents

Counsel Dew: Phatmedel: 0 Yee 0 Patlent [Phone El Agent; U No 0 Had before. reason: Allergies Conditions

270 CAP Lyrica 150mg Pmgebslin 150mg Mfr PMS DIN: 02268460 145.76/60 on firma -311474 Days: 90

Brampton ON REFILL (29 d Phone: (905) 456-7774

186 Main Street South No Script Image Keshrhiriart, J Doc# 01:67128

TAKE 1 CAPSULE THREE TIMES DAIL DIRECTED . Orig Rx:8$4909 Auth:10110 Ram:270 (1) Prav:09•Feb•18(865113) Ago:61 First 15-Nov47(864909) Cost:665.92 Mkup:196.78 Fee:11.99 Total:864.69 Pab0.00 Diec:286,77 Old Moe:57742 T.P.:57742 - CS(577-92) DUP/THP - Antloonyulaant;

_ Allergies --Plato §

Rx:870524 Tue 20-Feb.2018 17:46

ESI: 32-312-0V PGX5 M13 CS; BX-37065- 100 TAB Crestor 40mg Rosuvastaiin Calcium 40mg DIN: 02247164 64_89/30 On nanu:-soiso Days: 100 Dr. Keshmirian, J 186 Main street South No

Dada :6712p0t1 tart

Pl3rone:t"

(905) ON

458-7774 REFILL (8 d

TAKEi TABLET EACH DAY AS DIREC ode fix:856956 AtIth:200 Pm:2041047(855856) Ago42 First:20-Nov-17(565856) Cose218,30 Mkup:180.00. Foe:11.99 Totel:408.29 Pab0.00 T.P.:383.50 • ES1(104.97);

Disc:24.79 CSIDEXt88.531

old Price:388.50

•.:Iums:±Iyhyperilolderrsles teadco•A Nuf Wass vrtoniunge (stem)

Zolmitriptan 2.5mg Mfr; AST 90 TAB Zomig 2.5mg

DIN: 02238660 90.73/6 on Nand: -89940 Days; 90 Dr. Keshmirian, J Dolt 01:67128 186 Main Street South NEW RX Brampton ON No Sod Phone: (905)45817774 PRI TAKE 1 TABLET AS DIRECTED WHE tfrED ONCE DAILY Orig Rx:854905 Auth:200 Ronr110 (11 Cost:1,360.95 MI:up:408.n Fee:11.99 Total:1.nrizs Pat:540 Mac:143.19 T.P.:1633.04 ES1(824 41); OS(Dt3)(809.03) ORG/DRG • 3-Cipratax 10mg SSBIS; SNR1515HT-10 Al3ORISTS, DRGIDRG -3•Clpraka 20m0 85RIS; SNR18/5HT-1D ACIONIST8 • Additional DUE issues - cheek profile

Counsel Date: Phannedst: 0 Yes ❑Patient °Phone 0 Agent 0 NO U Hod berm reason:

F.61: 32-31 -INNOVGXSPN974M8 CS: RX-3706

Mir MN On Hand:4371es Days: 100

Doc* 01:87128 No Script 'ma e

REFILL (8 da

Mir: MIN

Rx:860538 Mon 18-Dec-201717:56

E5111111WI1 O GIIIIB

•

Rx:854905 Wed 16-Nov-201712:12

90 TAB Zomig 2,5mg Zolmitriptan 2.5mg Mfr; AST DIN: 02238660 90.73/6 on Nand: -89940 Days: 90 Dr. Keshmirian, J 186 Main Street South Brampton ON Phone: (905) 45817774 TAKE 1 TABLET AS DIRECTED WHE LIKED ONCE DAILY

Doc# 01:67128 NEW RX

No Soli PRI

Rx:868150

_ •

Fri 09-Feb-201815:44

CS: - 69:111111.1111.11.03 (p000 r


Rx:885015 Wed 11-Apr-2018 11:39

CS: RX-37 270 CAP Lyrica 150mg Pmgebslin 150mg Mfr PMS DIN: 02268450 145.76/60 on Nona -311474 Days: 90

04117/2018 11: 57AM FAX 9054567403

Rx:870522 Tue 20-Feb-201817:45 ' SS

11111

12w

;

EMIR -INNtriir.11X6P14874M8 cS: RX-3706

1

100 TAB Ezetro110mg Ezelimibe ( Ezeirol ) 10mg Mfr: MN DIN: 02247521 196.37/100 on nand; .e71 es Days: 100 Dr. Keshmirian, J Doo# 01:67128 186 Main Street South No Script Ima e Brampton ON REFILL (8 da Phone; (905) 456-7774 TAKE 1 TABLET EACH DAY Orig Rx:$561153 Auth:200 Ront:0 Prev:20-Nov-17(855654) Ago:92 FIrst20.-Nov-17(656663) Coat 198.37 Miu.p165.0.0 Fee:11.99 Tote1:46126 Pat0.00 Disc:7.72 Old Price:460.63 T.P.:455.63 ESI(151.32); CAD8)(150.78); CSIDEt](153.55)

kiternies

200 TAB Losec 20mg Omeprozoie Magnesium (LOSEC) 20rng Mfr, PMS DIN: 02190915 245.56/100 On Hand:-15730o Days: 100 Dr. Keshmirian, J Doo# 01:67128 186 Main Street South No Script Image Brampton ON REFILL (14 date e Phone: (005) 456-7774 PR II, TAKE 1 TABLET TWICE DAILY Orig liv48$4039 Auth:400 RaiTa Prey:I5-Nov-17(864939) Ago 86 Plist:16-Nov17064930) Coat:493,12 Mkup:400.00 Ftiort 1.99 Tota1:005.11 Pat0.04 Disc:12.12 Old Prica:897.99 T.P.:89299 - ESI(450,89); OSID131(442.10) IMMO • zilunt•Clophteand MRS CLORODGREUESOUPRAZOIE; OORPFL., IMMO - Se-iPaleg Oft EarALOPRAIS (b. QFt. Whitnalgem,cyp2_

-0riTi4P - Peat Ulcer Agents

200 TAB Losec 20mg Omeprazole Magnesium (LOSEC) 20mg Mfr. PMS DIN: 02190915 246.56/100 On mend: -1173o0 Days: 100 Dr. Keshmirian, J Doog 01:67128 186 Main Street South NEW RX Brampton ON No Sc Phone: (905) 458-7774 REPRI

TAKE 1 TABLET TWICE DAILY Orig Rx:1190636 Atith:400 Rem:200 (1) Cost:49112 Mkup:400.00 Fee:11.99 Tota1i905.11 Pat:6.00 'Disc:7.12 TP.:692 90 - ESI(450,89): 0168161)(442.101 OR • 2•Pla4bc rknectOsitiooseuasoiesPRAZOiel MIEPRA7.0111 OReMRO kw urn sacrottoinesis is On. ea MGV3ELEOTCO OYP2... DUPMIP tio.Uloer Agontu Counsel owe: Ramada. 0 Yee 0 Pailent 0 Phbfie El Agent; U No 0 Had before. reason: Allergies Conditions

Keshrhlrian, J Doc# 01:67128 186 Main Street South No Script Image Brampton ON REFILL (29 d Phone'. (905) 456-7774 TAKE 1 CAPSULE THREE TIMES DAIL DIRECTED . Orig Ric:664909 Auth:1 Rem:270 (1) Prav:09•Fetw1 8(668113) Ago:61 Pirs615•Nov-17(864909) Cost:665.92 Mkup:196.76 Fee:11.99 Total:864.69 Pat0.00 Diec:286.77 Old Price:677.92 T.P.:577.92 - OV677-92) DUP/THP - Antisonyulaant;

_ Allergies

Rx:870524

32-312-1 0V PGX5 MEI CS; RX-37066- 100 TAB Crestor 40mg Rosuvastaiin Calcium 40mg DIN: 02247164 64_89/30 On Hand: -80160 Days: 100 Dr. Keshmirian, J 186 Main street South No

Dada :6712p0t1ko0

8

Pl3rone:t"(905ON) 458-7774 REFILL (8 d

TAKE 1 TABLET EACH DAY AS DIREC Orig Flx:866056 AUth:200 Pre4:20-Nov-17(856856) Ago:82 Firet.:20-Nov-1763656661 Cost.216.30 Mkup:180.00. Fee:11.99 Totel:4011.29 Pat0.00 T.P.:383.60 • ES1(184.97); CS(08)(188.53)

Pict:24.79 old Price:368.50

•xium:±1yhyperlipldorrslcs iimeco•A uctase tresistois (S/arm)

Orig Rs:664906 Auth:200 Fienr110 (1 Cost 1,360.95 iiikup:408.29 Fee:11.99 Total:1.781 is Pat:6,00 bisc:143.19 T.P.:1633.04 ES1(824 .01); OS(D0)(809.03) OREM RG • 3-Clpralex 10mg SSBIS; SNRIS16HT-10 ADORISTS, DRGIDRG -3•01prakir 2010 SSRIS; SNRISSHT-1D AGONISTS • Additional DUE issues - cheek profile

Counsel Date Pherinectst OW'S q Patient 0 Phone 0 Agent

No U Had before, mason:

Tue 20-Feb.2018 17:46

Mfr: MIN

Rx:854905 Wed 15440v-2017 12:12 SS

CS: RX.29 5-00030001PF OS: RX.37065•0000200

Rx:854909 Wed 15.Nov-2017 12SS:14

#q3

04/17/2018 11: 49AM FAX 90 54667903 MD HEALTH PHARMACY

lk-rv. Ana nalik,- @0001/0002

06-Mar-201810b8

90 TAB Zornig_2.0119 Zolmitriptan 2.5mg . Mfr: AST pI N: 02P8660 90,73/6 on Hard -69940 Days: 90

Dr. Keshmirien, J DWI 01:67128 186 Maki Street South NEW RX Brampton ON No Sod Phone: (905) 466-7774

TAKE 1 TABLET AS DIRECTED WHEN REQUIRED ONCE DAILY Orig Ex:864906 Atith:200 Rern:110 (1) Cost:1.386.95 Mkup:406.29 Fen:11.99 Total:1,78123 Pat:5.00 Disc:143.19 T.P.:1633.04 - ESI(824,01); 0$(091(809.03) OROIDRQ - 3-Ciprelex 10mg $SRI$; ISNRI$15H7-1D AGONISTS DRWORG - 3-04prolex 20mg SOME: 8NRISIEHT•10 AGONISTS • Additional DUE 109tree • Cheek Draft

Counsel Daft. Phermaolat OYes ❑Walt 0 Phone r]Agent U No 0 Hee before. reason: Anemia;

-.Cot rlgiglta

270 CAP Lyrica 150mg Pregabatin 150mg Mfr: PMS PIN: 02268450 145,76/60 on Hand: 411474 Days: 90

Dr, Koshmlrian, J Doc I01:87126 186 Main Street South NEW RX Brampton ON No Sod Phone: (905) 456-7774 TAKE 1 CAPSULE THREE TIMES DAIL DIRECTED

01PF • • Vit. 01..2111

240 TAB Serormet 200mg - QueliapIne Fumarate 200mg Mir, AZC t DIN' 02236953 203.61/100 on Henn:-310740 Days: 60 Dr:Kashmtrian, J DWI 01:67128 186 Mein Street South No Script Image Brampton ON REFILL (4 Phone: (905) 456-7774 RE 177,---KETTATILET871:-WITE DAILY AS DIRE T oaf, PA:eager ---- Audi:7230- -fterm4130 ( Prey:Oa-Jan-10(8821/2) Ago:56 Firat:15•Ncer•17(8548137)

2) Coot:704.58 Mkup:520.00 Pee:11.99 Total:1,236.6E Pat:0,00 Dhic:20.42 Old Price:1,221.23 T.P.:1216.23 • 681(640.86); C3(138)(576.37) motile • 2-Adopt 54,a OT PROLoNOING OENTSialsErtarete: or Prom., PIM= • 2.0101144 044 QT PROLOMMOO AGENT5105TMPAE: not-- Additional DUE Issues . cheek profile

.4"..pnclitions • •••••

Rx:870523

_ : .312. . GXSPN74M8 c ...... ....-.........-____________ 100 TAB Creator Orng Rosuvastatin Calcium 20 Mg (Creator) 20mg Mk MIN DI : 02-247_163 55.29/30 on Kane: -mos_____-____ Dim 100 ----- Dr. KeetimIriao, J --- 186 Main Street South DocAti01:67128 Brampton ON

REFILL Is da No Script Image • Phone: (505) 456.7774

TAKE 1 TABLET EACH DAY AS DIREC .... --

-67ifiTixTaiiiii -A-uti-576 ----- Iien76 Pre1a20•Nov-17(865856). Ago:92 Firsi.'20•Nov.17(855956) Pet0.00

Cost:184,30 Aikup:140.00 Fee:11.99 Total:338.29 isc:10.35 T.P.:325.94 - ESI(160.75t CS(08X180.19) Old erke:aao.o4 .5,_ouptrup. Amhyp.mothwmov HaleCo•A Raskielatit Inhibitors Maims) '-'"4-0.-s7"......

Rx:874103 or-2018 15:39

20-Feb-201817:d5 SS

Orlg Rx:864909 Auth:600 Rem:330 (1) Coat:655.92 tillwp;198.78 Fee:11.99 Total:1181489 Pat:6.00

Conditions 7:1:1166°V:112"wantil °API*

Counsel Date: Pharmacist

❑ No Had before, Muir Allergies

ESI: 32-312-INNOVNGIIH293h48 100 TAB ArimIdex 1mg Anastrozole mg Mfr: MIN DIN: 02224135. 164,15/30 on Hand: -45280 Days: 100 I Dr. KeshMirlan, J Docit 01:67128 186 Main Street South NEW RX Brampton ON No Son I e Phone: (905) 456-7774 TAKE 1 TABLET EACH DAY ;4911=874183 Auflu400 ^ Rem:300 (3) Cost:547.17 NIkup:400.00 Paa:11.99 Totall959.16 Pat0.00 T.P.:468.66 • ESI(466,56); CSID121(0.00) Disc:482.00

Dlem299,85

Counsel Dale: _ pharmacist ...__ °Yes n Patient ❑Phone ❑Agent:- 0 No .0 Had before. reason. Alletpies Conditions

Rx:854905 Wed 15440v-2017 12:12 SS

CS: RX.29 5-00030001PF OS: RX.37065•0000200

Rx:854909 Wed 15.Nov-2017 12SS:14

#q3


lk-rv. Ana nalik,- @0001/0002

06-Mar-201810b8

90 TAB Zornig_2.0119 Zolmitriptan 2.5mg . Mfr: AST pI N: 02P8660 90,73/6 on Hard -69940 Days: 90

Dr. Keshmirien, J DWI 01:67128 186 Maki Street South NEW RX Brampton ON No Sod Phone: (905) 466-7774

TAKE 1 TABLET AS DIRECTED WHEN REQUIRED ONCE DAILY Orig Ex:864906 Atith:200 Rern:110 (1) Cost:1.386.95 Mkup:406.29 Fen:11.99 Total:1,78123 Pat:5.00 Disc:143.19 T.P.:1633.04 - ESI(824,01); 0$(091(809.03) OROIDRQ - 3-Ciprelex 10mg $SRI$; ISNRI$15H7-1D AGONISTS DRWORG - 3-04prolex 20mg SOME: 8NRISIEHT•10 AGONISTS • Additional DUE 109tree • Cheek Draft

Counsel Daft. Phermaolat OYes ❑Walt 0 Phone r]Agent U No 0 Hee before. reason: Anemia;

-.Cot rlgiglta


Dr, Koshmlrian, J Doc I01:87126 186 Main Street South NEW RX Brampton ON No Sod Phone: (905) 456-7774 TAKE 1 CAPSULE THREE TIMES DAIL DIRECTED

01PF • • Vit. 01..2111

240 TAB Serormet 200mg - QueliapIne Fumarate 200mg Mir, AZC t DIN' 02236953 203.61/100 on Henn:-310740 Days: 60 Dr:Kashmtrian, J DWI 01:67128 186 Mein Street South No Script Image Brampton ON REFILL (4 Phone: (905) 456-7774 RE 177,---KETTATILET871:-WITE DAILY AS DIRE T oaf, PA:eager ---- Audi:7230- -fterm4130 ( Prey:Oa-Jan-10(8821/2) Ago:56 Firat:15•Ncer•17(8548137)

2) Coot:704.58 Mkup:520.00 Pee:11.99 Total:1,236.6E Pat:0,00 Dhic:20.42 Old Price:1,221.23 T.P.:1216.23 • 681(640.86); C3(138)(576.37) motile • 2-Adopt 54,a OT PROLoNOING OENTSialsErtarete: or Prom., PIM= • 2.0101144 044 QT PROLOMMOO AGENT5105TMPAE: not-- Additional DUE Issues . cheek profile

.4"..pnclitions • •••••

Rx:870523

_ : .312. . GXSPN74M8 c ...... ....-.........-____________ 100 TAB Creator Orng Rosuvastatin Calcium 20 Mg (Creator) 20mg Mk MIN DI : 02-247_163 55.29/30 on Kane: -mos_____-____ Dim 100 ----- Dr. KeetimIriao, J --- 186 Main Street South DocAti01:67128 Brampton ON




Cost:184,30 Aikup:140.00 Fee:11.99 Total:338.29 isc:10.35 T.P.:325.94 - ESI(160.75t CS(08X180.19) Old erke:aao.o4 .5,_ouptrup. Amhyp.mothwmov HaleCo•A Raskielatit Inhibitors Maims) '-'"4-0.-s7"......

Rx:874103 or-2018 15:39

20-Feb-201817:d5 SS


Conditions 7:1:1166°V:112"wantil °API*


❑ No Had before, Muir Allergies

ESI: 32-312-INNOVNGIIH293h48 100 TAB ArimIdex 1mg Anastrozole mg Mfr: MIN DIN: 02224135. 164,15/30 on Hand: -45280 Days: 100 I Dr. KeshMirlan, J Docit 01:67128 186 Main Street South NEW RX Brampton ON No Son I e Phone: (905) 456-7774 TAKE 1 TABLET EACH DAY ;4911=874183 Auflu400 ^ Rem:300 (3) Cost:547.17 NIkup:400.00 Paa:11.99 Totall959.16 Pat0.00 T.P.:468.66 • ESI(466,56); CSID121(0.00) Disc:482.00

Dlem299,85

Counsel Dale: _ pharmacist ...__ °Yes n Patient ❑Phone ❑Agent:- 0 No .0 Had before. reason. Alletpies Conditions

Rx:854905 Wed 15440v-2017 12:12 SS

CS: RX.29 5-00030001PF OS: RX.37065•0000200

Rx:854909 Wed 15.Nov-2017 12SS:14

#q3


lk-rv. Ana nal& - @0001/0002

o6-Mar-2o18 10b8

90 TAB Zornig_2.0119 Zolmitriptan 2.5mg . Mfr: AST pI N: 02P8660 90,73/6 on tient -MD Days: 90

Dr. Keshmirien, J DWI 01:67128 186 Maki Street South NEW RX Brampton ON No Scri Phone: (905) 466-7774 TAKE 1 TABLET AS DIRECTED WHEN REQUIRED ONCE DAILY Orig Ex:864905 Atith:200 Rern:110 (1) Cost:1.386.95 Mkup:406.29 Fen:11.99 Total:1,78123 Pat:5.00 Disc:143.19 T.P.:1633.04 - ESI(824,01); 0$(091(809.03) OROIDRQ - 3-Ciprelex 10mg $SRI$; ISNRI$15H7-1D AGONISTS DRWORG - 3-04prolex 20mg SOME: 8NRISIEHT•10 AGONISTS • Additional DUE 109tree • Cheek Draft

Counsel Dale: Phermadat OYes q Petkot 0 Phone r]Agent U No 0 Hee before. reason: Anemia;

-.Cot rlgiglta


Dr, Keshmtrian, J Doc I01:87126 186 Main Street South NEW RX Brampton ON No Sod Phone: (905) 456-7774 TAKE 1 CAPSULE THREE TIMES DAIL DIRECTED

• •••••

Rx:870523

_ : .312. . GXSPN74M8 c ...... ....-.........-____________ 100 TAB Creator Orng Rosuvastatin Calcium 20 Mg (Creator) 20mg Mk MIN DI : 02-247_163 55.29/30 on Kane: -mos_____-____ Dim 100 ----- Dr. KeetimIriao, J --- 186 Main Street South DocAi01:67128 Brampton ON




Cost:184,30 Aikup:140.00 Fee:11.99 Total:338.29 isc:10.35 T.P.:325.94 - ESI(160.75t CS(08X180.19) Old erke:aao.o4 - ,_oupfrup. Amhyp.mothwmov ItheaCo•A Raskrelate Inhibitors Maims) . '-'......

Rx:874103 or-2018 15:39

20-Feb-201817:d5 SS

01PF • • Vit. 01..2111

240 TAB Serormet 200mg - QueliapIne Fumarate 200mg Mir, AZC t DIN' 02236953 203.61/100 on Henn:-310740 Days: 60 Dr:Kashmtrian, J DWI 01:67128 186 Mein Street South No Script Image Brampton ON REFILL (4 Phone: (905) 456-7774 RE 177,---KETTABLET871:-WITE DAILY AS DIRE T oaf, PA:eager ---- Audi:7230- -ftern:480 ( Prey:Oa-Jan-10(8821/2) Ago:56 Firat:15•Ncer•17(854687)

2) Coot:704.58 Mkup:520.00 Pee:11.99 Total:1,236.6E Pat:0,00 Dhic:20.42 Old Price:1,221.23 T.P.:1216.23 • 681(640.86); C3(08)(576.37) motile • 2-Adopt 54,a OT PROLostairic hOENTSialsEriartrear Nom., PIM= • 2.0101144 044 QT PROLOMMOO asousatUenolliE: not-- Additional DUE lemon . cheek profile

.4"..pnclitions


TL3CD-PU:P."niTH56:itf:io. Conditions 7:1:1166°V:112"wantil °API* -


q No Had MOM WNW Allergies

1111ESI: 01111MMIIIIMMI

32-312-INNOVNGIIH293h48 100 TAB ArimIdex 1mg Anastrozole mg Mfr: MIN DIN: 02224135. 164,15/30 on Hand: -45280 Days: 100 I Dr. KeshMirlan, J Docit 01:67128 186 Main Street South NEW RX Brampton ON No Script IOoage Phone: (905) 456-7774 TAKE 1 TABLET EACH DAY ;4911=874183 Aullu400 ^ Eem:300 (3) Cost:547.17 NIkup:400.00 Pea:11.99 Total:459.16 Pat0.00 T.P.:468.66 • ESI(466,56); CSIDER0.00) Disc:482.00

Dlem299,85

Counsel Dale: Pharmacist ...__ °Yes n Patient q Phone q Agent -

No .0 Had before. reason. Alletpies Conditions

4;4

MD Health Pharmacy Accreditation # 300990

Audit & Exhibits 186 Main St South Brampton, ON L6W 2E2

Exhibit 4: Physician Verification re Dr. Keshmirian

ClaimSecure Inc, Confidential 5

4;4





4;4





clabensecure 1 City Centre Drive

Suite 620 Mississauga ON 15131M2 1-888-479-7587 ext. 3038

Fax: 905-949-3029

To: Dr. Jalal Keshmirian Phone: 905-456-7774 Fax: 905-456-1158

From: Anna Malik, Auditor Date: May 28, 2018

Re: Physician Prescription Verification yes: tklidth.ts WEIL_ CC:

E) Urgent El For Review 0 Please Comment 0 Please Reply 0 Please Recycle

Dear Dr. Keshmirian,

ClaimSecure Inc. manages health benefit claims on behalf of drug plan sponsors, which include employers, insurers and third party administrators (TPAs).

The attached list of claims dispensed by MD Health Pharmacy, paid for by ClaimSecure, has been selected for an audit review. As per our records and prescription review, you are the prescribing physician of those claims.

Could you kindly verify/confirm if you have indeed prescribed the medications listed for the patients by indicating a YES or NO in the space provided on the attached sheets.

Please fax the completed form to my attention once completed.

Should you have any questions or concerns please do not hesitate to contact me.

Thank you, Anna Malik Auditor

c5c/ainisecure

Toll Free 1-888-479-7587 Ext. 3038 Fax: 905-949-3029

The information contained in this transmission is privileged and confidential, and intended only for the use of the individual or entity to whom it is addressed. If yon are not the intended recipient, you are hereby notified that any distribution, copying, disclosure, or taking of any action in reliance on the contents of this transmission is strictly prohibited and review by an individual other than the intended recipient shall not constitute waiver of privilege.

If you have received this transmission in error, please notify the sender immediately and return the original transmission to the sender marked private and confidential.

If all pages are not clearly received, please contact the sender immediately.



Fax: 905-949-3029












c5c/ainisecure

Toll Free 1-888-479-7587 Ext. 3038 Fax: 905-949-3029






Fax: 905-949-3029












c5c/ainisecure

Toll Free 1-888-479-7587 Ext. 3038 Fax: 905-949-3029




Physician Verification - Dr. Keshmirian

.. fit 0 e ;141 0- qiiz:1;- :',7;1 ; TZ:i1P,:;:., •&•-:'! Witt .1)-SYkstPCP Ylr, 1140 . Pa ---' thl' '' ,,f ifeSqlbefID 1 SEROQUEL 200MG 240 60 , 12-Feb-18 868685 ' 67128 2 3

LOSEC 20mg TAB 200 - 100 • 18-Dec-17 860538 67128 SEROQUEL 200MG 240 , 60 ' 18-Dec-17 860556 67128

4 ZOMIG 2.5MG TAB * 90 ' 90 18-Dec-17 860542 ,- 67128 5 CRESTOR 20 MG 100 , 100 18-Dec-17 860572 67128 6 7

ZOMIG RAPIMELT 2.5 MG 100 ' 90 18-Dec-17 ! 860543 67128 Seroquel 300mg Tab i 200 100 18-Dec-17 860557 . 67128

8 SEROQUEL XR 400MG 100 100 18-Dec-17 860558 67128 CRESTOR 40MG TAB —1 100 i 100 18-Dec-17 i 860573 : 67128 . _ _ . ___

10 11

CRESTOR 20 MG 100 100

100 x_20-Nov-17 I 855855 67128 ......._ CRESTOR 40MG TAB 100 ' 20-Nov-17 855856 67128

12 -1.3 14 ......._. 15 16 17

—18 19

SEROQUEL 200MG i 240 , 60 15-Nov-17 854919 1 67128 SEROQUEL 200MG 240 i 60 -1- 15-Nov-17

i 15-Nov-17 , 854887 ' 854939

67128 67128 LOSEC 20mg TAB 200 100

LOSEC 20mg TAB . , 200 100 : 15-Nov-17 854901 67128 ZOMIG 2.5MG TAB * . 90 90 15-Nov-17 85.4874. 67128 ZOMIG 2.5MG TAB * , 90 90 1 15-Nov-17

15-Nov-17 _.

854905 67128 67128 67128 67128

Seroquel i00mg Tab i 200 100 200

100 90

100

: 854888

i

ZOMIG RAPIMELT 2.5 MG1 15-Nov-17 854906 20 Seroquel 300mg Tab i 15-Nov-17 854920 21 22 23

ZOMIG RAPIMELT 2.5 MG 1 100 90 j 15-Nov-17 . 854875 67128 CRESTOR 20 MG 1 100

100 100 15-Nov-17 1 854895

i 854937 67128 ____ 67121

__ _ CRESTOR 20 MG i 100 15-Nov-17

24 _25 :21.6 27 28 I

SEROQUEL XR 400MG I 100 I 100 1 15-Nov-17 15-Nov-17

854922 1 854890

854936

67128 ; SEROQUEL XR 400MG 100 100 67128

67128 CRESTOR 40MG TAB 1 100 100 ' 15-Nov-17 CRESTOR 40MG 40MG TAB 100 100 . 15-Nov-17 - 854894 67128 ARIMIDEX 1mg TAB i 100 100 ' 15-Nov-17 , 854902 67128

29 CRESTOR 20 MG I 100 , 100 8-Nov-17 : 853378 67128 30 I CRESTOR 20 MG ! 100 . 100 8-Nov-17 i 853346 67128 31 SEROQUEL XR 400MG 100 100 i 8-Nov-17 853329 67128 32 I LOSEC 20mg TAB . _ !.._ 33 SEROQUEL 206IVI--G-.

200 100 _.. 60

_....p-Oct-17,... ! 17-Oct-17

. 849608 : 849657

67128 240 : 1 67128

ClaimSecure Inc. Confidential 5/28/2018 Page 1


.. fit 0 e ;141 0- qiiz:1;- :',7;1 ; TZ:i1P,:;:., •&•-:'! Witt .1)-SYkstPCP Ylr, 1140 . Pa ---' thl' '' ,,f ifeSqlbefID 1 SEROQUEL 200MG 240 60 , 12-Feb-18 868685 ' 67128 2 3




8 SEROQUEL XR 400MG 100 100 18-Dec-17 860558 67128 CRESTOR 40MG TAB —1 100 i 100 18-Dec-17 i 860573 : 67128 . _ _ . ___

10 11



12 -1.3 14 ......._. 15 16 17

—18 19


i 15-Nov-17 , 854887 ' 854939

67128 67128 LOSEC 20mg TAB 200 100

LOSEC 20mg TAB . , 200 100 : 15-Nov-17 854901 67128 ZOMIG 2.5MG TAB * . 90 90 15-Nov-17 85.4874. 67128 ZOMIG 2.5MG TAB * , 90 90 1 15-Nov-17

15-Nov-17 _.

854905 67128 67128 67128 67128


100 90

100

: 854888

i


ZOMIG RAPIMELT 2.5 MG 1 100 90 j 15-Nov-17 . 854875 67128 CRESTOR 20 MG 1 100

100 100 15-Nov-17 1 854895

i 854937 67128 ____ 67121

__ _ CRESTOR 20 MG i 100 15-Nov-17

24 _25 :21.6 27 28 I


854922 1 854890

854936

67128 ; SEROQUEL XR 400MG 100 100 67128


29 CRESTOR 20 MG I 100 , 100 8-Nov-17 : 853378 67128 30 I CRESTOR 20 MG ! 100 . 100 8-Nov-17 i 853346 67128 31 SEROQUEL XR 400MG 100 100 i 8-Nov-17 853329 67128 32 I LOSEC 20mg TAB . _ !.._ 33 SEROQUEL 206IVI--G-.

200 100 _.. 60

_....p-Oct-17,... ! 17-Oct-17

. 849608 : 849657

67128 240 : 1 67128



.. fit 0 e ;141 0- qiiz:1;- :',7;1 ; TZ:i1P,:;:., •&•-:'! Witt .1)-SYkstPCP Ylr, 1140 . Pa ---' thl' '' ,,f ifeSqlbefID 1 SEROQUEL 200MG 240 60 • 12-Feb-18 868685 67128 2 3




8 SEROQUEL XR 400MG 100 100 18-Dec-17 860558 67128 CRESTOR 40MG TAB —1 100 i 100 18-Dec-17 i 860573 : 67128 _ ___

10 11



12 -1.3 14 ......._. 15 16 17

—18 19


i 15-Nov-17 , 854887 ' 854939

67128 67128 LOSEC 20mg TAB 200 100

LOSEC 20mg TAB ; , 200 100 : 15-Nov-17 854901 67128 ZOMIG 2.5MG TAB * . 90 90 15-Nov-17 85.4874. 67128 ZOMIG 2.5MG TAB * ; 90 90 1 15-Nov-17

15-Nov-17 _.

854905 67128 67128 67128 67128


100 90

100

: 854888

i


ZOMIG RAPIMELT 2.5 MG 1 100 90 j 15-Nov-17 . 854875 67128 CRESTOR 20 MG 1 1 100

100 100 15-Nov-17 _ ....._. 1 854895

i 854937 . 67128 ___

67128 • — .__..

CRESTOR 20 MG i 100 15-Nov-17 24

_25 :21.6 27 28 I


854922 1 854890

854936

67128 ; SEROQUEL XR 400MG 100 100 67128


29 CRESTOR 20 MG I 100 , 100 8-Nov-17 : 853378 67128 30 I CRESTOR 20 MG ! 100 . 100 8-Nov-17 i 853346 67128 31 SEROQUEL XR 400MG 100 100 i 8-Nov-17 853329 67128 32 I LOSEC 20mg TAB . _ i.._ 33 SEROQUEL 2061V1--G-.

200 100 _.. 60

_. p-Oct-17,... ! 17-Oct-17

. 849608 : 849657

67128 240 : 1 67128


Da: Oiler lit.

37 38 39 40 ;


34. 35 . 36 ;

41 42.1 IZOMIG RAPIMELT2.5 MG(_ 100 I

43' 1CRESTOR 20 MG I 100 1

44 ! !SEROQUEL XR 400MG 1 100 !

--45: SEROQUEl. XR 400MG 100 .

46 , 1CRESTOR 40MG TAB 100 '

47 1 ICRESTOR 40MG TAB 100 , ------1 48 I IARIMIDEX 1mg TAB 100 i

49 !ZOMIG 2.5MG TAB * 90 :

501 IZOMIG 2.5MG TAB * 90 i

51 J !ZOMIG RAPIMELT2.5 MG I 100 '

52 I IZOMIG RAPIMELT2.5 MG; 100

53 I ;ZOMIG 2.5MG TAB * ; 90 :

54 'ZOMIG RAPIMELT 2.5 MG i 100

55 J ;ZOMIG RAPIMELT 2.5 MGI 100 '

56 E IZOMIG 2.5MG TAB * ; 90

57 ':ZOMIG 2.5MG TAB * I 90

58 1 IZOMIG RAPIMELT 2,5 MG1 100 r-

59 i IZOMIG RAPIMELT 2.5 MG! 100

60 I IZOMIG RAPIELT 2.5 MG! 100 i

61 IZOMIG 2.5MG TAB * 90

62 'ZOMIG 2,5MG TAB * 90

i 63 SEROQUEL 200MG 240

64 ! (ZQMIG 2.5MG TAB * 90

65 i LOSEC 20mg TAB 200 _..! 66 ' ZOMIG RAPIMELT2.5 M61 100

ClaimSecure Inc. Confidential 5/28/2018

iZOMIG 2.5MG TAB * 90 !SEROQUEL 200MG 240 I LOSEC 20mgTAB , 200 ! ZOMIG 2.5MG TAB * 90 . iSeroquel 300mg Tab 200 : IZOMIG RAPIMELT2.5 MG; 100 * iSeroquel 300mg Tab i 200 ICRESTOR 20 MG I 100

0#0:ettP

i —

Page 2

90 17-Oct-17 ! 849642 67128 60

100 ~ 17-Oct-17 17-Oct-17

: 849621 i 849647

67128 67128

90 17-Oct-17 849605 67128 100 ! , 17-Oct-17 849655 67128 100 17-Oct-17 ' 849643

I 849620 67128

100 17-Oct-17 67128 100 17-0447 I 849632 67128 100 17-Oct-17 ! 849606 67128 100 17-Oct-17 ! 849667 67128 100 17.Oct-17 s 849622 67128 100 17-Oct-17 849658 67128 100 i 17-Oct-17 : 849668 67128 100 100 "

17-Oct-17 i 849631 ' 67128 17-Oct-17 ; 849602 , 67128

90 : 13-Oct-17 I 849080 : 67128 90 ' 13-Oct-17 849117

100 13-Oct-17 ! 849079 67128 100 13-Oct-17 ; 849118 67128 90 11-Oct-17 ' 848704 67128

100 11-Oct-17 848649 67128 100 11-Oct-17

-,- 848705 67128 67128 90 11-Oct-17 848650 1

90 11-Oct-17 848818 i 67128 100 11-Oct-17 : 848817 j 67128 100 11-Oct-17 848742 67128 100 11.Oct-17 = 848780 67128 90 11-Oct-17 ' 848743 67128 90 11-Oct-17 848781 67128 60 6-Oct-17 I 848190 67128

67128 90 ' 6-Oct-17 ; 848200 100 6-Oct-17 I 848194 I— 67128 100 6-Oct-17 848199 , 67128

Da: Oiler lit.

37 38 39 40 ;


34. 35 . 36 ;

41 42.1 IZOMIG RAPIMELT2.5 MG(_ 100 I

43' 1CRESTOR 20 MG I 100 1

44 ! !SEROQUEL XR 400MG 1 100 !

--45: SEROQUEl. XR 400MG 100 .

46 , 1CRESTOR 40MG TAB 100 '

47 1 ICRESTOR 40MG TAB 100 , ------1 48 I IARIMIDEX 1mg TAB 100 i

49 !ZOMIG 2.5MG TAB * 90 :

501 IZOMIG 2.5MG TAB * 90 i

51 J !ZOMIG RAPIMELT2.5 MG I 100 '

52 I IZOMIG RAPIMELT2.5 MG; 100

53 I ;ZOMIG 2.5MG TAB * ; 90 :

54 'ZOMIG RAPIMELT 2.5 MG i 100

55 J ;ZOMIG RAPIMELT 2.5 MGI 100 '

56 E IZOMIG 2.5MG TAB * ; 90

57 ':ZOMIG 2.5MG TAB * I 90

58 1 IZOMIG RAPIMELT 2,5 MG1 100 r-

59 i IZOMIG RAPIMELT 2.5 MG! 100

60 I IZOMIG RAPIELT 2.5 MG! 100 i

61 IZOMIG 2.5MG TAB * 90

62 'ZOMIG 2,5MG TAB * 90

i 63 SEROQUEL 200MG 240

64 ! (ZQMIG 2.5MG TAB * 90

65 i LOSEC 20mg TAB 200 _..! 66 ' ZOMIG RAPIMELT2.5 M61 100

ClaimSecure Inc. Confidential 5/28/2018

iZOMIG 2.5MG TAB * 90 !SEROQUEL 200MG 240 I LOSEC 20mgTAB , 200 ! ZOMIG 2.5MG TAB * 90 . iSeroquel 300mg Tab 200 : IZOMIG RAPIMELT2.5 MG; 100 * iSeroquel 300mg Tab i 200 ICRESTOR 20 MG I 100

0#0:ettP

i —

Page 2

90 17-Oct-17 ! 849642 67128 60

100 ~ 17-Oct-17 17-Oct-17

: 849621 i 849647

67128 67128

90 17-Oct-17 849605 67128 100 ! , 17-Oct-17 849655 67128 100 17-Oct-17 ' 849643

I 849620 67128

100 17-Oct-17 67128 100 17-0447 I 849632 67128 100 17-Oct-17 ! 849606 67128 100 17-Oct-17 ! 849667 67128 100 17.Oct-17 s 849622 67128 100 17-Oct-17 849658 67128 100 i 17-Oct-17 : 849668 67128 100 100 "

17-Oct-17 i 849631 ' 67128 17-Oct-17 ; 849602 , 67128

90 : 13-Oct-17 I 849080 : 67128 90 ' 13-Oct-17 849117

100 13-Oct-17 ! 849079 67128 100 13-Oct-17 ; 849118 67128 90 11-Oct-17 ' 848704 67128

100 11-Oct-17 848649 67128 100 11-Oct-17

-,- 848705 67128 67128 90 11-Oct-17 848650 1

90 11-Oct-17 848818 i 67128 100 11-Oct-17 : 848817 j 67128 100 11-Oct-17 848742 67128 100 11.Oct-17 = 848780 67128 90 11-Oct-17 ' 848743 67128 90 11-Oct-17 848781 67128 60 6-Oct-17 I 848190 67128

67128 90 ' 6-Oct-17 ; 848200 100 6-Oct-17 I 848194 I— 67128 100 6-Oct-17 848199 , 67128

Day gs..9101 arms lit a

34. !ZOMIG 2.5MG TAB * 90 90 17-Oct-17 I 849642 67128

35 , !SEROQUEL 200MG 240 60 17-Oct-17 : 849621 1 67128

36 LOSEC 20mg TAB 200 ! 100 ~ 17-Oct-17 849647 I 67128

37 ZOMIG 2.5MG TAB * 90 90 17-Oct-17 849605 67128

38 iSeroque1300mg Tab 200 100 , 17-Oct-17 849655 67128 39 IZOMIG RAPIMELT 2.5 MG 100 100 17-Oct-17 ' 849643 67128

40 ; iSeroquel 300mg Tab i 200 100 17-Oct-17 i 849620 67128

41 ICRESTOR 20 MG I 1 100 100 17-Oct-17 849632 67128

IZOMIG RAPIMELT 2.5 MG(- 100 1 100 17-Oct-17 1 849606 67128 421 43 1 1CRESTOR 20 MG ,

1 100 ; i

100 17-Oct-17 849667 67128

44 SEROQUEL XR 400MG 1 100 ! 100 17.Oct-17 849622 67128

45 SEROQUEl. XR 400MG 100 . 100 17-Oct-17 849658 67128

46 ICRESTOR 40MG TAB 100 100 17-Oct-17 849668 67128

47 I CRESTOR 40MG TAB 100 100 17-Oct-17 849631 67128

48 ARIMIDEX 1mg TAB 100 100 " 17-Oct-17 ; 849602 67128 49 IZOMIG 2.5MG TAB * 90 • 90 13-Oct-17 I 849080 : 67128

50_1 IZOMIG 2.5MG TAB * 90 90 13-Oct-17 ; 849117

51 J IZOMIG RAPIMELT 2.5 MG 100 100 13-Oct-17 849079 67128

52 1 !ZOMIG RAPIMELT 2.5 MG! 100 100 13-Oct-17 , 849118 67128 •

53 I ;ZOMIG 2.5MG TAB * ; 90 : 90 11-Oct-17 ' 848704 67128

54 'ZOMIG RAPIMELT 2.5 MG i 100 100 11-Oct-17 848649 67128

_55.1 ;ZOMIG RAPIMELT 2.5 MGI 100 100 11-Oct-17 848705 67128 IZOMIG 2.5MG TAB * ; 90 90 11-Oct-17 56 848650 1 67128

57 'ZOMIG 2.5MG TAB * I 90 90 11-Oct-17 848818 i 67128

58 1 1ZOMIG RAPIMELT MG; 100 r-

100 11-Oct-17 , 848817 i 67128

59 ! jZOMIG RAPIMELT 2.5 MG: 100 j 100 11-Oct-17 848742 67128

60 IZOMIG RAPIMELT 2.5 MG 100 i 100 11.Oct-17 = 848780 67128

61 2.5MG TAB * 1 90 90 11-Oct-17 ' 848743 67128

62 'ZOMIG 2,5MG TAB * 90 90 11-Oct-17 848781 i 67128

63 SEROQUEL 200MG 240 60 6-Oct-17 848190 67128

64 " (My)* 2.5MG TAB * 90 90 ' 6-Oct-17 ; 848200 i 67128

65 ; LOSEC 20mg TAB 200 100 6-Oct-17 848194 I- 67128

66 ZOMIG RAPIMELT 2.5 M61 100 100 6-Oct-17 848199 , 67128




=#;•Fir#-NarnA 11•1*Ititil - 7; — — r--- ,,_E:,;,..4:4cokiitity DAWSOPISIODilsiteiWD1 e 9_,,,:ii. Ctik500ii,

67128 1 67 1Seroque1300mgTab i 200 I 100 6-Oct-17 , 848189 68 69

i CRESTOR 20 MG ; 100 100 6-Oct-17 ' 848212 67128 CRESTOR 40MG TAB 1 100 100 6-Oct-17 I 848211 1 67128 1

70 iSEROQUEL XR 400MG 100 100 6-Oct-17 848191 67128 71 iARIMIDEX 1mg TAB ! 100 100 6-Oct-17 848196 1 67128 72 73

'ZOMIG 2.5MG TAB * 90 ! V 90 !

90 26-Sep-17 , 846734 , 67128 i ZOMIG 2.5MG TAB * 90 26-Sep-17 846700

-

67128 1 74 75 76

:ZOMIG RAPIMELT 2.5 MG 100 ! 100 100

26-Sep-17 T 26-Sep-17

846733 846699

67128 67128

- i ZOMIG RAPIMELT 2.5 MG ZOMIG 2.5MG TAB *

100 ; ; 90

100 i 90

' 13-Sep-17 ' 845350 . 67128

77 78 79

1.ZOMIG RAP1MELT 2.5 MG1 100 13-Sep-17 845349 67128 (ZOMIG RAPIMELT 2.5 MG! 100 ' 100 i 13-Sep-17 • 845322 67128 1ZOMIG 2.5MG TAB * ! 90 ; 90 1 13-Sep-17 845323 t 67128

80 1SEROQUEL 200MG • 240 60 12-Sep-17 845006 i 67128 81 82 83

' ZOMIG 2.5MG TAB * 90 90 ! 12-Sep-17 845025 : 67128 ISEROQUEL 200MG 240 60 12-Sep-17 845036 67128 I20MIG 2.5MG TAB * 90 90 12-Sep-17 844999 67128

84 85 86

LOSEC 20mg TAB j 200 ;i 100 ; 12-Sep-17 845032 1 67128 _ 1CRESTOR 40MG TAB 100 i 100 ! 12-Sep-17

-1844990 67128

ICRESTOR 40MG TAB 100 t 100 12-Sep-17 845017 I 67128 87 1ZOMIG RAPIMELT 2.5 MG 100 ! 100 12-Sep-17 844998 ; 67128 88 CRESTOR 20 MG 100 ; 100 12-Sep-17 845018 i 67128

67128 89 90

,Seroquel 300mg Tab 200 100 i 12-Sep-17 845005

Seroquel 300mg Tab 200 100 12-Sep-17 i 845035 67128 91 92 93

I CRESTOR 20 MG ; 100 100 1 12-Sep-17 1 844991 ! 67128 IZOMIG RAPIMELT 2.5 MGI 100 I 100 !

• 12-Sep-17 ! 845024 67128

!SEROQUEL XR 400MG , 100 100 12-Sep-17 845007 67128 94 !SEROQUELXR 400MG ' 100 100 12-Sep-17 i 845037 ' 67128 95 96 97 98 ;

•

ARIMIDEX lmg TAB ! 100 ' 100 12-Sep-17 844997 . 67128 LOSEC 20mg TAB ' 200

90 : 100

90 . 12-Sep-17 845002

: 844476 67128 67128

.. . . _ ' ZOMIG 2.5MG TAB * 8-Sep-17 .ZOMIG 2.5MG TAB * • 90 . 90 8-Sep-17 ! 844414 ; 67128

99 ZOMIG RAPIMELT 2.5 MG1 100 100 8-Sep-17 844475 ; 67128

ClaimSecure Inc. Confidential 5128/2018 Page 3


=#;•Fir#-NarnA 11•1*Ititil - 7; — — r--- ,,_E:,;,..4:4cokiitity DAWSOPISIODilsiteiWD1 e 9_,,,:ii. Ctik500ii,

67128 1 67 1Seroque1300mgTab i 200 I 100 6-Oct-17 , 848189 68 69

i CRESTOR 20 MG ; 100 100 6-Oct-17 ' 848212 67128 CRESTOR 40MG TAB 1 100 100 6-Oct-17 I 848211 1 67128 1

70 iSEROQUEL XR 400MG 100 100 6-Oct-17 848191 67128 71 iARIMIDEX 1mg TAB ! 100 100 6-Oct-17 848196 1 67128 72 73

'ZOMIG 2.5MG TAB * 90 ! V 90 !

90 26-Sep-17 , 846734 , 67128 i ZOMIG 2.5MG TAB * 90 26-Sep-17 846700

-

67128 1 74 75 76

:ZOMIG RAPIMELT 2.5 MG 100 ! 100 100

26-Sep-17 T 26-Sep-17

846733 846699

67128 67128

- i ZOMIG RAPIMELT 2.5 MG ZOMIG 2.5MG TAB *

100 ; ; 90

100 i 90

' 13-Sep-17 ' 845350 . 67128

77 78 79

1.ZOMIG RAP1MELT 2.5 MG1 100 13-Sep-17 845349 67128 (ZOMIG RAPIMELT 2.5 MG! 100 ' 100 i 13-Sep-17 • 845322 67128 1ZOMIG 2.5MG TAB * ! 90 ; 90 1 13-Sep-17 845323 t 67128

80 1SEROQUEL 200MG • 240 60 12-Sep-17 845006 i 67128 81 82 83

' ZOMIG 2.5MG TAB * 90 90 ! 12-Sep-17 845025 : 67128 ISEROQUEL 200MG 240 60 12-Sep-17 845036 67128 I20MIG 2.5MG TAB * 90 90 12-Sep-17 844999 67128

84 85 86

LOSEC 20mg TAB j 200 ;i 100 ; 12-Sep-17 845032 1 67128 _ 1CRESTOR 40MG TAB 100 i 100 ! 12-Sep-17

-1844990 67128

ICRESTOR 40MG TAB 100 t 100 12-Sep-17 845017 I 67128 87 1ZOMIG RAPIMELT 2.5 MG 100 ! 100 12-Sep-17 844998 ; 67128 88 CRESTOR 20 MG 100 ; 100 12-Sep-17 845018 i 67128

67128 89 90

,Seroquel 300mg Tab 200 100 i 12-Sep-17 845005

Seroquel 300mg Tab 200 100 12-Sep-17 i 845035 67128 91 92 93

I CRESTOR 20 MG ; 100 100 1 12-Sep-17 1 844991 ! 67128 IZOMIG RAPIMELT 2.5 MGI 100 I 100 !

• 12-Sep-17 ! 845024 67128

!SEROQUEL XR 400MG , 100 100 12-Sep-17 845007 67128 94 !SEROQUELXR 400MG ' 100 100 12-Sep-17 i 845037 ' 67128 95 96 97 98 ;

•

ARIMIDEX lmg TAB ! 100 ' 100 12-Sep-17 844997 . 67128 LOSEC 20mg TAB ' 200

90 : 100

90 . 12-Sep-17 845002

: 844476 67128 67128

.. . . _ ' ZOMIG 2.5MG TAB * 8-Sep-17 .ZOMIG 2.5MG TAB * • 90 . 90 8-Sep-17 ! 844414 ; 67128

99 ZOMIG RAPIMELT 2.5 MG1 100 100 8-Sep-17 844475 ; 67128



=#; • orst- Name '' --stliatil - ,.... — - -.Drug:_-_._,,..i3A-poiritity DAW.440) 10 filen,FfP,a_ 0 I 100 6-Oct-17

...:04.;

, 848189 04--q0010;

67128 1 67 ISeroque1300mgTab , 200 68 i CRESTOR 20 MG ; 100 100 6-Oct-17 ' 848212 , 67128 69 CRESTOR 40MG TAB 1 100 100 6-Oct-17 I 848211 I 67128 70 iSEROQUEL XR 400MG 100 100 6-Oct-17 848191 i 67128 71 iARIMIDEX 1mg TAB ! 100 100 6-Oct-17 848196 1 67128 72 73

'ZOMIG 2.5MG TAB * 90 90

90 26-Sep-17 , 846734 , 67128 i ZOMIG 2.5MG TAB * 90 26-Sep-17 846700 67128 1

74 75 76

:ZOMIG RAPIMELT 2.5 MG 100 100 100

26-Sep-17 T 26-Sep-17

846733 846699 -

67128 67128

- i ZOMIG RAPIMELT2.5 MG ZOMIG 2.5MG TAB *

100 ; 90

100 i 90

' 13-Sep-17 ' 845350 , 67128

77 78 79

ZOMIG RAPIMELT2.5 MG1 100 13-Sep-17 845349 67128 (ZOMIG RAPIMELT2.5 MG! 100 100 i 13-Sep-17 ; 845322 ' 67128 1ZOMIG 2.5MG TAB * 90 ; 90 13-Sep-17 845323 t 67128

80 1SEROQUEL 200MG , 240 60 12-Sep-17 845006 i 67128 81 82 83

' ZOMIG 2.5MG TAB * 90 90 12-Sep-17 845025 : 67128 ISEROQUEL 200MG 240 , 60 12-Sep-17 845036 67128 120MIG 2.5MG TAB * 90 90 12-Sep-17 844999 67128

84 85 86

LOSEC 20mg TAB j 200 1i 100 12-Sep-17 845032 1 67128 _

1CRESTOR 40MG TAB 100 i 100 12-Sep-17 -1844990 67128

ICRESTOR 40MG TAB 100 t 100 12-Sep-17 845017 I 67128

87 1ZOMIG RAPIMELT 2.5 MG 100 ! 100 12-Sep-17 844998 ' 67128 88 CRESTOR 20 MG 100 : 100 12-Sep-17

12-Sep-17 ; 845018 i 845005 i

67128 67128 • 89

90 ,Seroquel 300mg Tab 200 100 'Seroquel 300mg Tab 200 100 12-Sep-17 i 845035 ! 67128

91 92 93

1CRESTOR 20 MG 100 100 1 12-Sep-17 1 844991 ! 67128 IZOMIG RAPIMELT 2.5 MGI 100 ! 100 !

• 12-Sep-17 ! 845024 1 67128

!SEROQUEL XR 400MG , 100 100 12-Sep-17 ' 845007 67128 94 ISEROQUELXR 400MG ' 100 100 12-Sep-17 i 845037 ' 67128 95 • 96 97 98 i

ARIMIDEX lmg TAB , 100 ' 100 12-Sep-17 844997 . 67128 LOSEC 20mg TAB ' 200

90 : 100

90 . !

12-Sep-17 845002 844476 '

67128 67128

.. . __. ' ZOMIG 2.5MG TAB * 8-Sep-17 : .ZOMIG 2.5MG TAB * • 90 . 90 8-Sep-17 ! 844414 ; 67128

99 i ZOMIG RAPIMELT2.5 MG 100 i 100 8-Sep-17 844475 : 67128



ClalmSecure Inc. Confidential 5/28/2018 Page 4

67128

—

67128 67128 67128 67128

TimNaltie !Last110)Wej, ;iMailRfOginEa CiOW:§400! y g'F*N0170 :ZOMIG RAP(MELT 2.5 MG' 100 100 8-Sep-17 844413 j SEROQUEL 200MG 240 60 6-Sep-17 aitOQUEL 200iV1G ' 240 ! 60 6-Sep-17 844186

103 LOSEC 20mg TAB 200 f 100 1 6-Sep-17 844160 _ 104 I.LOSEC 20mg TAB I 200 100 6-Sep-17 1 844232 105 120MIG 2.5MG TAB * 90 90 6-Sep-17 ' 844217 106 !ZOMIG 2.5MG TAB * I 90 90 i 6-Sep-17 844162 107 !Servo ue I 300mg Tab I 200 " 100 6-Sep-17 : 844185 1

108 ;ZOMIG RAPIMELT 2.5 MGI 100 100 6-Sep-17 844216 I 109: lSeroquel 300mg Tab 1 200 100 6-Sep-17 844224 1 1101 I CRESTOR 20 MG 1 100 1 100 6-Sep-17 844207 111' IZOMIG RAPIMELT 2.5 MG! 100 I 100 ; 6-Sep-17 j 844163 I 112; ICRESTOR 20 MG i 100 I 100 6-Sep-17 844174 1131 1SEROQUEL XR 400MG ' 100 100 i 6-Sep-17 844226 j 114: CRESTOR 40MG TAB 100 1 100 ; 6-Sep-17 844173 115; ICRESTOR 40MG TAB 100 100 ! 6-Sep-17 . 844206 i 1161 ISEROQUEL XR 400MG 100 ' 100 l 6-Sep-17 844187 1171 IARIMIDEX 1mg TAB 100 • 100 1 6-Sep-17 844161 118 I S EROQUEL 200MG 1 240 1 60 6-Sep-17 844307: 119i I SEROQUEL 200MG 240 i 60 6-Sep-17 1 844272 , 1201 LOSEC 20mg TAB ; 200 ; 100 i 6-Sep-17 - 844245 ' 121: LOSEC 20mg TAB i 200 100 I 6-Sep-17 844291 i 1221 ZOMIG 2.5MG TAB* 90 90 6-Sep-17 844302 t 123' ;ZOMIG 2.5MG TAB * 90 " 90 6-Sep-17 844249 12Z Seroquel 300mg Tab : 200 I 100 : 6-Sep-17 844306 125i ;ZOMIG RAPIMELT 2.5 MG; 100 : 100 ! 6-Sep-17

J

844248 iSeroquel 300mg Tab 200 1 100 6-Sep-17 844271--;

1271 IZOMIG RAPIMELT 2.5 MG 100 ' 100 6-Sep-17 844301 128; ICRESTOR 20 MG 100 , 100 6-Sep-17 844269

129i iSEROQUEL XR 400MG ' 100 ; 100 1 6-Sep-17 844273

1301 !CRESTOR 20 MG : 100 100 6-Sep-17 844288

131! CRESTOR 40MG TAB 100 ! 100 f 6-Sep-17 844268

132! CRESTOR 40MG TAB 100 100 i 6-Sep-17 : 844287 ,

67128 • 67128 67128 67128 67128 67128 1

— 67128 ;1 67128 67128

67128 ' 67128 67128

. 67128 67128 67128 . . ...__ 67128 67128 67128 67128 67128 67128 67128 67128 67128 67128

67128 67128_._ 67128


ClalmSecure Inc. Confidential 5/28/2018 Page 4

67128

—

67128 67128 67128 67128

TimNaltie !Last110)Wej, ;iMailRfOginEa CiOW:§400! y g'F*N0170 :ZOMIG RAP(MELT 2.5 MG' 100 100 8-Sep-17 844413 j SEROQUEL 200MG 240 60 6-Sep-17 aitOQUEL 200iV1G ' 240 ! 60 6-Sep-17 844186

103 LOSEC 20mg TAB 200 f 100 1 6-Sep-17 844160 _ 104 I.LOSEC 20mg TAB I 200 100 6-Sep-17 1 844232 105 120MIG 2.5MG TAB * 90 90 6-Sep-17 ' 844217 106 !ZOMIG 2.5MG TAB * I 90 90 i 6-Sep-17 844162 107 !Servo ue I 300mg Tab I 200 " 100 6-Sep-17 : 844185 1

108 ;ZOMIG RAPIMELT 2.5 MGI 100 100 6-Sep-17 844216 I 109: lSeroquel 300mg Tab 1 200 100 6-Sep-17 844224 1 1101 I CRESTOR 20 MG 1 100 1 100 6-Sep-17 844207 111' IZOMIG RAPIMELT 2.5 MG! 100 I 100 ; 6-Sep-17 j 844163 I 112; ICRESTOR 20 MG i 100 I 100 6-Sep-17 844174 1131 1SEROQUEL XR 400MG ' 100 100 i 6-Sep-17 844226 j 114: CRESTOR 40MG TAB 100 1 100 ; 6-Sep-17 844173 115; ICRESTOR 40MG TAB 100 100 ! 6-Sep-17 . 844206 i 1161 ISEROQUEL XR 400MG 100 ' 100 l 6-Sep-17 844187 1171 IARIMIDEX 1mg TAB 100 • 100 1 6-Sep-17 844161 118 I S EROQUEL 200MG 1 240 1 60 6-Sep-17 844307: 119i I SEROQUEL 200MG 240 i 60 6-Sep-17 1 844272 , 1201 LOSEC 20mg TAB ; 200 ; 100 i 6-Sep-17 - 844245 ' 121: LOSEC 20mg TAB i 200 100 I 6-Sep-17 844291 i 1221 ZOMIG 2.5MG TAB* 90 90 6-Sep-17 844302 t 123' ;ZOMIG 2.5MG TAB * 90 " 90 6-Sep-17 844249 12Z Seroquel 300mg Tab : 200 I 100 : 6-Sep-17 844306 125i ;ZOMIG RAPIMELT 2.5 MG; 100 : 100 ! 6-Sep-17

J

844248 iSeroquel 300mg Tab 200 1 100 6-Sep-17 844271--;

1271 IZOMIG RAPIMELT 2.5 MG 100 ' 100 6-Sep-17 844301 128; ICRESTOR 20 MG 100 , 100 6-Sep-17 844269

129i iSEROQUEL XR 400MG ' 100 ; 100 1 6-Sep-17 844273

1301 !CRESTOR 20 MG : 100 100 6-Sep-17 844288

131! CRESTOR 40MG TAB 100 ! 100 f 6-Sep-17 844268

132! CRESTOR 40MG TAB 100 100 i 6-Sep-17 : 844287 ,

67128 • 67128 67128 67128 67128 67128 1

— 67128 ;1 67128 67128

67128 ' 67128 67128

. 67128 67128 67128 . . ...__ 67128 67128 67128 67128 67128 67128 67128 67128 67128 67128

67128 67128_._ 67128


5/28/2018 Page 4 ClalmSecure Inc. Confidential

eT?•;•-: ;Quantity TiNt:Nairie M Dispense=[ !Lastlila)niaj• Ci4rig§aPpfy (!i*cfrili'09D

:ZOMIG RAP(MELT 2.5 MG 100 100 8-Sep-17 844413 j 67128 SEROQUEL 200MG 240 60

60 6-Sep-17 844225 1 67128

200MG 240 ! 6-Sep-17 844186 67128 103 LOSEC 20mg TAB 200 100 i 6-Sep-17 ; 844160 _ 67128 104 1•LOSEC 20mg TAB C 200 100 1 6-Sep-17 844232 67128 105 106

120MIG 2.5MG TAB * 90 90 90

----; : 1

6-Sep-17 6-Sep-17

' 844217 67128 844162 67128 !ZOMIG 2.5MG TAB * — 90

107 lSeroquel 300mg Tab I 200 ' 100 ' 6-Sep-17 844185 1 ; 67128 108 ;ZOMIG RAPIMELT 2.5 MGi 100 100 6-Sep-17 : 844216 I 67128 109 iSeroquel 300mg Tab 1 200 100 6-Sep-17 844224 1 67128 1101 I CRESTOR 20 MG 100 1 100 1 6-Sep-17 844207 67128 111 4ZOMIG RAPIMELT 2.5 MG, 100 I 100 6-Sep-17 j 844163 67128 1121 ICRESTOR 20 MG i 100 I 100 6-Sep-17 844174 67128 113; ISEROQUEL XR 400MG ' 100 100 6-Sep-17 844226 j 67128 114: CRESTOR 40MG TAB 100 1 100 6-Sep-17 844173 67128 115 ICRESTOR 40MG TAB 100 100 ! 6-Sep-17 . 844206 i 67128 116. ISEROQUEL XR 400MG 100 ' 100 l 6-Sep-17 i 844187 67128 117. IARIMIDEX 1mg TAB 100 • 100 1 6-Sep-17 i 844161 67128 118 I S EROQUEL 200MG 1 240 60 ; 6-Sep-17 • 844307: 67128 119k I SEROQUEL 200MG 240 60 6-Sep-17 I 844272 , 67128 120, LOSEC 20mg TAB ; 200 100 i 6-Sep-17 - 844245 ' 67128 121 LOSEC 20mg TAB 200 : 100 I 6-Sep-17 844291 I 67128 122 ZOMIG 2.5MG TAB* 90 90 6-Sep-17 844302 i 67128 123 ;ZOMIG 2.5MG TAB * 90 90 6-Sep-17 844249 l 67128

iSeroquel 300mg Tab : 200 I 100 . 6-Sep-17 844306 1 67128 125j ;ZOMIG RAPIMELT 2.5 MG; 100 : 100 6-Sep-17 844248 ; 67128 1261 iSeroquel 300mg Tab 200 1 100 6-Sep-17 J 844271.--1 ^ 67128 1271 IZOMIG RAPIMELT 2.5 MG 100 100 6-Sep-17 844301 67128 128' ICRESTOR 20 MG 100 , 100 6-Sep-17 844269 ! 67128 1291 iSEROQUEL XR 400MG 100 ; 100 i 6-Sep-17 . 844273 ; 67128 1301 !CRESTOR 20 MG : 100 100 6-Sep-17 - 844288 , 67128 131. CRESTOR 40MG TAB 100 . ; 100 f 6-Sep-17 i 844268 67128

CRESTOR 40MG TAB 100 6-Sep-17 : 844287 , 67128 132! i 100 i

•

•

1

I 100

100

• 240

1SEROQUEL XR 400MG

:ARIMIDEX 1mg TAB SEROQUEL 200MG •

LOSEC 20mg TAB

90

100 200

;ZOMIG 2.5MG TAB * !ZOMIG RAPIMELT 2.5 MG 1 iSeroquel 300mg Tab

100 I ,ARIMIDEX lmg TAB -

90 ZOMIG 2.5MG TAB



--Actu-knotirOweso restri er:1 i43)1Sferate:

ISEROQUEL XR 400MG 100

iSEROQUEL 200MG : 240

LOSEC 20mg TAB ! 200 1 SEROQUEL 200MG

. 240

LOSEC 20mg TAB

,

200

ZOMIG 2.5MG TAB 90

ISEROQUEL XR 400MG 100 • ISeroquel 300mg Tab 200 ; ZOMIG RAPIMELT 2.5 MG! 100 Seroquel 300mg Tab 200 CRESTOR 20 MG 100_,

CRESTOR 20 MG s 100

;ZOMIG RAPIMELT 2.5 MG; 100

;CRESTOR 40MG TAB 100


ICRESTOR 40MG TAB ; 100 !

ARIMIDEX 1mg TAB - 100 IZOMIG 2.5MG TAB * : 90 .

ZOMIG 2.5MG TAB_* 90

ZOMIG RAPIMELT 2.5 MG; 100

ZOMIG RAPIMELT 2.5 MG 100 i

SEROQUEL 200MG -1 240 SEROQUEL 200MG 240 !

LOSEC 20mg TAB 2

100 6-Sep-17 844308 67128 100 6-Sep-17 844247 67128 60 - 1-Sep-17 843785 67128

100 1-Sep-17 843787 67128 90 1-Sep-17 843779 67128

100 1-Sep-17 843778 67128 100 I 1-Sep-17 843784 i 67128 100 1-Sep-17 843777 67128

100 1-Sep-17 843786 67128 60 29-Aug-17 843135 67128

100 29-Aug-17 , 843180 67128 60 29-Aug-17 843186 67128

100 29-Aug-17 , 843122 67128 90 29-Aug-17 843107 67128 90 29-Aug-17 ; 843175 67128

100 r 29 -Aug-17 1 843136 67128 100 29-Aug-17 843132 67128 100 ; 29-Aug-17 . 843174 67128' 100 29-Aug-17 i 843185 67128 100 29-Aug-17 843113 67128 100 ; 29-Aug-17 i 843153 67128 100 29-Aug-17 843106 67128 100 29-Aug-17 ! 843112 1 67128 100 29-Aug-17 843187 ; 67128 100 29-Aug-17 843150 67128 100 29-Aug-17 843105 67128

90 29-Aug-17 843321 67128 90 ; 29-Aug-17 843342 67128

100 29-Aug-17 843320 67128 100 i 29-Aug-17 i 843341 67128 60 1 23-Aug-17 842938 67128 90 23-Aug-17 842962, 67128

100 23-Aug-17 842947 67128 I

162

163 164 165

157

158

159

160

161

153

15

155

156

15

15 15

14

14 14

14

14

13

14

14

13 13

14

14

14

13

13

13

13

200

;t;

I 100

100

• 240

1SEROQUEL XR 400MG

:ARIMIDEX 1mg TAB SEROQUEL 200MG •

LOSEC 20mg TAB

90

100 200

;ZOMIG 2.5MG TAB * !ZOMIG RAPIMELT 2.5 MG 1 iSeroquel 300mg Tab

100 I ,ARIMIDEX lmg TAB -

90 ZOMIG 2.5MG TAB



--Actu-knotirOweso restri er:1 i43)1Sferate:


iSEROQUEL 200MG : 240

LOSEC 20mg TAB ! 200 1 SEROQUEL 200MG

. 240

LOSEC 20mg TAB

,

200

ZOMIG 2.5MG TAB 90

ISEROQUEL XR 400MG 100 • ISeroquel 300mg Tab 200 ; ZOMIG RAPIMELT 2.5 MG! 100 Seroquel 300mg Tab 200 CRESTOR 20 MG 100_,

CRESTOR 20 MG s 100

;ZOMIG RAPIMELT 2.5 MG; 100

;CRESTOR 40MG TAB 100


ICRESTOR 40MG TAB ; 100 !

ARIMIDEX 1mg TAB - 100 IZOMIG 2.5MG TAB * : 90 .

ZOMIG 2.5MG TAB_* 90

ZOMIG RAPIMELT 2.5 MG; 100

ZOMIG RAPIMELT 2.5 MG 100 i

SEROQUEL 200MG -1 240 SEROQUEL 200MG 240 !

LOSEC 20mg TAB 2

100 6-Sep-17 844308 67128 100 6-Sep-17 844247 67128 60 - 1-Sep-17 843785 67128

100 1-Sep-17 843787 67128 90 1-Sep-17 843779 67128

100 1-Sep-17 843778 67128 100 I 1-Sep-17 843784 i 67128 100 1-Sep-17 843777 67128

100 1-Sep-17 843786 67128 60 29-Aug-17 843135 67128

100 29-Aug-17 , 843180 67128 60 29-Aug-17 843186 67128

100 29-Aug-17 , 843122 67128 90 29-Aug-17 843107 67128 90 29-Aug-17 ; 843175 67128

100 r 29 -Aug-17 1 843136 67128 100 29-Aug-17 843132 67128 100 ; 29-Aug-17 . 843174 67128' 100 29-Aug-17 i 843185 67128 100 29-Aug-17 843113 67128 100 ; 29-Aug-17 i 843153 67128 100 29-Aug-17 843106 67128 100 29-Aug-17 ! 843112 1 67128 100 29-Aug-17 843187 ; 67128 100 29-Aug-17 843150 67128 100 29-Aug-17 843105 67128

90 29-Aug-17 843321 67128 90 ; 29-Aug-17 843342 67128

100 29-Aug-17 843320 67128 100 i 29-Aug-17 i 843341 67128 60 1 23-Aug-17 842938 67128 90 23-Aug-17 842962, 67128

100 23-Aug-17 842947 67128 I

162

163 164 165

157

158

159

160

161

153

15

155

156

15

15 15

14

14 14

14

14

13

14

14

13 13

14

14

14

13

13

13

13

200

;t;

90 90

ZOMIG 2.5MG TAB ZOMIG 2.5MG TAB

2 LOSEC 20mg TAB



flP ,Acxt4-ko'otWPAtxsutt i43)1Sferate: A read; -eel

1SEROQUEL XR 400MG 100 :ARIMIDEX 1mg TAB 100 ; 'SEROQUEL 200MG • 240 ! LOSEC 20mg TAB 200 ;

;ZOMIG 2.5MG TAB * 90 IZOMIG RAPIMELT 2.5 MGI 100 iSeroquel 300mg Tab ' 200

,ARIMIDEX 1mg TAB 100 1 ISEROQUEL XR 400MG 100 iSEROQUEL 200MG 240 LOSEC 20mg TAB 200 1 SEROQUEL 200MG . 240 LOSEC 20mg TAB 200

f Seroquel 300mg Tab I 200 CRESTOR 20 MG 100_, CRESTOR 20 MG s 100 .

;ZOMIG RAPIMELT 2.5 MG; 100 ' ;CRESTOR 40MG TAB ' 100 i ISEROQUEL XR 400MG I 100 ICRESTOR 40MG TAB ; 100 ! ARIMIDEX 1mg TAB - 100 liOMIG 2.5MG TAB * : 90 . ZOMIG 2.5MG TAB_* ' 90 .: ZOMIG RAPIMELT 2.5 MG; 100 . ZOMIG RAPIMELT 2.5 MG= 100 i SEROQUEL 200MG -1 240 I SEROQUEL 200MG 240

100 6-Sep-17 844308 67128 100 6-Sep-17 844247 67128 60 1-Sep-17 843785 67128

100 1-Sep-17 I

!

843787 843779

67128 67128 90 1-Sep-17

100 1-Sep-17 843778 67128 100 I 1-Sep-17 843784 i 67128 100 1-Sep-17 843777 67128 100 1-Sep-17 843786 67128 60 29-Aug-17 843135 67128

100 29-Aug-17 , 843180 67128 60 29-Aug-17 843186 67128

100 29-Aug-17 843122 67128 90 29-Aug-17 I 843107 67128 90 29-Aug-17 ; 843175 67128

100 100

(

...,L 29-Aug-17 1 843136 67128 29-Aug-17

. 843132 67128

67128 ' 100 ; 29-Aug-17 843174 100 29-Aug-17 i 843185

__- 67128

100 I 29-Aug-17 843113 67128 67128 100 ; 29-Aug-17 1

i 843153 ;

100 100

, !

29-Aug-17 843106 i 67128 29-Aug-17 843112 1 67128

100 100 100

: 29-Aug-17 843187 . . 67128 29-Aug-17 843150 67128 29-Aug-17 843105 67128

90 ;

29-Aug-17 843321 843342

67128

67128 90 29-Aug-17 100 i

1 29-Aug-17 843320 67128

100 29-Aug-17 t 843341 67128 . - 67128 I 60 1 23-Aug-17 842938

90 23-Aug-17 842962, 67128 100 23-Aug-17 842947 67128

162 163 164 165

157 158 159 160 161

153 15 155 156

15

15 15

14 14 14 14

14

13

14

14

13 13

14 14 14

13 13

13 13

ISEROQUEL XR 400MG 100 • I Seroquel 300mg Tab i 200 ; .ZOMIG RAPIMELT 2.5 MG! 100 4 .

;t;

5/28/2018 Page 6 ClaimSecure Inc. Confidential

Physician Verification - Dr. Keshmirlan

git*fltitif 008-0.00:01 .5110401- P 90 90 23-Aug-17 842917 i 67128

200 100 23-Aug-17 i -4 842924 ! 67128 90 23-Aug-17 67128 90 842975

200 100 23-Aug-17 842937 67128 100 100 23-Aug-17 842974 67128 100 100 23-Aug-17 842916 67128 100 100 23-Aug-17 842928 67128 200 100 23-Aug-17 842961 67128 100 100 23-Aug-17 842971 67128 100 100 23-Aug-17_ 842963 67128 100 V1007 23-Aug-17 842927 i 67128 100 100 23-Aug-17 842970 67128 100 100 23-Aug-17 842939 67128 100 i 100 23-Aug-17 842915 67128 200 100 22-Aug-17 • 842574 ' 67128 200 ! 100 22-Aug-17 ; 842601 67128 240 ; 60 —22-Aug-17 ; 842619 67128 90 90 22-Aug-17 842610 67128

r--- 60 22-Aug-17 842585 67128 240 90 90 22-Aug-17 842579 j 67128

100 100 22-Aug-17 842620 I 67128 200 100 22-Aug-17 842584 67128 100 1 100 i

1- 22-Aug-17 842609 67128

100 100 1 22-Aug-17 842568 67128 100 100 i 22-Aug-17 i 842578 67128 200 100 22-Aug-17 842618 67128 100 1 100 1 22-Aug-17 842598 67128 100 i 100 22-Aug-17 842586 67128 100 i 100 22-Aug-17 842567 67128 100 ; 100 22-Aug-17 842597 67128 100 i 100 22-Aug-17. 842577 67128 240 60 I 19-Aug-17 842239 67128 200 100 19-Aug-17 842222 67128

,ZOMIG 2.5MG TAB * LOSEC 20mg TAB ,ZOMIG 2.5MG TAB * Seroquel 300mg Tab ZOMIG RAPIMELT 2.5 MG ZOMIG RAPIMELT 2.5 MG CRESTOR 20 MG Seroquel 300mg Tab CRESTOR 20 MG SEROQUEL XR 400MG CRESTOR 40MG TAB CRESTOR 40MG TAB SEROQUEL XR 400MG ARIMIDEX 1mg TAB 179 LOSEC 20mg TAB LOSEC 20mg TAB

18 181

SEROQUEL 200MG ZOMIG 2.5MG TAB *

• SEROQUEL 200MG ZOMIG 2.5MG TAB * SEROQUEL XR 400MG ' Seroquel 300mg Tab ZOMIG RAPIMELT 2.5 MG; CRESTOR 20 MG

ZOMIG RAP1MELT 2.5 MGI Seroquel 300mg Tab CRESTOR 20 MG 1 EROQUEL XR 400MG

CRESTOR 40MG TAB RESTOR 40MG TAB i RIMIDEX 1mg TAB j EROQUEL 200MG OSEC 20mg TAB

16 16 16 16 17 17 17 17 17 7

17 17 17

182 183 18 185 186 187 188 189 190 191 192 193 194 195 196 197 198



git*fltitif 008-0.00:01 .5110401- P 90 90 23-Aug-17 842917 i 67128

200 100 23-Aug-17 i -4 842924 ! 67128 90 23-Aug-17 67128 90 842975

200 100 23-Aug-17 842937 67128 100 100 23-Aug-17 842974 67128 100 100 23-Aug-17 842916 67128 100 100 23-Aug-17 842928 67128 200 100 23-Aug-17 842961 67128 100 100 23-Aug-17 842971 67128 100 100 23-Aug-17_ 842963 67128 100 V1007 23-Aug-17 842927 i 67128 100 100 23-Aug-17 842970 67128 100 100 23-Aug-17 842939 67128 100 i 100 23-Aug-17 842915 67128 200 100 22-Aug-17 • 842574 ' 67128 200 ! 100 22-Aug-17 ; 842601 67128 240 ; 60 —22-Aug-17 ; 842619 67128 90 90 22-Aug-17 842610 67128

r--- 60 22-Aug-17 842585 67128 240 90 90 22-Aug-17 842579 j 67128

100 100 22-Aug-17 842620 I 67128 200 100 22-Aug-17 842584 67128 100 1 100 i

1- 22-Aug-17 842609 67128

100 100 1 22-Aug-17 842568 67128 100 100 i 22-Aug-17 i 842578 67128 200 100 22-Aug-17 842618 67128 100 1 100 1 22-Aug-17 842598 67128 100 i 100 22-Aug-17 842586 67128 100 i 100 22-Aug-17 842567 67128 100 ; 100 22-Aug-17 842597 67128 100 i 100 22-Aug-17. 842577 67128 240 60 I 19-Aug-17 842239 67128 200 100 19-Aug-17 842222 67128

,ZOMIG 2.5MG TAB * LOSEC 20mg TAB ,ZOMIG 2.5MG TAB * Seroquel 300mg Tab ZOMIG RAPIMELT 2.5 MG ZOMIG RAPIMELT 2.5 MG CRESTOR 20 MG Seroquel 300mg Tab CRESTOR 20 MG SEROQUEL XR 400MG CRESTOR 40MG TAB CRESTOR 40MG TAB SEROQUEL XR 400MG ARIMIDEX 1mg TAB 179 LOSEC 20mg TAB LOSEC 20mg TAB

18 181

SEROQUEL 200MG ZOMIG 2.5MG TAB *

• SEROQUEL 200MG ZOMIG 2.5MG TAB * SEROQUEL XR 400MG ' Seroquel 300mg Tab ZOMIG RAPIMELT 2.5 MG; CRESTOR 20 MG

ZOMIG RAP1MELT 2.5 MGI Seroquel 300mg Tab CRESTOR 20 MG 1 EROQUEL XR 400MG

CRESTOR 40MG TAB RESTOR 40MG TAB i RIMIDEX 1mg TAB j EROQUEL 200MG OSEC 20mg TAB

16 16 16 16 17 17 17 17 17 7

17 17 17

182 183 18 185 186 187 188 189 190 191 192 193 194 195 196 197 198



aPrOkig:N4-nigra ,;21: "74::

,ZOMIG 2.5MG TAB * 16 LOSEC 20mg TAB ,ZOMIG 2.5MG TAB * j Seroquel 300mg Tab ZOMIG RAPIMELT 2.5 MG ZOMIG RAPIMELT 2.5 MGi CRESTOR 20 MG j Seroquel 300mg Tab CRESTOR 20 MG SEROQUEL XR 400MG CRESTOR 40MG TAB CRESTOR 40MG TAB SEROQUEL XR 400MG ARIMIDEX 1mg TAB 179 LOSEC 20mg TAB LOSEC 20mg TAB

18 181

SEROQUEL 200MG ZOMIG 2.5MG TAB * i SEROQUEL 200MG ZOMIG 2.5 MG TAB * SEROQUEL XR 400MG ' Seroquel 300mg Tab ; ZOMIG RAPIMELT 2.5 MG; CRESTOR 20 MG

ZOMIG RAPIMELT 2.5 MG I Seroquel 300mg Tab i CRESTOR 20 MG 1 EROQUEL XR 400MG

CRESTOR 40MG TAB RESTOR 40MG TAB RIMIDEX 1mg TAB j EROQUEL 200MG OSEC 20mg TAB

16 16 16 17 17 17 17 17 7

17 17 17

182 183 18 185 186 187 188 189 190 191 192 193 194 195 196 197 198

gi-Wititif 008-0.00.01 P efID

90 90 23-Aug-17 842917 i 67128 200 100 23-Aug-17 i 842924 67128 90 90 ; 23-Aug-17

-4 842975 67128

200 100 23-Aug-17 842937 67128

.100 100 23-Aug-17 842974 j 67128 100 100 23-Aug-17 ; 842916 67128 100 100 23-Aug-17 842928 67128 200 100 23-Aug-17 842961 67128 100 100 23-Aug-17 842971 67128 100 100. 23-Aug-17 842963 3 67128 100 : 100 23-Aug-17 1 842927 i 67128 100 10.0 23-Aug-17 842970 1 67128 100 100 23-Aug-17 842939 67128 100 i 100 i 23-Aug-17 842915 67128 200 100 22-Aug-17 842574 67128 200 ! 100 22-Aug-17 842601 i 67128 240 , 60 22-Aug-17 = 842619 i 67128 90 90 22-Aug-17 842610 1 67128 240 ' ,

60 22-Aug-17 ' 842585 67128 90 90 22-Aug-17 , 842579 ! 67128

100 100 22-Aug-17 , 842620 I 67128 200 = 100 22-Aug-17 842584 67128 100 ; 100 i 22-Aug-17 842609 67128 100 100 1 22-Aug-17 842568 67128 100 100 i 22-Aug-17 842578 67128 200 100 ! 22-Aug-17 842618 67128 100 100 1 22-Aug-17 842598 67128 100 i 100 22-Aug-17 842586 1 67128 100 i 100 22-Aug-17 842567 67128 100 100 22-Aug-17 842597 67128 100 100 22-Aug-17 842577 67128 240 60 j 19-Aug-17 842239 67128 200 100 19-Aug-17 842222 67128


firitilkiife MatNOM - . CWantity:RatOtifigsi, .,,'Ditii.460-fiCW: ,., INIToy=. ?regilheYlp 67128 1991 ILOSEC 20mg TAB 200 ' 100 • I 19-Aug-17 842253 I

2001 I SEROQUEL 200MG 240 60 19-Aug-17 842260 67128 201 IZOMIG 2.5MG TAB * I 90 90 ; 19-Aug-17 842237 67128 . 202' ZOMIG 2.5MG TAB * 90 r 90 19-Aug-17 I842252 1 67128 203' 204 2051 206

;Seroquel 300mg Tab 200 100 19-Augr17 842259 67128 IZOMIG RAPIMELT 2.5 MG i 100 100 i 19-Aug-17 1 842251 : 67128 IZOMIG RAPIMELT 2.5 MG: 100 100 19-Aug-17 842236 67128 (Seroquel 300mg Tab 200 100 19-Aug-17 842238 67128

2071 208 209: 2101 211 212. 213:

'CRESTOR 20 MG i 100 100

1 ;

100 100

i 19-Aug-17 19-Aug-17

842221 ' 842271

67128 CRESTOR 20 MG 67128 . Y-

1SEROQ1JEL XR 400MG 100 ; 100 1 19-Aug-17 842240 67128 CRESTOR 40MG TAB 100.. i 100 19-Aug-17 842220 67128

1SEROQUE1 XR 400MG 100 100 ) 19-Aug-17 ! 842261 67128 CRESTOR 40MG TAB 100 . 100 : ' 19-Aug-17 : 842270 . 67128

' 1ARIMIDEX 1mg TAB 100 100 90

19-Aug-17 ; 842235 67128 214' 215

IZOMIG 2.5MG TAB * , 90 18-Aug-17 841999 67128 IZOMIG 2.5MG TAB * , 90 . 90 18-Aug-17 841991 67128

2161 2171

IZOMIG RAPIMELT 2.5 MG! 100 100 j 18-Aug-17 841998 ! . 67128 ; ! 1ZOMIG RAP1MELT 2.5 MGI 100 ; 100 I 18-Aug-17 i 841990: 67128

2181 219f

LOSEC 20mg TAB 1 200 1 100 17-Aug-17 841881 67128 1LOSEC 20mg TAB 200 i 100 17-Aug-17 841910 67128

220; 221;

223

IZOMIG 2.5MG TAB * . 90 90

90 ' 17-Aug-17 841893 67128 ZOMIG 2.5MG TAB * 90

. ., 17-Aug-17 841912 67128

222: ZOMIG' RAPIMELT 2.5 MG; 100 ' 100 17-Aug-17 .... 841914 67128 ZOMIG RAPIMELT 2.5 MG! 100 100 17-Aug-17 841892 67128

224i Seroquel 300mg Tab ' 200 100 j 17-Aug-17 841899 67128 ' 225! Seroquel 300mg Tab 200 100 27-Aug-17 841920 67128 I 226; 22-77 2281

CRESTOR 20 MG 1 100 100 , _ I 17-Aug-17 841926 1 67128 I CRESTOR 20 MG 100 100 ' 17-Aug-17 841898 67128 SEROQUEL XR 400MG 100 • 100 ; 17-Aug-17 841922 1 67128

229; 23(X 231 i

SEROQUEL XR 400MG 100 i 100 17-Aug-17 841901 67128 j CRESTOR 40MG TAB 100 i 100 17-Aug-17 841925 . 67128 -CRESTOR 40MG TAB 100 100 17-Aug-17 1 841896 i 67128



firitilkiife MatNOM - . CWantity:RatOtifigsi, .,,'Ditii.460-fiCW: ,., INIToy=. ?regilheYlp 67128 1991 ILOSEC 20mg TAB 200 ' 100 • I 19-Aug-17 842253 I

2001 I SEROQUEL 200MG 240 60 19-Aug-17 842260 67128 201 IZOMIG 2.5MG TAB * I 90 90 ; 19-Aug-17 842237 67128 . 202' ZOMIG 2.5MG TAB * 90 r 90 19-Aug-17 I842252 1 67128 203' 204 2051 206

;Seroquel 300mg Tab 200 100 19-Augr17 842259 67128 IZOMIG RAPIMELT 2.5 MG i 100 100 i 19-Aug-17 1 842251 : 67128 IZOMIG RAPIMELT 2.5 MG: 100 100 19-Aug-17 842236 67128 (Seroquel 300mg Tab 200 100 19-Aug-17 842238 67128

2071 208 209: 2101 211 212. 213:


1 ;

100 100

i 19-Aug-17 19-Aug-17

842221 ' 842271

67128 CRESTOR 20 MG 67128 . Y-




19-Aug-17 ; 842235 67128 214' 215

IZOMIG 2.5MG TAB * , 90 18-Aug-17 841999 67128 IZOMIG 2.5MG TAB * , 90 . 90 18-Aug-17 841991 67128

2161 2171


2181 219f

LOSEC 20mg TAB 1 200 1 100 17-Aug-17 841881 67128 1LOSEC 20mg TAB 200 i 100 17-Aug-17 841910 67128

220; 221;

223


90 ' 17-Aug-17 841893 67128 ZOMIG 2.5MG TAB * 90

. ., 17-Aug-17 841912 67128



CRESTOR 20 MG 1 100 100 , _ I 17-Aug-17 841926 1 67128 I CRESTOR 20 MG 100 100 ' 17-Aug-17 841898 67128 SEROQUEL XR 400MG 100 • 100 ; 17-Aug-17 841922 1 67128

229; 23(X 231 i

SEROQUEL XR 400MG 100 i 100 17-Aug-17 841901 67128 j CRESTOR 40MG TAB 100 i 100 17-Aug-17 841925 . 67128 -CRESTOR 40MG TAB 100 100 17-Aug-17 1 841896 i 67128



fin-M*10 Mat NOM . Cifialltiti RatfStifigSipitli.460-ipat: ,., INfoY=... ?regilbeWlp

67128 1991 ILOSEC 20mg TAB 200 ' 100 • I 19-Aug-17 842253 I 2001 I SEROQUEL 200MG 240 60 19-Aug-17 842260 67128 201 IZOMIG 2.5MG TAB * I 90 90 ; 19-Aug-17 842237 67128 . 202' ZOMIG 2.5MG TAB * 90 r 90 19-Aug-17 1 842252 1 67128 203' 204 2051 206

;Seroquel 300mg Tab 200 100 19-Augr17 842259 67128 IZOMIG RAPIMELT 2.5 MG i 100 100 i 19-Aug-17 i 842251 : 67128 IZOMIG RAPIMELT 2.5 MG: 100 100 19-Aug-17 842236 67128 (Seroquel 300mg Tab 200 100 19-Aug-17 842238 67128

2071 208 209: 2101 211 212. 213:


1 ;

100 100

i 19-Aug-17 19-Aug-17

842221 ' 842271

67128 CRESTOR 20 MG 67128 . Y-




19-Aug-17 ; 842235 67128 214' 215

IZOMIG 2.5MG TAB * 90 18-Aug-17 841999 67128 IZOMIG 2.SMG TAB * , 90 90 18-Aug-17 841991 67128

2161 2171


2181 219f

LOSEC 20mg TAB 1 200 I 100 17-Aug-17 841881 67128 1LOSEC 20mg TAB 200 i 100 17-Aug-17 841910 67128

220; 221;

223


90 ' 17-Aug-17 841893 67128 ZOMIG 2.5MG TAB * 90

. ., 17-Aug-17 841912 67128



CRESTOR 20 MG 1 100 100 , _ I 17-Aug-17 841926 67128 I CRESTOR 20 MG 100 100 ' 17-Aug-17 841898 67128 SEROQUEL XR 400MG 100 • 100 ; 17-Aug-17 841922 1 67128

229; 23(X 231i

SEROQUEL XR 400MG 100 i 100 17-Aug-17 841901 67128 j CRESTOR 40MG TAB 100 i 100 17-Aug-17 841925 . 67128 -CRESTOR 40MG TAB 100 100 17-Aug-17 841896 i 67128



:Z t First i .'..0,g0,traffif. i-:•t:T.;:'; ., ._.:43 ;i,i'WZ:7.,',ZOIiiiPi::;g:,46-ZI: !Rkfifititif, Pitt$00. -; -;.gpir",:r1!1-07D-EiftZ 4Ibt::NO- 1!!0-0.10A .M ' •.il

232

233

234

ARIMIDEX 1mg TAB 100 I 100 ' 17-Aug-17 841911 67128 SEROQUEL 200MG 240 . 60 : 17-Aug-17 841900 67128 ' SEROQUEL 200MG 240 ' 60 : 17-Aug-17 841921 67128 .

235 ZOM1G 2.5MG TAB * 90 90 17-Aug-17 I 841853 i 67128 ,

236

237

ZOMIG RAPIMELT2.5 MG! 100 i 100 100

: !

17-Aug-17 841854 67128 ZOMIG RAPIMELT2.5 MG 100 17-Aug-17 . 841846 f 67128

238 ZOMIG 2.5MG TAB * , 90 I 90 17-Aug-17 ; 841845 .

841705

67128

67128 239 240

ZOMIG 2.5MG TAB * 90 . 90

100

, .i 16-Aug-17 e

ZOMIG RAPIMELT2.5 MG 100 ' 1 16-Aug-17 841704 67128

241

242

ZOMIG 2.5MG TAB * 90 4 90 1 ----t—

i

9-Aug-17 ; 840841 67128

ZOMIG 2.5MG TAB * 90 i 90 9-Aug-17 840811 i 67128

243 244

245

ZOMIG RAPIMELT2.5 MG 100 i 100 I 9-Aug-17 840840 ' 67128 _-

! ZOMIG RAP1M ELT 2.5 MG 100 i

SEROQUEL 200MG 240 I 100 1 9-Aug-17 840810 67128 60 8-Aug-17 840775 67128 . __

246 SEROQUEL 200MG 200 100 ' 8-Aug-17 840747 67128

247 LOSEC 20mg TAB 200 • 100 i 8-Aug-17 840773 i 67128

2.48 249 250

LOSEC 20mg TAB t200 ZOMIG 2.5MG TAB * 90 :

100 8-Aug-17 840753 67128 90 i 8-Aug-17 840755 67128

ZOMIG 2.5MG TAB * 90 1 90 8-Aug-17 .._ 840759 67128

251 SEROQUEL XR 400MG 100 I 100 8-Aug-17 840748 l 67128

252 ZOMIG RAPIMELT2.5 MG 100 i 100 8-Aug-17 840758 67128

253 2541

2551

2561

2571 2581

Seroquel 300mg Tab ! 200 1 100 — 8-Aug-17 840774 67128

Seroquel 300mg Tab 200

r OMIG RAP1M ELT 2.5 MGI 100 !

100 8-Aug-17 840746 j 67128 , 100 _ 8-Aug-17 840754 F 67128 •

RESTOR 40MG TAB 1 100 ' 100 8-Aug-17 840762 67128

CRESTOR 40MG TAB 1 100 • 100 — 8-Aug-17 j 840756 ' 67128 : RIMIDEX 1mg TAB I 100 . 100 8-Aug-17 840757 . 67128



:Z t First i .'..0,g0,traffif. i-:•t:T.;:'; ., ._.:43 ;i,i'WZ:7.,',ZOIiiiPi::;g:,46-ZI: !Rkfifititif, Pitt$00. -; -;.gpir",:r1!1-07D-EiftZ 4Ibt::NO- 1!!0-0.10A .M ' •.il

232

233

234

ARIMIDEX 1mg TAB 100 I 100 ' 17-Aug-17 841911 67128 SEROQUEL 200MG 240 . 60 : 17-Aug-17 841900 67128 ' SEROQUEL 200MG 240 ' 60 : 17-Aug-17 841921 67128 .

235 ZOM1G 2.5MG TAB * 90 90 17-Aug-17 I 841853 i 67128 ,

236

237

ZOMIG RAPIMELT2.5 MG! 100 i 100 100

: !

17-Aug-17 841854 67128 ZOMIG RAPIMELT2.5 MG 100 17-Aug-17 . 841846 f 67128

238 ZOMIG 2.5MG TAB * , 90 I 90 17-Aug-17 ; 841845 .

841705

67128

67128 239 240

ZOMIG 2.5MG TAB * 90 . 90

100

, .i 16-Aug-17 e

ZOMIG RAPIMELT2.5 MG 100 ' 1 16-Aug-17 841704 67128

241

242

ZOMIG 2.5MG TAB * 90 4 90 1 ----t—

i

9-Aug-17 ; 840841 67128


243 244

245

ZOMIG RAPIMELT2.5 MG 100 i 100 I 9-Aug-17 840840 ' 67128 _-

! ZOMIG RAP1M ELT 2.5 MG 100 i

SEROQUEL 200MG 240 I 100 1 9-Aug-17 840810 67128 60 8-Aug-17 840775 67128 . __

246 SEROQUEL 200MG 200 100 ' 8-Aug-17 840747 67128

247 LOSEC 20mg TAB 200 • 100 i 8-Aug-17 840773 i 67128

2.48 249 250

LOSEC 20mg TAB t200 ZOMIG 2.5MG TAB * 90 :

100 8-Aug-17 840753 67128 90 i 8-Aug-17 840755 67128

ZOMIG 2.5MG TAB * 90 1 90 8-Aug-17 .._ 840759 67128



253 2541

2551

2561

2571 2581

Seroquel 300mg Tab ! 200 1 100 — 8-Aug-17 840774 67128

Seroquel 300mg Tab 200

r OMIG RAP1M ELT 2.5 MGI 100 !

100 8-Aug-17 840746 j 67128 , 100 _ 8-Aug-17 840754 F 67128 •

RESTOR 40MG TAB 1 100 ' 100 8-Aug-17 840762 67128

CRESTOR 40MG TAB 1 100 • 100 — 8-Aug-17 j 840756 ' 67128 : RIMIDEX 1mg TAB I 100 . 100 8-Aug-17 840757 . 67128



•_ Tifgilal*340Naffit: , .;;s.a. ,,,;:., , - ,.. !goofy, piveisow ,-,.,,a, it--70-falitez .34.._,_ .i.: FAktgilbAIP .v 232

233

234

ARIMIDEX 1mg TAB 100 I 100 17-Aug-17 841911 67128 SEROQUEL 200MG 240 • 60 : 17-Aug-17 841900 67128 _ .. SEROQUEL 200MG 240 60 17-Aug-17 841921 67128

235 ZOM1G 2.5MG TAB * 90 90 17-Aug-17 I 841853 i 67128

236

237

ZOMIG RAPIMELT2.5 MG! 100 , 100 100

. 17-Aug-17 841854 67128 ZOMIG RAPIMELT2.5 MG1 100 17-Aug-17 . 841846 f 67128

238 ZOMIG 2.5MG TAB * 90 I 90 17-Aug-17 841845 . 67128

239 240

ZOMIG 2.5MG TAB * 90 , 90

100

- .i 16-Aug-17 e 841705 67128 T ZOMIG RAPIMELT2.5 MG 100 ' 1 16-Aug-17 841704 67128

241

242

ZOMIG 2.5MG TAB * 90 4

90 1 ----t-

i

9-Aug-17 ;_840841 67128


243 244

245

ZOMIG RAPIMELT2.5 MG 100 ] 100 I 9-Aug-17 840840 ' 67128 ZOMIG RAP1M ELT 2.5 MG

SEROQUEL 200MG

100

240 !

100 I

"

9-Aug-17 840810 67128 60 8-Aug-17 840775 67128 ____

246 SEROQUEL 200MG 200 100 , 8-Aug-17 840747 67128

247 LOSEC 20mg TAB •

200 • 100 i 8-Aug-17 840773 i 67128

2.48 249 250

LOSEC 20mg TAB ' ZOMIG 2.5MG TAB *

200 90 :

100 8-Aug-17 840753 67128 90 1 8-Aug-17 840755 67128 •

ZOMIG 2.5MG TAB * ! 90 1 90 I 8-Aug-17 840759 ........ 67128



253 i 2541

255;

2561

257! 2581 _

Seroquel 300mg Tab ! 200 I 100 : -- -

i 8-Aug-17 840774 67128

Seroquel 300mg Tab

r OMIG RAP1MELT 2.5 MGI 200 , .

100 r

100 8-Aug-17 840746 j 67128 100 8-Aug-17 840754 F 67128

RESTOR 40MG TAB , 100 ' 100 r 8-Aug-17 840762 67128

CRESTOR 40MG TAB 1 RIMIDEX 1mg TAB I

100 100 8-Aug-17 __.... j 840756 . ' 67128 "

100 . 100 8-Aug-17 840757 67128 1


ASTRAZENECA CANADA INC. -and- SAMEH SADEK also known as SAM Court File No. CV-18-602745-00 CL SADEK et al.

Plaintiff Defendants

ONTARIO SUPERIOR COURT OF JUSTICE

(COMMERCIAL LIST)

Proceeding commenced at Toronto

AFFIDAVIT OF DOUG QUAN SWORN SEPTEMBER 10, 2018

BLAKE, CASSELS & GRAYDON LLP Banisters & Solicitors 199 Bay Street Suite 4000, Commerce Court West Toronto ON M5L 1A9

R. Seumas M. Woods LSO #301691 Tel: 416-863-3876 [email protected]

Erin Hoult LSO #54002C Tel: 416-863-4011 Fax: 416-863-2653 [email protected]

Lawyers for the plaintiff

'40




(COMMERCIAL LIST)







'40




(COMMERCIAL LIST)







'40

Court File No. CV-18-602745-00-CL


COMMERCIAL LIST

BETWEEN:

ASTRAZENECA CANADA INC.

Plaintiff

- and -

SAMEH SADEK also known as SAM SADEK, ST. MAHARIAL PHARMACY INC. dba MD HEALTH PHARMACY, ST. MAHARIAL CLINIC INC., SRX INVESTMENT INC.,

SHEPHERD RX PHARMACY INC. and LILIAN FAM

Defendants

CONSENT

The undersigned, Alvarez & Marsal Canada Inc. ("A&M"), hereby consents to the

appointment of A&M as receiver, without security, of all of the assets, undertakings and

properties of Sameh Sadek also known as Sam Sadek, St. Maharial Pharmacy Inc. dba MD

Health Pharmacy, St. Maharial Clinic Inc., SRX Investment Inc., Shepherd RX Pharmacy Inc.

and Lilian Fam (collectively, the "Defendants"), pursuant to the provisions of section 101 of the

Courts of Justice Act, R.S.O. 1990, c. C.43, as amended, and the tetras of an order substantially

in the form filed in the above proceeding.

DATED at Toronto, this day of September, 2018.

ALVAREZ & MARSAL CANADA INC.

Name: Title:

41-1



COMMERCIAL LIST

BETWEEN:


Plaintiff

- and -



Defendants

CONSENT










Name: Title:

41-1



COMMERCIAL LIST

BETWEEN:


Plaintiff

- and -



Defendants

CONSENT










Name: Title:

41-1

ASTRAZENECA CANADA INC. - and - SAMEH SADEK, ET AL.

Plaintiff Defendants Court File No. CV-18-602745-00-CL


COMMERCIAL LIST

Proceedings commenced at Toronto

CONSENT

AIRD & BERLIS LLP Brookfield Place

181 Bay Street, Suite 1800 Toronto, ON M5J 2T9

Ian Aversa (LSUC # 55449N) Tel: (416) 865-3082 Fax: (416) 863-1515 Email: [email protected]

Kyle Plunkett (LSUC # 61044N) Tel: (416) 865-3406 Fax: (416) 863-1515 Email: kplunketta,airdberlis.com

Lawyers for Alvarez & Marsal Canada Inc. 33638309.2




COMMERCIAL LIST


CONSENT









COMMERCIAL LIST


CONSENT






Court File No. CV- I 8-602745-00-CL


COMMERCIAL LIST

THE HONOURABLE MR. TUESDAY, THE 11TH DAY

JUSTICE DUNPHY OF SEPTEMBER, 2018

ASTRAZENECA CANADA INC. Plaintiff

- and -

SAMEH SADEK also known as SAM SADEK, ST. MAHARIAL PHARMACY INC. dba MD HEALTH PHARMACY, ST. MAHARIAL

CLINIC INC., SRX INVESTMENT INC., SHEPHERD RX PHARMACY INC. and LILIAN FAM

Defendants

ORDER (appointing Receiver)

THIS MOTION made ex parte by Astrazeneca Canada Inc. (the "Plaintiff') for an Order

pursuant to section 101 of the Courts of Justice Act, R.S.O. 1990, c. C.43, as amended (the

"CJA") appointing Alvarez & Marsal Canada Inc. ("A&M") as receiver (in such capacity, the

"Receiver"), without security, of all of the domestic assets, undertakings and properties of

Sameh Sadek also known as Sam Sadek, St. Maharial Pharmacy Inc. dba MD Health Pharmacy,

St. Maharial Clinic Inc., SRX Investment Inc., Shepherd RX Pharmacy Inc. and Lilian Fam

(collectively, the "Defendants" and, individually, a "Defendant"), and for related relief, was

heard this day at 330 University Avenue, Toronto, Ontario.

ON READING the Motion Record and Factum of the Plaintiff dated August 8, 2018, the

Supplemental Motion Record of the Plaintiff dated August 17, 2018, the Second Supplemental

Motion Record of the Plaintiff dated September 5, 2018, and the Motion Record for a Receiver,

the Factum and Book of Authorities of the Plaintiff dated September 10, 2018, and the Orders of

23451639.11



COMMERCIAL LIST




- and -



Defendants














23451639.11



COMMERCIAL LIST




- and -



Defendants














23451639.11

414 2

the Honourable Justice Dunphy dated August 9, 2018 (the "August 9 Order"), August 17, 2018

(the "August 17 Order") and September 5, 2018 (the "September Order" and, together with

the August 9 Order and the August 17 Order, the "Mareva Orders"), and on hearing the

submissions of counsel for the Plaintiff, and on reading the consent of A&M to act as the

Receiver,

APPOINTMENT

1. THIS COURT ORDERS that, pursuant to section 101 of the CJA, A&M is hereby

appointed Receiver, without security, of all of the assets, undertakings and properties of the

Defendants, including all proceeds thereof to the extent that such assets, undertakings and

properties are located in Canada (the "Domestic Property"). Without limiting the generality of

the foregoing, the Domestic Property includes all of the right, title and interest of the Defendants

in and to the real property with the following legal descriptions:

PIN 14360 - 1750 (LT) Interest/Estate Fee Simple

Description PART OF LOT 11, PLAN 43M1663, DES PART 6, PL 43R30324; MISSISSAUGA. S/T EASEMENT FOR ENTRY AS IN PR806741. S/T EASEMENT FOR ENTRY AS IN PR1007490.

Address 5045 CHURCHILL MEADOWS BOULEVARD MISSISSAUGA, ONTARIO, L5M 7Z8


Description PT LT 26, PL 396, DES PART 1, 43R29866; MISSISSAUGA. S/T EASEMENT OVER PT LT 26, PL 396, DES PART 1, 43R29866, AS IN PR1037379.

Address 2334 HAMMOND ROAD MISSISSAUGA, ONTARIO, L5K 1T2

RECEIVER'S POWERS

2. THIS COURT ORDERS that the Receiver is hereby empowered and authorized, but not

obligated, to act at once in respect of the Domestic Property and, without in any way limiting the

generality of the foregoing, the Receiver is hereby expressly empowered and authorized to do

any of the following where the Receiver considers it necessary or desirable:

23451639.11

414 2





Receiver,

APPOINTMENT













RECEIVER'S POWERS





23451639.11

414 2





Receiver,

APPOINTMENT













RECEIVER'S POWERS





23451639.11

3

(a) to take possession of and exercise control over the Domestic Property and any and

all proceeds, receipts and disbursements arising out of or from the Domestic

Property, but, for greater certainty, excluding any business and/or operations

carried on by any of the Defendants;

(b) to receive, preserve, and protect the Domestic Property, or any part or parts

thereof, including, but not limited to, the changing of locks and security codes, the

relocating of Domestic Property to safeguard it, the engaging of independent

security personnel, the taking of physical inventories and the placement of such

insurance coverage as may be necessary or desirable;

(c) to identify and segregate any Domestic Property that in the Receiver's reasonable

judgment constitutes property that: (a) is exempt from forced seizure or sale

pursuant to the Execution Act, R.S.O. 1990, c. E-24 (the "Execution Act"); or (b)

constitutes "consumer goods", as that term is defined in the Personal Property

Security Act, R.S.O. 1990, c. P.10 (the "PPSA"), and in the case of property so

segregated, to hold such property pending further order of this Court;

(d) to access all information relating to the Defendants' accounts or finance activities

at any financial institution, with any trade creditor, with any supplier or with any

third party;

(e) to engage consultants, appraisers, agents, experts, auditors, accountants,

managers, insurance brokers, realtors, counsel and such other persons from time

to time and on whatever basis, including on a temporary basis, to assist with the

exercise of the Receiver's powers and duties, including without limitation those

conferred by this Order;

(f) to receive and collect all monies and accounts now owed or hereafter owing to the

Defendants and to exercise all remedies of the Defendants in collecting such

monies, including, without limitation, to enforce any security held by any

Defendant;

(g) to settle, extend or compromise any indebtedness owing to any Defendant;

23451639.11

3


















third party;









Defendant;


23451639.11

3


















third party;









Defendant;


23451639.11

-4

(h) to execute, assign, issue and endorse documents of whatever nature in respect of

any of the Domestic Property, whether in the Receiver's name or in the name and

on behalf of any Defendant, for any purpose pursuant to this Order;

(i) to initiate, prosecute and continue the prosecution of any and all proceedings and

to defend all proceedings now pending or hereafter instituted with respect to any

Defendant, the Domestic Property or the Receiver, and to settle or compromise

any such proceedings. The authority hereby conveyed shall extend to such appeals

or applications for judicial review in respect of any order or judgment pronounced

in any such proceeding;

(j) to undertake any investigations deemed necessary by the Receiver with respect to

the location and/or disposition of assets reasonably believed to be, or to have

been, Domestic Property, including, without limitation, the transfer of any funds

of the Defendants to any related or unrelated parties;

(k) subject to any applicable exemption under the Execution Act or the PPSA to

which the individual Defendants are entitled, to market any or all of the Domestic

Property, including advertising and soliciting offers in respect of the Domestic

Property or any part or parts thereof and negotiating such terms and conditions of

sale as the Receiver in its discretion may deem appropriate;

(1) subject to any applicable exemption under the Execution Act or the PPSA to

which the individual Defendants are entitled, to sell, convey, transfer, lease or

assign the Domestic Property or any part or parts thereof out of the ordinary

course of business;

(i) without the approval of this Court in respect of any transaction not

exceeding $250,000, provided that the aggregate consideration for all such

transactions does not exceed $500,000; and

(ii) with the approval of this Court in respect of any transaction in which the

purchase price or the aggregate purchase price exceeds the applicable

amount set out in the preceding clause,

23451639.11

-4






















course of business;







23451639.11

-4






















course of business;







23451639.11

-5 449-

and in each such case notice under subsection 63(4) of the PPSA, or section 31 of

the Ontario Mortgages Act, as the case may be, shall not be required;

(m) to apply for any vesting order or other orders necessary to convey the Domestic

Property or any part or parts thereof to a purchaser or purchasers thereof, free and

clear of any liens or encumbrances affecting such Domestic Property;

(n) to report to, meet with and discuss with such affected Persons (as defined below)

as the Receiver deems appropriate on all matters relating to the Domestic Property

and the receivership, and to share information; subject in all cases to such terms

as to confidentiality as the Receiver deems advisable;

(o) to make inquiries of any recipient financial institution in respect of any and all

funds transferred by any of the Defendants to any related or unrelated parties,

including, but not limited to, the circumstances in which such transfer was

prepared, issued or effected;

(p) to register a copy of this Order and any other Orders in respect of the Domestic

Property against title to any of the Domestic Property;

(q) to apply for any permits, licences, approvals or permissions as may be required by

any governmental authority and any renewals thereof for and on behalf of and, if

thought desirable by the Receiver, in the name of any Defendant;

(r) to enter into agreements with any trustee in bankruptcy appointed in respect of

any Defendant, including, without limiting the generality of the foregoing, the

ability to enter into occupation agreements for any property owned or leased by

any Defendant;

(s) to exercise any shareholder, partnership, joint venture or other rights which any

Defendant may have; and

(t) to take any steps reasonably incidental to the exercise of these powers or the

performance of any statutory obligations, including opening any mail addressed to

any Defendant,

23451639.11

-5 449-






















any Defendant;





any Defendant,

23451639.11

-5 449-






















any Defendant;





any Defendant,

23451639.11

-6

and in each case where the Receiver takes any such actions or steps, it shall be exclusively

authorized and empowered to do so, to the exclusion of all other Persons (as defined below),

including the Defendants, and without interference from any other Person.


obligated, to act at once in respect of all of the assets, undertakings and properties of the


properties are located outside of Canada (the "Foreign Property", and together with the

Domestic Property, the "Property") and, without in any way limiting the generality of the

foregoing, the Receiver is hereby expressly empowered and authorized to do any of the

following where the Receiver considers it necessary or desirable:

(a) to access all information relating to the Defendants' accounts or finance activities


third party;

(b) to undertake any investigations deemed necessary by the Receiver with respect to


been, Foreign Property, including, without limitation, the transfer of any funds of

the Defendants to any related or unrelated parties;

(c) to report to, meet with and discuss with such affected Persons (as defined below)

as the Receiver deems appropriate on all matters relating to the Foreign Property

and the receivership, and to share information, subject in all cases to such terms as

to confidentiality as the Receiver deems advisable; and

(d) to take any steps reasonably incidental to the exercise of these powers or the


any Defendant.

DUTY TO PROVIDE ACCESS AND CO-OPERATION TO THE RECEIVER

4. THIS COURT ORDERS that (i) the Defendants, (ii) all of their current and former

directors, officers, employees, agents, accountants, legal counsel and shareholders (as

23451639,11

-6













third party;











any Defendant.




23451639,11

-6













third party;











any Defendant.




23451639,11

7

applicable), and all other persons acting on their instructions or behalf, and (iii) all other

individuals, firms, corporations, governmental bodies or agencies, or other entities having notice

of this Order, including, without limitation, any brokers, banks, credit card processors, creditors,

financial institutions, or suppliers (all of the foregoing, collectively, being "Persons" and each

being a "Person") shall forthwith advise the Receiver of the existence of any Property in such

Person's possession or control, shall grant immediate and continued access to the Domestic

Property to the Receiver, and shall deliver all such Domestic Property to the Receiver upon the

Receiver's request.

5. THIS COURT ORDERS that all Persons shall forthwith advise the Receiver of the

existence of any client records and prescription information, books, documents, securities,

contracts, orders, corporate and accounting records, and any other papers, records and

information of any kind related to the business or affairs of the Defendants, any transfers of

money or Property, or obligations incurred by the Defendants, out of the ordinary course of

business or personal conduct and any computer programs, computer tapes, computer disks, or

other data storage media containing any such information (the foregoing, collectively, the

"Records") in that Person's possession or control, and shall provide to the Receiver or permit the

Receiver to make, retain and take away copies thereof and grant to the Receiver unfettered

access to and use of accounting, computer, software and physical facilities relating thereto,

provided however that nothing in this paragraph 5 or in paragraph 6 of this Order shall require

the delivery of Records, or the granting of access to Records, which may not be disclosed or

provided to the Receiver due to the privilege attaching to solicitor-client communication or due

to statutory provisions prohibiting such disclosure.

6. THIS COURT ORDERS that if any Records are stored or otherwise contained on a

computer or other electronic system of infollnation storage, whether by independent service

provider or otherwise, all Persons in possession or control of such Records shall forthwith give

unfettered access to the Receiver for the purpose of allowing the Receiver to recover and fully

copy all of the information contained therein whether by way of printing the information onto

paper or making copies of computer disks or such other manner of retrieving and copying the

information as the Receiver in its discretion deems expedient, and shall not alter, erase or destroy

any Records without the prior written consent of the Receiver. Further, for the purposes of this

23451639.11

7








Receiver's request.























23451639.11

7








Receiver's request.























23451639.11

8

paragraph, all Persons shall provide the Receiver with all such assistance in gaining immediate

access to the information in the Records as the Receiver may in its discretion require including

providing the Receiver with instructions on the use of any computer or other system and

providing the Receiver with any and all access codes, account names and account numbers that

may be required to gain access to the information.

6A. THIS COURT ORDERS that, in respect to the Records subject to the Regulated Health

Professions Act, 1991, the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, 1990

or any other applicable governing Ontario or Canadian statute (collectively, the "Pharmacy

Regulations"), the Receiver shall: (i) take all steps reasonably necessary to maintain the integrity

of the confidential aspect of such Records; (ii) to the extent possible, provide such Records to the

Ontario College of Pharmacists ("College") or any pharmacy to which the College directs the

Receiver to provide such Records; (iii) if necessary, appoint a pharmacist licensed and qualified

to practice in the Province of Ontario to act as custodian (the "Custodian") for such Records;

(iv) not allow anyone other than the Receiver, the College, a pharmacy designated by the College

or the Custodian to have access to such Records; (iv) have access to such Records for any

purposes required pursuant to the Pharmacy Regulations that requires the Defendants, from time

to time, to perform certain obligations.

7. THIS COURT ORDERS that the Receiver shall provide each of the relevant landlords

with notice of the Receiver's intention to remove any fixtures from any leased premises at least

seven (7) days prior to the date of the intended removal. The relevant landlord shall be entitled

to have a representative present in the leased premises to observe such removal and, if the

landlord disputes the Receiver's entitlement to remove any such fixture under the provisions of

the lease, such fixture shall remain on the premises and shall be dealt with as agreed between any

applicable secured creditors, such landlord and the Receiver, or by further Order of this Court

upon application by the Receiver on at least two (2) days notice to such landlord and any such

secured creditors.

23451639.11

8


























secured creditors.

23451639.11

8


























secured creditors.

23451639.11

9-

NO PROCEEDINGS AGAINST THE RECEIVER

8. THIS COURT ORDERS that no proceeding or enforcement process in any court or

tribunal (each, a "Proceeding"), shall be commenced or continued against the Receiver except

with the written consent of the Receiver or with leave of this Court.

NO PROCEEDINGS AGAINST THE DEFENDANTS OR THE DOMESTIC PROPERTY

9. THIS COURT ORDERS that no Proceeding in Canada (a "Domestic Proceeding")

against or in respect of any of the Defendants or the Domestic Property shall be commenced or

continued except with the written consent of the Receiver or with leave of this Court, and,

subject to paragraph 37 hereof, any and all Domestic Proceedings currently under way against or

in respect of any of the Defendants or the Domestic Property are hereby stayed and suspended

pending further Order of this Court.

NO EXERCISE OF RIGHTS OR REMEDIES

10. THIS COURT ORDERS that all rights and remedies against any Defendant, the

Receiver, or affecting the Domestic Property, are hereby stayed and suspended except with the

written consent of the Receiver or leave of this Court, provided however that this stay and

suspension does not apply in respect of (i) any "eligible financial contract" as defined in the

Bankruptcy and Insolvency Act, R.S.C., 1985, c. B-3 (the "BIA"), or (ii) any rights and remedies

in respect of a Proceeding that is not a Domestic Proceeding, further provided that nothing in this

paragraph shall (a) empower the Receiver or any Defendant to carry on any business which any

Defendant is not lawfully entitled to carry on, (b) exempt the Receiver or any Defendant from

compliance with statutory or regulatory provisions relating to health, safety or the environment,

(c) prevent the filing of any registration to preserve or perfect a security interest, or (d) prevent

the registration of a claim for lien.

NO INTERFERENCE WITH THE RECEIVER

11. THIS COURT ORDERS that no Person shall discontinue, fail to honour, alter, interfere

with, repudiate, terminate or cease to perform any right, renewal right, contract, agreement,

23451639.11

9-



























23451639.11

9-



























23451639.11

id a - 1 0 -

licence or permit in favour of or held by any Defendant, without written consent of the Receiver

or leave of this Court.

CONTINUATION OF SERVICES

12. THIS COURT ORDERS that all Persons having oral or written agreements with any

Defendant or statutory or regulatory mandates for the supply of goods and/or services, including,

without limitation, all computer software, communication and other data services, centralized

banking services, payroll services, insurance, transportation services, utility or other services to

the Defendant are hereby restrained until further Order of this Court from discontinuing, altering,

interfering with or terminating the supply of such goods or services as may be required by the

Receiver, and that the Receiver shall be entitled to the continued use of any Defendant's current

telephone numbers, facsimile numbers, internet addresses and domain names, provided in each

case that the normal prices or charges for all such goods or services received after the date of this

Order are paid by the Receiver in accordance with normal payment practices of such Defendant

or such other practices as may be agreed upon by the supplier or service provider and the

Receiver, or as may be ordered by this Court.

RECEIVER TO HOLD FUNDS

13. THIS COURT ORDERS that all funds, monies, cheques, instruments, and other forms of

payments received or collected by the Receiver from and after the making of this Order from any

source whatsoever, including, without limitation, the sale of all or any of the Domestic Property

and the collection of any accounts receivable in whole or in part, whether in existence on the date

of this Order or hereafter coming into existence, shall be deposited into one or more new

accounts to be opened by the Receiver (the "Post Receivership Accounts") and the monies

standing to the credit of such Post Receivership Accounts from time to time, net of any

disbursements provided for herein, shall be held by the Receiver to be paid in accordance with

the terms of this Order or any further Order of this Court. The Receiver shall segregate any funds

received by it that constitute Foreign Property, and record and keep such Foreign Property

separate and apart from any Domestic Property, pending further Order of this Court.

EMPLOYEES

23451639.11

id a - 1 0 -




























EMPLOYEES

23451639.11

id a - 10 -




























EMPLOYEES

23451639.11

-11- 423

14. THIS COURT ORDERS that all employees of the Defendants, if any, shall remain the

employees of the Defendants until such time as the Receiver, on the Defendants' behalf, may

terminate the employment of such employees. The Receiver shall not be liable for any employee-

related liabilities, including any successor employer liabilities as provided for in section

14.06(1.2) of the BIA, other than such amounts as the Receiver may specifically agree in writing

to pay, or in respect of its obligations under subsections 81.4(5) or 81.6(3) of the BIA or under

the Wage Earner Protection Program Act.

PIPEDA

15. THIS COURT ORDERS that, pursuant to clause 7(3)(c) of the Canada Personal

Information Protection and Electronic Documents Act, the Receiver shall disclose personal

information of identifiable individuals to prospective purchasers or bidders for the Domestic

Property and to their advisors, but only to the extent desirable or required to negotiate and

attempt to complete one or more sales of the Domestic Property (each, a "Sale"). Each

prospective purchaser or bidder to whom such personal information is disclosed shall maintain

and protect the privacy of such infoimation and limit the use of such information to its evaluation

of the Sale, and if it does not complete a Sale, shall return all such information to the Receiver,

or in the alternative destroy all such information. The purchaser of any Domestic Property shall

be entitled to continue to use the personal information provided to it, and related to the Domestic

Property purchased, in a manner which is in all material respects identical to the prior use of such

information by any Defendant, and shall return all other personal information to the Receiver, or

ensure that all other personal information is destroyed.

LIMITATION ON ENVIRONMENTAL LIABILITIES

16. THIS COURT ORDERS that nothing herein contained shall require the Receiver to

occupy or to take control, care, charge, possession or management (separately and/or

collectively, "Possession") of any of the Domestic Property that might be environmentally

contaminated, might be a pollutant or a contaminant, or might cause or contribute to a spill,

discharge, release or deposit of a substance contrary to any federal, provincial or other law

respecting the protection, conservation, enhancement, remediation or rehabilitation of the

environment or relating to the disposal of waste or other contamination including, without

23451639.11

-11- 423








PIPEDA






















23451639.11

-11- 423








PIPEDA






















23451639.11

- 12 -

limitation, the Canadian Environmental Protection Act, the Ontario Environmental Protection

Act, the Ontario Water Resources Act, or the Ontario Occupational Health and Safety Act and

regulations thereunder (the "Environmental Legislation"), provided however that nothing

herein shall exempt the Receiver from any duty to report or make disclosure imposed by

applicable Environmental Legislation. The Receiver shall not, as a result of this Order or

anything done in pursuance of the Receiver's duties and powers under this Order, be deemed to

be in Possession of any of the Domestic Property within the meaning of any Environmental

Legislation, unless it is actually in possession.

LIMITATION ON THE RECEIVER'S LIABILITY

17. THIS COURT ORDERS that the Receiver shall incur no liability or obligation as a result

of its appointment or the carrying out the provisions of this Order, save and except for any gross

negligence or wilful misconduct on its part. Nothing in this Order shall derogate from the

protections afforded the Receiver by section 14.06 of the BIA or by any other applicable

legislation.

RECEIVER'S ACCOUNTS

18. THIS COURT ORDERS that the Receiver and counsel to the Receiver shall be paid their

reasonable fees and disbursements, in each case at their standard rates and charges unless

otherwise ordered by the Court on the passing of accounts, and that the Receiver and counsel to

the Receiver shall be entitled to and are hereby granted a charge (the "Receiver's Charge") on

the Domestic Property, as security for such fees and disbursements, both before and after the

making of this Order in respect of these proceedings, and that the Receiver's Charge shall form a

first charge on the Domestic Property in priority to all security interests, trusts, liens, charges and

encumbrances, statutory or otherwise (collectively, "Encumbrances"), in favour of any Person

other than (a) any validly perfected security interest under the PPSA, or such other applicable

legislation, and (b) statutory super-priority deemed trusts and liens for unpaid employee source

deductions ((a) and (b), collectively, the "Priority Charges").

23451639.11

- 12 -














legislation.

RECEIVER'S ACCOUNTS












23451639.11

- 12 -














legislation.

RECEIVER'S ACCOUNTS












23451639.11

48C -13-

19. THIS COURT ORDERS that the Receiver and its legal counsel shall pass its accounts

from time to time, and for this purpose the accounts of the Receiver and its legal counsel are

hereby referred to a judge of the Commercial List of the Ontario Superior Court of Justice.

20. THIS COURT ORDERS that prior to the passing of its accounts, the Receiver shall be at

liberty from time to time to apply reasonable amounts, out of the monies in its hands, against its

fees and disbursements, including legal fees and disbursements, incurred at the standard rates

and charges of the Receiver or its counsel, and such amounts shall constitute advances against its

remuneration and disbursements when and as approved by this Court.

FUNDING OF THE RECEIVERSHIP

21. THIS COURT ORDERS that the Receiver be at liberty and it is hereby empowered to

borrow by way of a revolving credit or otherwise, such monies from time to time as it may

consider necessary or desirable, provided that the outstanding principal amount does not exceed

$150,000 (or such greater amount as this Court may by further Order authorize) at any time, at

such rate or rates of interest as it deems advisable for such period or periods of time as it may

arrange, for the purpose of funding the exercise of the powers and duties conferred upon the

Receiver by this Order, including interim expenditures. The whole of the Domestic Property

shall be and is hereby charged by way of a fixed and specific charge (the "Receiver's

Borrowings Charge") as security for the payment of the monies borrowed, together with

interest and charges thereon, in priority to all Encumbrances in favour of any Person, other than

the Priority Charges and the Receiver's Charge.

22. THIS COURT ORDERS that neither the Receiver's Charge, Receiver's Borrowings

Charge nor any other security granted by the Receiver in connection with its borrowings under

this Order shall be enforced without leave of this Court.

23. THIS COURT ORDERS that the Receiver is at liberty and authorized to issue certificates

substantially in the form annexed as Schedule "A" hereto (the "Receiver's Certificates") for any

amount borrowed by it pursuant to this Order.

24. THIS COURT ORDERS that the monies from time to time borrowed by the Receiver

pursuant to this Order or any further order of this Court and any and all Receiver's Certificates

23451639.11

48C -13-





























23451639.11

48C -13-





























23451639.11

#gG- 14 -

evidencing the same or any part thereof shall rank on a pani passu basis, unless otherwise agreed

to by the holders of any prior issued Receiver's Certificates.

25. THIS COURT ORDERS that the Plaintiff or the Receiver shall be entitled, on a

subsequent motion on not less than seven (7) days' notice to those Persons likely to be affected

thereby, to seek priority of the Receiver's Charge and/or the Receiver's Borrowings Charge,

ahead of any Encumbrances over which such charges have not obtained priority.

SERVICE AND NOTICE

26. THIS COURT ORDERS that the E-Service Protocol of the Commercial List (the

"Protocol") is approved and adopted by reference herein and, in these proceedings, the service

of documents made in accordance with the Protocol (which can be found on the Commercial List

website at http ://www.ontariocourts.ca/scj/practice/practice-directionsitoronto/eservice-

commercial/) shall be valid and effective service. Subject to Rule 17.05 of the Ontario Rules of

Civil Procedure (the "Rules"), this Order shall constitute an order for substituted service

pursuant to Rule 16.04 of the Rules. Subject to Rule 3.01(d) of the Rules and paragraph 21 of

the Protocol, service of documents in accordance with the Protocol will be effective on

transmission. This Court further orders that a Case Website shall be established in accordance

with the Protocol with the following URL: www.alvarezandmarsal.com/mdhealth.

27. THIS COURT ORDERS that if the service or distribution of documents in accordance

with the Protocol is not practicable, the Receiver is at liberty to serve or distribute this Order, any

other materials and orders in these proceedings, any notices or other correspondence, by

forwarding true copies thereof by prepaid ordinary mail, courier, personal delivery or facsimile

transmission to the Defendants' creditors or other interested parties at their respective addresses

as last shown on the records of the Defendants and that any such service or distribution by

courier, personal delivery or facsimile transmission shall be deemed to be received on the next

business day following the date of forwarding thereof, or if sent by ordinary mail, on the third

business day after mailing.

23451639.11

#gG- 14 -







SERVICE AND NOTICE




















23451639.11

#gG - 14 -







SERVICE AND NOTICE




















23451639.11

- 15 -

GENERAL

28. THIS COURT ORDERS that the Receiver may from time to time apply to this Court for

advice and directions in the discharge of its powers and duties hereunder.

29. THIS COURT ORDERS that nothing in this Order shall prevent the Receiver from acting

as a trustee in bankruptcy of any Defendant.

30. THIS COURT HEREBY REQUESTS the aid and recognition of any court, tribunal,

regulatory or administrative body having jurisdiction in Canada or in any foreign jurisdiction to

give effect to this Order and to assist the Receiver and its agents in carrying out the terms of this

Order. All courts, tribunals, regulatory and administrative bodies are hereby respectfully

requested to make such orders and to provide such assistance to the Receiver, as an officer of this

Court, as may be necessary or desirable to give effect to this Order or to assist the Receiver and

its agents in carrying out the terms of this Order.

31. THIS COURT ORDERS that the Receiver be at liberty and is hereby authorized and

empowered to apply to any court, tribunal, regulatory or administrative body, wherever located,

for the recognition of this Order and for assistance in carrying out the terms of this Order, and

that the Receiver is authorized and empowered to act as a representative in respect of the within

proceedings for the purpose of having these proceedings recognized in a jurisdiction outside

Canada.

32. THIS COURT ORDERS that the Plaintiff shall have its costs of this motion, up to and

including entry and service of this Order, and the costs of the Plaintiff's motion to obtain the

Mareva Orders, in each case on a full indemnity basis, to be paid by the Receiver from the

Defendants' estates with such priority and at such time as this Court may determine.

MISCELLANEOUS AND PROCEDURAL MATTERS

33. THIS COURT ORDERS that any interested party may apply to this Court to vary or

amend this Order on not less than seven (7) days' notice to the Receiver and to any other party

likely to be affected by the order sought or upon such other notice, if any, as this Court may

order.

23451639.11

- 15 -

GENERAL

















Canada.









order.

23451639.11

- 15 -

GENERAL

















Canada.









order.

23451639.11

I48Y-16-

34. THIS COURT ORDERS that the Plaintiff is granted leave to bring this motion without

notice.

35. THIS COURT ORDERS that the Motion Record for a Receiver, the Factum, and Book of

Authorities, of the Plaintiff, all dated September 10, 2018, and this Order (the "Sealed

Materials") are hereby sealed and that no one shall have access to the Sealed Materials except

for the parties in this proceeding and their respective legal counsel until five (5) days from the

date of this Order have elapsed, subject to paragraph 36 of this Order.

36. THIS COURT ORDERS that this Order:

(a) may be provided by the Receiver to such persons at such times as the Receiver in

its sole discretion deems necessary or advisable to permit or assist the Receiver in

the exercise of the Receiver's powers and duties conferred by this Order; and

(b) shall be served on the persons listed on the Service List attached at Schedule "B"

hereto in accordance with paragraphs 26 and 27 of this Order within ten days of

the date of this Order, or at such earlier time at the Receiver may determine in its

discretion.

PLAINTIFF'S MOTION FOR JUDGMENT

37. THIS COURT ORDERS that, notwithstanding paragraphs 9 and 10 of this Order, the

Plaintiff is granted leave to (a) bring a motion for judgment in this action and to take out any

judgment or order arising therefrom, (b) take any steps in furtherance of or that follow from such

judgment or order (except to the extent such steps would interfere with the Receiver's exclusive

powers in paragraph 2 of this Order), (c) bring any motion to add parties to this action, (d) take

any steps to enforce any judgment or order in a Proceeding that is not a Domestic Proceeding,

and (e) take any steps permitted by the Mareva Orders and/or to bring any motion to vary or

amend the Mareva Orders, in each case without further notice to the Defendants unless required

by law. The Plaintiff's motion for judgment shall be returnable on a date to be set by this Court

at a 9:30 appointment.

23451639.11

I48Y-16-


notice.













discretion.












23451639.11

I48Y -16-


notice.













discretion.












23451639.11

- 17 - 4y 9

CONTINUATION OF THE MAREVA ORDERS

38. THIS COURT ORDERS that the Mareva Orders shall not in any way affect or limit the

powers and duties of the Receiver conferred by this Order.

39. THIS COURT ORDERS that the Receiver shall disclose to the Plaintiff all relevant

information acquired or received by the Receiver regarding the Defendants, the Domestic

Property, and the Foreign Property, subject in all cases to such terms as to confidentiality as the

Receiver deems advisable.

40. THIS COURT ORDERS that, subject to paragraph 38 of this Order, the Mareva Orders

remain in full force and effect in all other respects.

41. THIS COURT ORDERS that TD Canada Trust forthwith freeze and prevent any removal

or transfer of monies or assets held in any account (the "DS Account"), until

further Order of the Court.

42. THIS COURT ORDERS that TD Canada Trust forthwith disclose and deliver up to the

Receiver and the Plaintiff any and all records held by it concerning the DS Account.

Justice Dunphy

23451639.11

- 17 - 4y 9















Justice Dunphy

23451639.11

- 17 - 4y 9















Justice Dunphy

23451639.11

SCHEDULE "A"

RECEIVER CERTIFICATE

CERTIFICATE NO.

AMOUNT $

1. THIS IS TO CERTIFY that Alvarez & Marsal Canada Inc., the receiver (the "Receiver")

of all of the assets, undertakings and properties of Sameh Sadek also known as Sam Sadek, St.

Maharial Pharmacy Inc. dba MD Health Pharmacy, St. Maharial Clinic Inc., SRX Investment

Inc., Shepherd RX Pharmacy Inc. and Lilian Fam, including all proceeds thereof, to the extent

such assets, undertakings and properties are located in Canada (collectively, the "Domestic

Property") appointed by Order of the Ontario Superior Court of Justice (Commercial List) (the

"Court") dated the 11th day of September, 2018 (the "Order") made in an action having Court

file number CV-18-602745-00-CL, has received as such Receiver from the holder of this

certificate (the "Lender") the principal sum of $ , being part of the total principal

sum of $ which the Receiver is authorized to borrow under and pursuant to the

Order.

2. The principal sum evidenced by this certificate is payable on demand by the Lender with

interest thereon calculated and compounded [daily] [monthly not in advance on the

of each month] after the date hereof at a notional rate per annum equal to the rate of

cent above the prime commercial lending rate of Bank of from time to time.

3. Such principal sum with interest thereon is, by the terms of the Order, together with the

principal sums and interest thereon of all other certificates issued by the Receiver pursuant to the

Order or to any further order of the Court, a charge upon the whole of the Domestic Property, in

priority to the security interests of any other person (other than the Priority Charges, as defined

in the Order), but subject to the priority of the charges set out in the Order and in the Bankruptcy

and Insolvency Act, R.S.C. 1985, c. B-3 (the "BIA"), and the right of the Receiver to indemnify

itself out of such Property in respect of its remuneration and expenses.

23451639.11

day

per

SCHEDULE "A"


CERTIFICATE NO.

AMOUNT $











Order.












23451639.11

day

per

SCHEDULE "A"


CERTIFICATE NO.

AMOUNT $











Order.












23451639.11

day

per

-2

4. All sums payable in respect of principal and interest under this certificate are payable at

the main office of the Lender at Toronto, Ontario.

5. Until all liability in respect of this certificate has been terminated, no certificates creating

charges ranking or purporting to rank in priority to this certificate shall be issued by the Receiver

to any person other than the holder of this certificate without the prior written consent of the

holder of this certificate.

6. The charge securing this certificate shall operate so as to permit the Receiver to deal with

the Domestic Property as authorized by the Order and as authorized by any further or other order

of the Court.

7. The Receiver does not undertake, and it is not under any personal liability, to pay any

sum in respect of which it may issue certificates under the terms of the Order.

DATED the day of , 20_.

ALVAREZ & MARSAL CANADA INC., solely in its capacity as Receiver of the Property, and not in its personal capacity

Per:

Name:

Title:

23451639.11

-2









of the Court.





Per:

Name:

Title:

23451639.11

-2









of the Court.





Per:

Name:

Title:

23451639.11

4 3

SCHEDULE "B" SERVICE LIST

Defendants

TO: SAMEH SADEK ALSO KNOWN AS SAM SADEK, ST. MAHARIAL PHARMACY INC. dba MD HEALTH PHARMACY, ST. MAHARIAL CLINIC INC., SRX INVESTMENT INC. and SHEPHERD RX PHARMACY INC.

E-mail: [email protected]

AND TO: LILIAN FAM 5045 Churchill Meadows Blvd. Mississauga ON L5M 7Z8


Banks named in August 9, 2018 and September 5, 2018 Orders of the Honourable Justice Dunphy

AND TO: RBC ROYAL BANK Kathrine Smirle 200 Bay Street Toronto, ON M5J 2J5 [email protected]

AND TO: THE BANK OF NOVA SCOTIA Ian Arellano, Executive Vice-President and General Counsel 44 King Street West Toronto, ON M5H 1H1 [email protected]

AND TO: CANADIAN IMPERIAL BANK OF COMMERCE Stephen Scholtz Senior Vice-President and General Counsel (Canada) 199 Bay Street, Commerce Court West, 11th Floor Toronto, ON M5L 1A2 [email protected]

23451639.11

4 3


Defendants









23451639.11

4 3


Defendants









23451639.11

493 4

AND TO: TD CANADA TRUST Ellen Patterson Group Head and General Counsel TD Bank Group 12th Floor, TD Tower, TD Centre PO Box 1, Stn. Toronto Dom. Toronto, Ontario M5K 1A2 [email protected]

Legal Demands Department 4720 Tahoe Boulevard, 3rd Floor Mississauga, ON L4W 5P2 Phone: 877-372-3972 Fax: 855-569-1640 ATTN: Rosanna Paolitto

AND TO: BANK OF MONTREAL Miguel Mendes Senior Counsel & VP, BMO Financial Group 1 First Canadian Place, 21st Floor Toronto, Ontario M5X 1A1 [email protected]

AND TO: HSBC BANK CANADA Lilac Bosma Senior Vice-President and General Counsel 1100-885 West Georgia Street Vancouver, BC V6C 3E8 E-mail: lilac.bosmaAhsbc.ca

HSBC Branch 1675 The Chase Mississauga, ON L5M 5Y7

HSBC Branch 101-3029 Argentia Rd Mississauga, ON L5N8P7

23451639.11

493 4







23451639.11

493 4







23451639.11

5

AND TO: NATIONAL BANK OF CANADA Dominic Paradis Vice-President, Legal Affairs and Corporate Secretary Corporate Secretary's Office 600 De La Gauchetiere Street West, 4th Floor Montreal, Quebec H3B 4L2 [email protected]

Parties to other proceedings involving the defendants

McKesson Canada Corporation v. St. Maharial Pharmacy Inc. et al.

AND TO: MILLS & MILLS LLP 2 St. Clair Avenue West — Suite 700 Toronto, ON M4V 1L5

Richard Worsfold Tel: 416-682-7113 Fax: 416-863-3997 E-mail: [email protected]

Lawyers for the plaintiff in the above-noted proceeding, McKesson Canada Corporation

ESI Canada v. St. Maharial Pharmacy Inc. dba MD Health pharmacy

AND TO: STIKEMAN ELLIOTT LLP 5300 Commerce Court West 199 Bay Street Toronto, ON M5L 1B9

Alex Rose Tel: 416-869-5261 E-mail: [email protected]

Lawyers for the applicant in the above-noted proceeding, ESI Canada

23451639.11

5











23451639.11

5











23451639.11

-6

Teva Canada Limited v. St. Maharial Pharmacy Inc. et al.

AND TO: BENNETT JONES LLP 100 King Street West, Suite 3400 Toronto, ON M5X 1A4

Dominique T. Hussey Tel: 416-777-6230 E-mail: [email protected]

Lawyers for the plaintiff in the above-noted proceeding, Teva Canada Limited

170735 Ontario Inc. et al. v. Emily Rx Pharm Inc. et al.

AND TO: BISCEGLIA & ASSOCIATES PROFESSIONAL CORPORATION

7941 Jane Street, Suite 200 Concord, ON L4K 4L6

Emilio Bisceglia Tel: (905)-695-5200 E-mail: [email protected]

Lawyers for the plaintiffs in the above-noted proceeding, 170735 Ontario Inc., MD Investments Inc. and MD Health Medical Centre (Brampton) Inc.

AND TO: BLANEY MCMURTRY LLP

2 Queen Street East, Suite 1500 Toronto, ON MSC 3G5

Lou Brzezinski Tel: (416)-594-2952 Fax: (416)-594-5084 E-mail : [email protected]

Varouj an Arman Tel: (416)-596-2884 Fax: (416)-593-2960 E-mail: [email protected]

Lawyers for the defendant in the above-noted proceeding, Emily Rx Phann Inc.

23451639.11

-6















23451639.11

-6















23451639.11

7

AND TO: POTESTIO LAW 253 Jevlan Drive Vaughan, ON L4L 7Z6

Timothy Gindy Dir: (905)-850-2642 Fax: (905)-850-8544 E-mail: [email protected]

Lawyers for the defendant in the above-noted proceeding, Medhat Saad, also known as Matty Saad

Creditors (if not named above)

AND TO: MAXIUM FINANCIAL SERVICES INC. AND CWB MAXIUM FINANCIAL INC. 30 Vogell Rd. #1 Richmond Hill, ON L4B 3K6

AND TO: STUART BUDD & SONS LTD. 2430 S Service Rd W Oakville, ON L6L M59

AND TO: KOHL & FRITSCH LIMITED 7622 Keele Street Concord, ON L4K 2R5

Other

AND TO: STI TECHNOLOGIES LTD. 38 Solutions Drive #200 Halifax, NS B3S 1L8

AND TO: CLAIMSECURE INC. 1 City Centre Dr #620 Mississauga, ON L5B 1M2

AND TO: CAMERON STEWART LIFESCIENCE CANADA INC. 3470 Superior Court Oakville, ON L6L 0C4

23451639.11

7








Other




23451639.11

7








Other




23451639.11

8

AND TO: MINISTRY OF FINANCE (ONTARIO) Legal Service Branch 33 King Street West, 6th Floor Oshawa, ON L1H 8H5

Kevin O'Hara Tel: 905-433-6934 Fax: 905-436-4510 Email: [email protected]

AND TO: DEPARTMENT OF JUSTICE Counsel for the Canada Revenue Agency The Exchange Tower 130 King Street West, Suite 3400 PO Box 36 Toronto, ON M5X 1K6

Diane Winters Tel: 416-973-3172 Fax: 416-973-0810 Email: diane.winters@justice. gc.ca

AND TO: ONTARIO COLLEGE OF PHARMACISTS Investigations and Resolutions 483 Huron Street Toronto, ON M5R 2R4 Phone: 1-800-220-1921 Fax: 416-847-8499

ATTN: Complaints Intake Assistant complaintsocpinfo.com

ATTN: Shelina Manji, Investigator [email protected]

AND TO:

23451639.11

8








AND TO:

23451639.11

8








AND TO:

23451639.11

Tab 6Tab 6

RevisedJanuafy-11, 2014 G.213(1) BIA (National Receiver) and s. 101 CJA (Ontario) Receiver

Court File No.

CV-18-602745-00-CI,


COMMERCIAL LIST

THE HONOURABLE

JUSTICE MR.

WEEKDAYTIIESDAY, THE #11 TH

DAY OF MONTH, 20YR

ASTRAZENECA CANADA INC. PLAIlsaIFF1

- and -

DEFENDANT

OF SEPTEMBER. 2018

Plaintiff

Defendant



Defendants


THIS MOTION made by-ex parte by Astrazeneca Canada Inc. (the `_`_Plaintiff2D for an

Order pursuant to section443-(4)-ef4he Bankruptcy and insol-veney-A-eti--1- -',C, 1985, c. B 3, as

1 The Model Order Subcommittee notes that a receivership proceeding may be commenced by action or by application. -This-model order is drafted on the-bas-i-s4hat4he receiverchip proceeding-i-s-commenced by way of an action,

2-Section 2/13(1) of the BIA provides that the Court may appoint a receiver on application by a secured-cedior".

21:64.4441771712\9

RevisedJanuafy-11, 2014 G.213(1) BIA (National Receiver) and s. 101 CJA (Ontario) Receiver

Court File No.

CV-18-602745-00-CI,


COMMERCIAL LIST

THE HONOURABLE

JUSTICE MR.

WEEKDAYTIIESDAY, THE #11 TH

DAY OF MONTH, 20YR


- and -

DEFENDANT

OF SEPTEMBER. 2018

Plaintiff

Defendant



Defendants



Order pursuant to section443-(4)-ef4he Bankruptcy and insol-veney-A-eti--1- -',C, 1985, c. B 3, as



21:64.4441771712\9

G.213(1) B1A (National Receiver) and s. 101 CJA (Ontario) Receiver

Court File No.

CV-18-602745-00-CI,


COMMERCIAL LIST

THE HONOURABLE

JUSTICE MR.

WEEKDAYTIJESDAY, THE #11 TH

DAY OF MONTH, 20YR


- and -

DEFENDANT

OF SEPTEMBER. 2018

Plaintiff

Defendant



Defendants



Order pursuant to section443-(4)-ef-the Bankruptcy and in-sol-veney-A-et-i-fg,G, 1985, c. B 3, as



21:64.4441771712\9

DUC6TUR: 1771712 \ 9

2

amended (the "BIA") and section 101 of the Courts of Justice Act, R.S.O. 1990, c. C.43, as

amended (the L"CJAL") appointing [RECEIVER'S NAME]Alvarez & Marsal Canada Inc.

("A&M") as receiver fand-hranageil---(in such capacitiescapacity, the -Receiver-_), without

security, of all of the domestic assets, undertakings and properties of [DEBTOR'S NAME] (the

'Debtor"}asquired-for, or-use-d-in-re-l-ation-4o-a-business-eaffied-on-by the-DebterSameh Sadek

also known as Sam Sadek, St Maharial Pharmacy Inc dha MD Health Pharmacy, St Maharial

C1' • I SRX Investment Inc She .herd RX Pharmacy Inc and Lilian Fam (collectively

"Defendants" and, individually, a "Defendant"), and for related relief, was heard this day at 330

University Avenue, Toronto, Ontario.

ON READING the affidavit of [NAME] sworn [DATE] and the Exhibits theretoMotion

Record and Factum of the Plaintiff dated August 8, 2018, the Supplemental Motion Record of

the Plaintiff dated August 17, 2018, the Second Supplemental Motion Record of the Plaintiff

dated September 5, 2018, and t e Motion Record for a Receiver, the Factum and Book of

Authorities of the Plaintiff dated September 10, 2018, and the Orders of the Honourable Justice

Dunphy dated August 9, 2018 (the "August 9 Order"), August 17, 2018 (the "August 17

Order") and September 5, 2018 (the "September Order" and, together with the Au• • • q -

and the August 17 Order, the "Mareva Orders"), and on hearing the submissions of counsel for

{NAMES-fr-no-ene-appearing-for-INAMEI-aftheugh-duty-served-as appears-from the-affirlav-it-of-

Gervice of [NAME] sworn [DATE}the Plaintiff, and on reading the consent of [RECEIVER'S

NAME]A&M to act as the Receiver,

SERVICE

-1, T-HIS-GO-UR-T-ORDERS-that-the-time-for-serviee-ef-the-Net4ee-of-Motion-and4he-Motiew

is-hereby-ahridged-and-val-idate(43- so that-this motion is properly-returnable-tedad hereby-

dispenses with further service thereof.

er4Ilan-as-autherized-133414-e-Cmtario Rules of Civil Pre validating irregular service is required pursuant to Rule 16.08 of the Rules of Civil Procedure and may be granted in-apprepfiete-oire-umstanees,

23451639 11

4191 DUC6TUR: 1771712 \ 9

2



("A&M") as receiver fand-hranageil---(in such capacitiescapacity, the -Receiver-_), without


'Debtor"}asquired-for, or-use-d-in-re-l-ation-4o-a-business-eaffied-on-by the-DebterSameh Sadek


C1' • I SRX Investment Inc She .herd RX Pharmacy Inc and Lilian Fam (collectively




Record and Factum of the Plaintiff dated August 8, 2018, the Supplemental Motion Record of

the Plaintiff dated August 17, 2018, the Second Supplemental Motion Record of the Plaintiff


Authorities of the Plaintiff dated September 10, 2018, and the Orders of the Honourable Justice


Order") and September 5, 2018 (the "September Order" and, together with the Au• • • q -


{NAMES-fr-no-ene-appearing-for-INAMEI-aftheugh-duty-served-as appears-from the-affirlav-it-of-



SERVICE

-1, T-HIS-GO-UR-T-ORDERS-that-the-time-for-serviee-ef-the-Net4ee-of-Motion-and4he-Motiew

is-hereby-ahridged-and-val-idate(43- so that-this motion is properly-returnable-tedad hereby-


er4Ilan-as-autherized-133414-e-Cmtario Rules of Civil Pre validating irregular service is required pursuant to Rule 16.08 of the Rules of Civil Procedure and may be granted in-apprepfiete-oire-umstanees,

23451639 11

4191 DUC6TUR: 1771712 \ 9

2



("A&M") as receiver fartd-tn-anagetl---(in such capacitiescapacity, the -Receiver-_), without


'Debtor"}asquired-for, or-use-d-in-re-l-ation-4e-a-business-eaffied-on-by the-DebterSameh Sadek


Cl• • I SRX Investment Inc She .herd RX Pharmacy Inc and Lilian Fam (collectively




Record and Factumf the Plaintiff dated A t 8. 2018 the Sunnlemental Motion Record of

the Plaintiff dated A t 17. 2018 the Second S lemental Motion Record of the Plaintiff


Authorities f the Plaintiff dated S t b 10, 2018 and the Orders of the Honourable Justice


Order") and September 5, 2018 (the "September Order" and, together with the Au• • I q -


{NAMES-17-no-ene-appearing-for-lNAME1-aftheugh-duty-served-as appears-from the-affirfav-it-of-



SERVICE

-1, THIS COURT ORDERS that the time for service of the Notice of Motion and the Motion

&-her-ebabfi4ge-d--and--Ya144ate4 so that-this motion is properly-returnable-tedad hereby-


er4Ilan-as-autherized-133414-&-Cmtario Rules of Civil Pre validating irregular service is required pursuant to Rule 16.08 of the Rules of Civil Procedure and may be granted iti-apprepfiete-oire-umstanees,

23451639 11

4191

-144:4S I OR: 1771741V9

3

APPOINTMENT

2-THIS COURT ORDERS that pursuant to section 213(1) of the BIA and section 101 of

the CJA, [RECEIVER'S NAME]A&M is hereby appointed Receiver, without security, of all of

the assets, undertakings and properties of the Debtor acquired for, or used in relation to a

bu-s-i-ness-earried-oft-by-the-Debt-erDefendants, including all proceeds thereof (the "Property" to

the extent that '14 assets, undertakings and properties _are located in Canada (the "Domestic

Property"), Without limiting the generality of the foregoing, the Domestic Property includes all

of the right, title and interest of the Defendants in and to the real property with the following

legal descriptions.


Description PART OF LO 11, PLAN 43M1663, DES PART 6, PL 43R30324; MISSISSAUGA S/T EASEMENT FOR ENTRY AS TN PR806741. S/T EASEMENT FOR ENTRY AS IN PR1007490.

Address_ 5045 CHURCHILL MEADOWS BOULEVARD MISSISSAUGA, ONTARIO, L5M 7Z8


Description PT LT 26 PL 396 DES PART 1 43R29866• MTSSISSAIIGA S/T EASEMENT OVER PT LT 26 PL 396 DES PART 1 43R29866 AS IN PR1037379

Address 2334 HAMMOND ROAD MISSISSAUGA, ONTARIO, L5K I T2

RECEIVER'S POWERS

3,-THIS COURT ORDERS that the Receiver is hereby empowered and authorized, but

not obligated, to act at once in respect of the Domestic Property and, without in any way limiting

the generality of the foregoing, the Receiver is hereby expressly empowered and authorized to do



all proceeds, receipts and disbursements arising out of or from the

23451639.11

-144:4S I OR: 1771741V9

3

APPOINTMENT




bu-s-i-ness-earried-oft-by-the-Debt-erDefendants, including all proceeds thereof (the "Property" to




legal descriptions.


Description PART OF LO 11, PLAN 43M1663, DES PART 6, PL 43R30324; MISSISSAUGA S/T EASEMENT FOR ENTRY AS TN PR806741. S/T EASEMENT FOR ENTRY AS IN PR1007490.

Address_ 5045 CHURCHILL MEADOWS BOULEVARD MISSISSAUGA, ONTARIO, L5M 7Z8




RECEIVER'S POWERS







23451639.11

-144:4S I OR: 1771741V9

3

APPOINTMENT




bu-siness-earfied-oft-by-the-Debt-erDefendants, including all proceeds thereof (the "Property" to




legal descriptions.


Description PART OF LO 11, PLAN 43M1663, DES PART MISSISSAUGA S/T EASEMENT FOR ENTRY AS TN PR806741. FOR ENTRY AS IN PR1007490.

6, PL 43R30324; S/T EASEMENT

Address 5045 CHURCHILL MEADOWS BOULEVARD ONTARIO, L5M 7Z8


MISSISSAUGA,



RECEIVER'S POWERS







23451639.11

DOLS I OR: 1771'11219

4

Property;Domestic Property. but, for greater certainty, excluding any business

and/or operations carried on by any of the Defendants;






(c) to manege-T-eper-ate-;-arid-earr-y-en4he-husine-ss-ef-the-Debter3-inc-fudit+g-the-powers-

to enter into any agreements, incur any obligations in the-erdinary-c-ourse-of

business, cease to carry on all or any part of the business, or cease to perform any

entraets-ef4he-De1ter-identifv

forced seizure or sale pursuant to the Execution Act, R.S.O. 1990, c E-24 (the

"Execution Act"); or (b) constitutes "consumer goods", as that term is defined in

the F- • al Property15'_ecuoLv_zict 8,S_O 1990. c P 10 (the "PPSA") and in th-

case of property so segregated, to hold such property pending further order of this

Court;

(Al to access all information relating to the Defendants' accounts or finance activities


third party;

is) (61)-to engage consultants, appraisers, agents, experts, auditors, accountants,





(e) to purchase or lease such machinery, equipment, inventories, supplies,

premises or other-assets-to contiftue-the-business e€the Debtor-or any pail

-pafts-thefeef;-

23451639 11

Sol

DOLS I OR: 1771'11219

4













"Execution Act"); or (b) constitutes "consumer goods", as that term is defined in



Court;



third party;








-pafts-thefeef;-

23451639 11

Sol

DOLS I OR: 1771'11219

4













"Execution Act"): or (b) constitutes "consumer goods", as that term is defined in



Court;



third party;








-pafts-thefeef;-

23451639 11

Sol

OQUS 1 OK: 1 71 I 711_ \ 9

-5

to receive and collect all monies and accounts now owed or hereafter owing to the

DebtorDefenclants and to exercise all remedies of the DebtorDefendants in

collecting such monies, including, without limitation, to enforce any security held

by the Debtorany Defendant;

(g) to settle, extend or compromise any indebtedness owing to the Debtorany_

Defendant;


any of the Domestic Property, whether in the Receiverl's name or in the name and

on behalf of tie—Debtorany Defendant, for any purpose pursuant to this Order;


to defend all proceedings now pending or hereafter instituted with respect to the

Debtorany Defendant, the Domestic Property or the Receiver, and to settle or

compromise any such proceedings.4 The authority hereby conveyed shall extend to

such appeals or applications for judicial review in respect of any order or

judgment pronounced in any such proceeding;

(j) to undertak- any investigations deemed necessary by the Receiver with respect to

the location and/or disposition of assets reasonably believed to be, or to., have

been, Domestic ' roperty. including, without limitation, the transfer of any funds

of the Defendants to any related or unrelated pa ies;

(k) subject to any applicable exemption under the Execution Act or t e PPSA to





4 This-model order does-not-ineluele-speeific-author-ity-perntitting-the-Reeei-ver to-either file an assignment-in-

bankruptcy may have-the-effect of altering the-priorities among creditors, and therefore the specific authority of the Court should-be-sought if the Reeeiver wishes to take one of these steps.

23451639 11

OQUS 1 OK: 1 71 I 711_ \ 9

-5






Defendant;











the location and/or disposition of assets reasonably believed to be, or to., have



(k) subject to any applicable exemption under the Execution Act or t e PPSA to





4 This-model order does-not-ineluele-speeific-author-ity-perntitting-the-Reeei-ver to-either file an assignment-in-


23451639 11

OQUS 1 OK: 1 71 I 711_ \ 9

-5






Defendant;











the location and/or disposition of assets reasonably believed to be, or t•_ have



biect licable xemntion underthe ExecutionAct or t e PPSA to





4 This-model order does-not-ineluele-speeific-authority-permitting-the-Reeeiver to-either file an assignment-in-


DUOS FOR: 177179: \9

6

(k) subject to any applicabl

wh. thefividual Defendants are entitled._to sell, convey, transfer, lease or


course of business


exceeding $ ,250,000, provided that the aggregate consideration

for all such transactions does not exceed $ 500,000; and



amount set out in the preceding clause;,

and in each such case notice under subsection 63(4) of the Ontario-Personal-

Property Security Act, [PPSA, or section 31 of the Ontario Mortgages Act, as the

case may be,j5 shall not be required,-and-in each case the-Ontario

&hall-net-apply.;

(n) (1) to apply for any vesting order or other orders necessary to convey the Domestic



(n) (m)-to report to, meet with and discuss with such affected Persons (as defined

below) as the Receiver deems appropriate on all matters relating to the Domestic

Property and the receivership, and to share information;; subject in all cases to

such terms as to confidentiality as the Receiver deems advisable;

a)o make inquiries of anv recipient financial institution in respect of anv and all

fundstransferreilly_ any of the Defendants to anv related or unrelated arties _



other provinces. If this is done, those statutes must be reviewed to ensure that the Receiver is exempt from or can

exemption.

23451639.11

503

DUOS FOR: 177179: \9

6




course of business










&hall-net-apply.;













exemption.

23451639.11

503

DUOS FOR: 177179: \9

6




course of business










shall-net-apply.;













exemption.

23451639.11

503

436)(2S-101(: 1771742\9

- 7 -

(p) 49-to register a copy of this Order and any other Orders in respect of the Domestic

Property against title to any of the Dome ' Property;

01) (e)--to apply for any permits, licences, approvals or permissions as may be required

by any governmental authority and any renewals thereof for and on behalf of and,

if thought desirable by the Receiver, in the name of the Debtorany Defendant;

(1) (p)-to enter into agreements with any trustee in bankruptcy appointed in respect of

the--Debterany Defendant, including, without limiting the generality of the

foregoing, the ability to enter into occupation agreements for any property owned

or leased by the Debtor; any Defendant;

(s) (q-)-to exercise any shareholder, partnership, joint venture or other rights which the-

Debtorany Defendant may have; and

(r) to take any steps reasonably incidental to the exercise of these powers or the

performance of any statutory obligations,, including opening any mail addressed

to any Defendant,



including the DebterDefendants, and without interference from any other Person.

I

Defendants, including all roceeds thereof to the extent that such assets, undertakings and


Domestic Pro y the "Pro er "1 and without in any way limiting the generality of the

fore oing. the Receiver is hereby ex ressly empowered and authorized to do any of the following

where th- Receiver considers it necessary or desirable:

(4) to access all information relating to the Defendants' accounts or finance activities


third party;

$04

23451639.11

436)(2S-101(: 1771742\9

- 7 -














to any Defendant,




I








third party;

$04

23451639.11

436)(2S-101(: 1771742\9

- 7 -














to any Defendant,




I








third party;

$04

23451639.11

DOCS1 UR: 177171219

8

Q to undertake any investigations deemed necessary by the Receiver with respect to



the Defendants o anv related or unrelated alb

(g) to report to, meet with and discuss with such affected Persons (as defined below)

lasthe_Reeeiveems__nganpriatenifal attersrelating to the Foreign Property_

and the receivership, and to share information subject in all cases to such terms as

to conficlentiaJity as the Receiver deems advisable., and

(d)to take anv steps reasonably incidental to the exercise of these powers or the

performance of any statutory obligations. including o • - t' .1 se • • • • - -• •

any Defendant.


4. THIS COURT ORDERS that (i) the DebtecDefendants, (ii) all of itstheir current and

former directors, officers, employees, agents, accountants, legal counsel and shareholders_(as_

applicable), and all other persons acting on its-their instructions or behalf, and (iii) all other


of this Order. including,

financial institutions, or suppliers (all of the foregoing, collectively, being .2."Persons" and each

being a'"_`Person' ") shall forthwith advise the Receiver of the existence of any Property in such

Person'-'s possession or control, shall grant immediate and continued access to the Domestic


Receive's request.


existence of anyelient_recordsandpre.seription_informatiort, books, documents, securities,


information of any kind related to the business or affairs of the Debtor,Defendants, any transfers

of money or Property, or obligations incurred by the Defendants, out of the ordinary course of


5o5

23451639 11

DOCS1 UR: 177171219

8






lasthe_Reeeiveems__nganpriatenifal attersrelating to the Foreign Property_


to conficlentiaJity as the Receiver deems advisable., and

(d)to take anv steps reasonably incidental to the exercise of these powers or the


any Defendant.


4. THIS COURT ORDERS that (i) the DebtecDefendants, (ii) all of itstheir current and









Receive's request.


existence of anyelient_recordsandpre.seription_informatiort, books, documents, securities,





5o5

23451639 11

DOCS1 UR: 177171219

8






as the Receiver deems ap ropriate on all matters relating to the Foreign Property


to confidentiality as the Receiver deems advisable., and

(cl to take anv steps reasonably incidental to the exercise of these powers or the


any Defendant.


4. THIS COURT ORDERS that (i) the DebtecDefendants, (ii) all of itsthcir current and









Receive's request.


existence of anyelient_resordsandpre.seription_informatiort, books, documents, securities,





5o5

23451639 11

-9


1"Recordsn.") in that Person!' s possession or control, and shall provide to the Receiver or permit

the Receiver to make, retain and take away copies thereof and grant to the Receiver unfettered







computer or other electronic system of information storage, whether by independent service












6A. THIS COURT ORDERS that, in the Records subject to e 'e o'e


or a other applicable governing nntario or Canadian statute (collectively. the "Pharmacy

1 maintain

of the con

ntario College of Pharmacists ("College", or any pharmacy to which the College directs the

Receiver to provide such Records (iiil if necessary. annoint a pharmacist licensed and qualified

for such Records;


23451639 11

504

-9






















6A. THIS COURT ORDERS that, in the Records subject to e 'e o'e


or a other applicable governing nntario or Canadian statute (collectively. the "Pharmacy

1 maintain

of the con


Receiver to provide such Records (iiil if necessary. annoint a pharmacist licensed and qualified

for such Records;


23451639 11

504

-9






















6A. THIS COURT ORDERS that, in the Records subject to e 'e o'e I


64

lat><ons"l. the Receiver shall: (il take all steps reasonably necessary to maintain

of the con h


Receiver to provide such Records (iiil if necessary. appoint a pharmacist licensed and qualified

,, for such Records;


23451639 11

504

DQCS•11)R1 1771712W

- 10 -

DLthefatstadian_tohzseacs&astos ,s:(iy)hayeacces,sIQsuc y_

purposcs rewired ursuant to the Pharmacy Regulations that requires e_aefenclanta_fromAinie_










secured creditors.



tribunal (each, a il"Proceedingil"), shall be commenced or continued against the Receiver except


NO PROCEEDINGS AGAINST THE D-EBT-ORDEFD OR THE DOMESTIC

PROPERTY

9. THIS COURT ORDERS that no Proceeding inCanadaDDnesticErosteding'1)_

against or in respect of any of the DebtorDefendants or the Domestic Property shall be

commenced or continued except with the written consent of the Receiver or with leave of this

Court3 and, subject to paragraph 37 hereof, any and all Domestic Proceedings currently under

way against or in respect of any of the DebtorDefendants or the Domestic Property are hereby

stayed and suspended pending further Order of this Court.


10. THIS COURT ORDERS that all rights and remedies against the Debtorany Defendant,

the Receiver, or affecting the Domestic Property, are hereby stayed and suspended except with

sot

23451639 11

DQCS•11)R1 1771712W

- 10 -

DLthefatstadian_tohzseacs&astos ,s:(iy)hayeacces,sIQsuc y_

purposcs rewired ursuant to the Pharmacy Regulations that requires e_aefenclanta_fromAinie_










secured creditors.





NO PROCEEDINGS AGAINST THE D-EBT-ORDEFD OR THE DOMESTIC

PROPERTY










sot

23451639 11

DQCS•11)R1 1771712W

- 10 -

DLtheCllstachan_tohzseacs&astos s:(iy)hayeaccea,stQsuc y_










secured creditors.





NO PROCEEDINGS AGAINST THE D OR THE DOMESTIC

PROPERTY










sot

23451639 11

ROCS I OR: 1771742\9

the written consent of the Receiver or leave of this Court, provided however that this stay and

suspension does not apply in respect of Li)_any —'.`eligible financial contracC" as defined in the

BIA, and rights and

remedies in respect of a Proceeding that is not a Domestic Proceeding, further provided that

nothing in this paragraph shall (ia) empower the Receiver or the Debtorany Defendant to carry on

any business which the Debtorany Defendant is not lawfully entitled to carry on, (it) exempt the

Receiver or the Debtorany Defendant from compliance with statutory or regulatory provisions

relating to health, safety or the environment, prevent the filing of any registration to

preserve or perfect a security interest, or (ivd) prevent the registration of a claim for lien.




licence or permit in favour of or held by the Debtorany Defendant, without written consent of the

Receiver or leave of this Court.


12. THIS COURT ORDERS that all Persons having oral or written agreements with the-

Debtorany Defendant or statutory or regulatory mandates for the supply of goods and/or services,

including!, without limitation, all computer software, communication and other data services,

centralized banking services, payroll services, insurance, transportation services, utility or other

services to the DebtorDefendant are hereby restrained until further Order of this Court from

discontinuing, altering, interfering with or terminating the supply of such goods or services as

may be required by the Receiver, and that the Receiver shall be entitled to the continued use of

the Debtoriany Defendant's current telephone numbers, facsimile numbers, internet addresses and

domain names, provided in each case that the normal prices or charges for all such goods or

services received after the date of this Order are paid by the Receiver in accordance with normal

payment practices of the Debtorsuch Defendant or such other practices as may be agreed upon by

the supplier or service provider and the Receiver, or as may be ordered by this Court.

507

23451639.11

ROCS I OR: 1771742\9



BIA, and rights and

























507

23451639.11

ROCS I OR: 1771742\9



BIA, and rights and

























507

23451639.11

UOUSTOK: 1771792\9

- 12 -




source whatsoever, including., without limitation, the sale of all or any of the Domestic Property



accounts to be opened by the Receiver (the L"Post Receivership Accounts''!) and the monies





EMPLOYEES

14. THIS COURT ORDERS that all employees of the DebtorDefendants, if any, shall remain

the employees of the DebtorDefendants until such time as the Receiver, on the

Debtor'5Defendants' behalf, may terminate the employment of such employees. The Receiver

shall not be liable for any employee-related liabilities, including any successor employer

liabilities as provided for in section 14.06(1.2) of the BIA, other than such amounts as the

Receiver may specifically agree in writing to pay, or in respect of its obligations under

f,'ectionssubsectiQns 81.4(5) or 81.6(3) of the BIA or under the Wage Earner Protection Program

Act.

PIPEDA





attempt to complete one or more sales of the Domestic Property (each, a L"Sale"). Each


23451639 11

UOUSTOK: 1771792\9

- 12 -












EMPLOYEES








Act.

PIPEDA







23451639 11

UOUSTOK: 1771792\9

- 12 -












EMPLOYEES








Act.

PIPEDA







23451639 11

- 13 -

and protect the privacy of such information and limit the use of such information to its evaluation

of the Sale, and if it does not complete a Sale, shall return all such information to the Receiver, or

in the alternative destroy all such information. The purchaser of any Domestic Property shall be

entitled to continue to use the personal information provided to it, and related to the Domestic


information by the Debtorany Defendant, and shall return all other personal information to the

Receiver, or ensure that all other personal information is destroyed.



occupy or to take control, care, charge, possession or management (separately and/or collectively,

111Possessioe") of any of the I ornstic Property that might be environmentally contaminated,

might be a pollutant or a contaminant, or might cause or contribute to a spill, discharge, release

or deposit of a substance contrary to any federal, provincial or other law respecting the

protection, conservation, enhancement, remediation or rehabilitation of the environment or

relating to the disposal of waste or other contamination including, without limitation, the

Canadian Environmental Protection Act, the Ontario Environmental Protection Act, the Ontario

Water Resources Act, or the Ontario Occupational Health and Safety Act and regulations

thereunder (the L"Environmental Legislation'"'), provided however that nothing herein shall

exempt the Receiver from any duty to report or make disclosure imposed by applicable

Environmental Legislation. The Receiver shall not, as a result of this Order or anything done in

pursuance of the Receiverl's duties and powers under this Order, be deemed to be in Possession

of any of the Domestic Property within the meaning of any Environmental Legislation, unless it

is actually in possession.




negligence or wilful misconduct on its part, or in respect of its obligations under sections 81.4(5)

er--8-1A-3-)-ef--the-BIA-or-under-the--Wage-Earner---Preteetio;z Progr n--Ac4,-, Nothing in this Order

21451639.11

- 13 -





























21451639.11

- 13 -





























21451639.11

1344GSTUI{: I 7 7171219

- 14 -

shall derogate from the protections afforded the Receiver by section 14.06 of the BIA or by any

other applicable legislation.

RECEIVER='S ACCOUNTS




the Receiver shall be entitled to and are hereby granted a charge (the 11"Receiverts Charge') on



first charge on theiDomestic Property in priority to all security interests, trusts, liens, charges and

encumbrances, statutory or otherwise , in favour of any Person,-

but-subject-to sections-14,06(-7*-84,4(4*-and-8-1,6{-2)-ef-the BIA.6 other than (a) any validly

perfected security interest under the PPSA, or such other a.. • - • • , • • • er- riority deemed trusts and liens for unpaid em yee source deductions ((al and (bl

ollectivel the "Priori Charges"l.






fees and disbursements, including legal fees and disbursements, incurred at the standard rates and

charges of the Receiver or its counsel, and such amounts shall constitute advances against its





6-Nete4hat-sutaseet-ien-24-3-(6)-efthe-BIA-pr-oviEies4hat-the-Coui4-may-net-make-sue-h-an-er-d that-tlie-s-eeured-eredi4ers-who-kveutd-lae-ii reasenable-tietiee-anki-au-opportunity to make representations".

23451639 11

1344GSTUI{: I 7 7171219

- 14 -










first charge on theiDomestic Property in priority to all security interests, trusts, liens, charges and



perfected security interest under the PPSA, or such other a.. • - • • , • • • er- riority deemed trusts and liens for unpaid em yee source deductions ((al and (bl

ollectivel the "Priori Charges"l.












6-Nete4hat-sutaseet-ien-24-3-(6)-efthe-BIA-pr-oviEies4hat-the-Coui4-may-net-make-sue-h-an-er-d that-tlie-s-eeured-eredi4ers-who-kveutd-lae-ii reasenable-tietiee-anki-au-opportunity to make representations".

23451639 11

1344GSTUI{: I 7 7171219

- 14 -










first charge on the Pomestic Property in priority to all security interests, trusts, liens, charges and



perfected security interest under the PPSA, or such other a.. • - • • , • • . • er- riority deemed trusts and liens for unpaid em yee source deductions ((al and (bl

ollectivel the "Priori gml.












6-Nete4hat-sutaseet-ien-24-3-(6)-efthe-BIA-pr-oviEies4hat-the-Coui4-may-net-make-sue-h-an-er-d tha4-thesued creditors wha would be matorially affected by theorder•wero.given..reao opportunity to make representations".

DUCSTUR: 1771742 \

- 15 -


150,000 (or such greater amount as this Court may by further Order authorize) at any

time, at such rate or rates of interest as it deems advisable for such period or periods of time as it

may arrange, for the purpose of funding the exercise of the powers and duties conferred upon the


shall be and is hereby charged by way of a fixed and specific charge (the E"Receiverl's


interest and charges thereon, in priority to all secufity interests, trusts, 'ie»s, charges and

,Encumbrances in favour of any Person, but subordinate in

prieritHeother than the Priority Charg- the Receiver's Charge-and--t-h-e-eharges-as-set-eut--m--

sections 14.06(7), 81.4(4), and 81.6(2) of the BIA.

22. THIS COURT ORDERS that neither the Receivers Charge, Receive 's Borrowings




substantially in the form annexed as Schedule L"AL" . hereto (the 2."Receiver's Certificatesl!") for

any amount borrowed by it pursuant to this Order.



evidencing the same or any part thereof shall rank on a pari passu basis, unless otherwise agreed



subsequent motion on not less than seven ( ) days' notice to those Persons likely to he affected


ahead f anv i •

23451639,11

DUCSTUR: 1771742 \

- 15 -

























ahead f anv i •

23451639,11

DUCSTUR: 1771742 \

- 15 -

























ahead f anv i •

23451639,11

DUCSTURI 1771712\9

- 16 -

SERVICE AND NOTICE

25—THIS COURT ORDERS that the E-Service Protocol of the Commercial List (the

"Protocol") is approved and adopted by reference herein and, in this—proceed-Ingthtse_

proceedings, the service of documents made in accordance with the Protocol (which can be found

on the Commercial List website at

httpf/-Avww,ont-arioceurts,ea/-sej ractIce-/-practiee-dire-c-ti onsitterontole-serviec-protocallhl/p : //./

shall be valid

and effective service. Subject to Rule 17.05 of the Ontario Rules of Civil Procedure (the

"Rules"), this Order shall constitute an order for substituted service pursuant to Rule 16.04 of the

Rules of Civil Procedure. Subject to Rule 3.01(d) of the Rules of Civil Procedure and paragraph

21 of the Protocol, service of documents in accordance with the Protocol will be effective on


with the Protocol with the following URL: alvarezandmarsal.com/mdhealth.

27. 26-.--THIS COURT ORDERS that if the service or distribution of documents in

accordance with the Protocol is not practicable, the Receiver is at liberty to serve or distribute

this Order, any other materials and orders in these proceedings, any notices or other

correspondence, by forwarding true copies thereof by prepaid ordinary mail, courier, personal

delivery or facsimile transmission to the Debtor'sDefendants' creditors or other interested parties

at their respective addresses as last shown on the records of the DebtorDefendants and that any

such service or distribution by courier, personal delivery or facsimile transmission shall be

deemed to be received on the next business day following the date of forwarding thereof, or if

sent by ordinary mail, on the third business day after mailing.

GENERAL

2_8,, 27. THIS COURT ORDERS that the Receiver may from time to time apply to this Court

for advice and directions in the discharge of its powers and duties hereunder.

29. 2-8,-THIS COURT ORDERS that nothing in this Order shall prevent the Receiver from

acting as a trustee in bankruptcy of the Debtorany Defendant.

23451639 11

DUCSTURI 1771712\9

- 16 -

SERVICE AND NOTICE


"Protocol") is approved and adopted by reference herein and, in this—proceed-Ingthtse_

proceedings, the service of documents made in accordance with the Protocol (which can be found


httpf/-Avww,ont-arioceurts,ea/-sej ractIce-/-practiee-dire-c-ti onsitterontole-serviec-protocallhl/p : //./

shall be valid







27. 26-.--THIS COURT ORDERS that if the service or distribution of documents in









GENERAL





23451639 11

DUCSTURI 1771712\9

- 16 -

SERVICE AND NOTICE


"Protocol") is approved and adopted by reference herein and, in thi-s—proceedIngthtse_

roceedin• s, the service of documents made in accordance with the Protocol (which can be found


httpf/-Avww,ont-arieceurts,ea/-sej ractic-e-/-practiee-dire-c-ti onsitterontole-service-protocallhl/p : //./

shall be valid







27. 26,-THIS COURT ORDERS that if the service or distribution of documents in









GENERAL





23451639 11

DOCS.101k: 177171...19

-17-

30. 29,-THIS COURT HEREBY REQUESTS the aid and recognition of any court, tribunal,

regulatory or administrative body having jurisdiction in Canada or in the United Statesany_

foreign jurisdiction to give effect to this Order and to assist the Receiver and its agents in

carrying out the terms of this Order. All courts, tribunals, regulatory and administrative bodies

are hereby respectfully requested to make such orders and to provide such assistance to the

Receiver, as an officer of this Court, as may be necessary or desirable to give effect to this Order

or to assist the Receiver and its agents in carrying out the terms of this Order.

31 30. THIS COURT ORDERS that the Receiver be at liberty and is hereby authorized and





Canada.

32 31. THIS COURT ORDERS that the Plaintiff shall have its costs of this motion, up to

and including entry and service of this Order, provided for byand the termscosts of the Plaintiff's

see.-Lif ity ided-by-the-Plaint4f€ssecurity-then-en-a--substaiiti-almotio to obtain en--a--substaiitial e_

Mareva Orders, in each case on a full indemnity basis to be paid by the Receiver from the

Debtees--estateDefendants' estates with such priority and at such time as this Court may

determine.

misCELLANEDEsANDTROcEDERAL_MATTERS_

31 32. THIS COURT ORDERS that any interested party may apply to this Court to vary or

amend this Order on not less than seven (7) days!' notice to the Receiver and to any other party


order.

3.4._ THIS COURT ORDERS that the Plaintiff is granted leave to bring this motion without

notice

35. THIS COURT ORDERS that the Motion Record fora Receiver the Factum and Book of

Allthorities.01thePlaintiff,_alLstatedSepteral

23451639 H

5124 DOCS.101k: 177171...19

-17-













Canada.



see.-Lif ity ided-by-the-Plaint4f€ssecurity-then-en-a--substaiiti-almotio to obtain en--a--substaiitial e_



determine.





order.

3.4._ THIS COURT ORDERS that the Plaintiff is granted leave to bring this motion without

notice



23451639 H

5124 DOCS.101k: 177171...19

-17-













Canada.



see.-Lif ity ided-by-the-Plaint4f€securitythenn-en-a--substaiiti-almotio to obtain en--a--substaiitial e_



determine.





order.

3.4._ THIS COURT ORDERS that the Plaintiffisgxan t,

notice



23451639 H

5124

DOUSiUR: 1771711.\9

- 18 -

for the parties in thi proceeding andtheir respective legal counsel until five ( 1 daysf he

3_6_ THIS COURT ORDERS that this Order:

a may be provided by the R c eiv r o s ,ch persons at such times as lie Re ivet in


j shall be served on the persons listed on the Service List attached at Schedule "B" hereto in accordanc with p phs 26 and 27 of this Order within en days of

the date of this Order or at such earlier time at the Receiver main determine in its

discretion.


31. THIS CO RT ORDER hat no withstanding p g phs 9 and l0 of thi Ord r the Plaintiff is granted leave to (al bri g a motion forjugment in this cti „ and t take out any iudgment or order arising therefrom (bl take any steps in fu thelance of or that foll w rr m such

iudgment or order ( xcept to the exten such steps wo„ ld interfere with he Receiver's exclusive

now_ e> n paragraph 2 of this Order (c) bring any motion to add parties to this a tion (dl tale

anysteALtoufaccanyiudgmentaorclerinaPracetdingthaLtsnDL saDomestiQPro=ding._ and (el take any steps permitted by the Mareva Orders and/n to bring any motion to va y or amend the Mareva Orders, in each case without further notice to the Defendants unless required b law The Plaintiff's motion for 'ud m n s al r urea 1 a da s _ is uit at a 9.30 appointment.


3_8_ THIS COURT ORDERS that the Mareva Orders shall not in any way affect or limit the powers and duties of the Receiver conferred • this Order

39. THIS COURT ORDERS that the Receiver shall disclose to the Plaintiff all relevant information acquired or received by the Receiver regarding the Defendants the Domestic

23451639 11

615 DOUSiUR: 1771711.\9

- 18 -

for the parties in thi proceeding andtheir respective legal counsel until five (1 daysf he


a may be provided by the R c eiv r o s ,ch persons at such times as lie Re ivet in


j shall be served on the persons listed on the Service List attached at Schedule "B" hereto in accordanc with p phs 26 and 27 of this Order within en days of


discretion.


31. THIS CO RT ORDER hat no withstanding p g phs 9 and l0 of thi Ord r the Plaintiff is granted leave to (al bri g a motion forjugment in this cti „ and t take out any iudgment or order arising therefrom (bl take any steps in fu thelance of or that foll w rr m such

iudgment or order ( xcept to the exten such steps wo„ld interfere with he Receiver's exclusive


anysteALtoufaccanyiudgmentaorclerinaPracetdingthaLtsnDL saDomestiQPro=ding._ and (el take any steps permitted by the Mareva Orders and /n to bring any motion to va y or amend the Mareva Orders, in each case without further notice to the Defendants unless required b law The Plaintiff's motion for 'ud m n s al r urea 1 a da s _ is uit at a 9.30 appointment.




23451639 11

615 DOUSiUR: 1771711.\9

- 18 -

• ) ar hereby sealed any that no one shall have access to the c of a M + •

for the parties in thi proceeding andtheir respective legal counsel until five ( 1 daysf he



j shall be served on the persons listed on the Service List attached at Schedule "B" hereto in accordanc with p phs 26 and 27 of this Order within en clays of


discretion.


31. THIS CO RT ORDER hat no withstanding pgphs 9 and 10 of thi Ord r the Plaintiff is granted leave to (al bri e a motion forjuement in this

cti „ and t take out any iudgment or order arising therefrom (b) take any steps in furtherance of or that foll w rr m such

judgment or order ( xcept to the exten such steps wo„ ld interfere with he Receiver's exclusive


any step_s tomfaceanyiudgmentaorclerinaPracetdingthaLtsmtsaDomesticProuesthig._

and (el take any steps permitted by the Mareva Orders and /n to bring any motion to va y or amend the Mareva Orders, in each case without further notice to the Defendants unless required b law The Plaintiff's motion for 'ud m n s al r urea 1 a da s _ is uit at a 9.30 appointment.




23451639 11

615

DOLS I UR: 171171219 94. - 19 -


Receiver deems advisable,

40_


41 THIS COURT ORDERS that TD Canada Trust forthwith freeze and preventany removal

urther Order of the Court.


43.

23451639 11

DOLS I UR: 171171219 94. - 19 -



40_





43.

23451639 11

DOLS I UR: 171171219 94. - 19 -



40_





43.

23451639 11

Sr?'

SCHEDULE


CERTIFICATE NO.

AMOUNT $

-1,-L_THIS IS TO CERTIFY that {RECEIVER'S NAME]Alvarez & Marsal Canada Inc., the

receiver (the ItReceivern of all of assets, undertakings and properties [DEBTORS NAME]

aequifeil-fer-,--er---usefl-in-relatien-te-a-hu-s-iness-c-afr-i-e-E1-eny tlie-Debterof Sameh Sadek also

nown as Sam Sadek. St. Maharial Pharmacy Inc. dba MD Hea th Pharmacy. St. Maharial Clinic

Inc., SRX Investment Inc , Shepherd RX Pharmacy Inc. and Lilian Fam, including all proceeds

thereof, to the extent such assets, undertakings and properties are located in Canada (collectively,

the "Domestic Property") appointed by Order of the Ontario Superior Court of Justice

(Commercial List) (the L'2_,CourtL':) dated the 11th day of , 20_September, 2018 (the

11"_`Order'-"') made in an action having Court file number —CV-18-602745-00-CL , has

received as such Receiver from the holder of this certificate (the L"L en d e r•L") the principal sum

of $ , being part of the total principal sum of $ which the Receiver is

authorized to borrow under and pursuant to the Order.

2. 2. The principal sum evidenced by this certificate is payable on demand by the Lender with

interest thereon calculated and compounded [daily][monthly not in advance on the day

of each month] after the date hereof at a notional rate per annum equal to the rate of per


3. 3. Such principal sum with interest thereon is, by the terms of the Order, together with the



priority to the security interests of any other person (other than the Priority Charges, as defined in

the Order), but subject to the priority of the charges set out in the Order and in the Bankruptcy

and Insolvency Act, R S C 1985, c B-3 (the "BIA"), and the right of the Receiver to indemnify


23451639.11

Sr?'

SCHEDULE


CERTIFICATE NO.

AMOUNT $
























23451639.11

Sr?'

SCHEDULE


CERTIFICATE NO.

AMOUNT $
























23451639.11

DOL2-6'13,44.: 1771712W

- 2 -

sums payable in respect of principal and interest under this certificate are payable at the

main office of the Lender at Toronto, Ontario.

5,5. Until all liability in respect of this certificate has been terminated, no certificates creating




64_ The charge securing this certificate shall operate so as to permit the Receiver to deal with


of the Court.

7,7, The Receiver does not undertake, and it is not under any personal liability, to pay any sum

in respect of which it may issue certificates under the terms of the Order.


[RECEIVER'S .•176i-ME-IALVAREZ &

MARSAkCANADA INC, solely in its capacity as Receiver of the Property, and not in its personal capacity

Per:

Name:

Title:

$ii

DOCSTOR 81771742 v8 Model—Receivership_Ord 23451639 11

DOL2-6'13,44.: 1771712W

- 2 -









of the Court.






Per:

Name:

Title:

$ii


DOL2-6'13,44.: 1771712W

- 2 -









of the Court.






Per:

Name:

Title:

$ii


DUCS1 UR: 1771792\9

3


Defendants

SAMEH SADEK ALSO KNOWN AS SAM SADEK,

PHARMACL_ST.ANIAHARI: CLINIC INC., SRX INVESTMENT INC and ,SHEPHERD

,E-mail• sadancftmailsom

J,ITJAN FAM 5045 Churchill Meadows Blvd Missi. •

BanliknameairtAllgu, t 9. 2.018_auct September 5,201' Qrderkof the honourable JusticQDunphy

AND TO., BBC ROYAL BANK 1athrine Styli& 200 Bay Street lititonto. ON MS 215 katistrine—smirle

AND_1101 THE BANK OF NOY • COTIA resident and_General Co uns_e1

44_King Street West Toronto ON M5H 1H1 [email protected]

AND TO* CANADIAN IMPERIAL BANK OF COMMERCE Stephen

199 Bay Street. Commerce Court West. llth_Floot Toronto. ON 1VI5L 1A2 ,[email protected]

AND TO TlEANADA TRUST Ellen Patterson

.23451639.11

s11 DUCS1 UR: 1771792\9

3


Defendants



,E-mail• sadancftmailsom

J,ITJAN FAM 5045 Churchill Meadows Blvd Missi. •

BanliknameairtAllgu, t 9. 2.018_auct September 5,201' Qrderkof the honourable JusticQDunphy

AND TO., BBC ROYAL BANK 1athrine Styli& 200 Bay Street lititonto. ON MS 215 katistrine—smirle

AND_1101 THE BANK OF NOY • COTIA resident and_General Co uns_e1


AND TO* CANADIAN IMPERIAL BANK OF COMMERCE Stephen

199 Bay Street. Commerce Court West. llth_Floot Toronto. ON 1VI5L 1A2 ,[email protected]

AND TO TlEANADA TRUST Ellen Patterson

.23451639.11

s11 DUCS1 UR: 1771792\9

3


Defendants



,E-mail• sadarx ftmailsom

ANIXTD; J,ITJAN FAM 5045 Churchill Meadows Blvd Missi. • *a_ON_J-15......4._

Banliknumed_inAilgu. t 9. 2.018_and.S_eptembvr 5,201' Orderkofthe honourable JusticQDunphy

AND TO., BBC ROYAL BANK 1athrine Smirl- 200 Bay Street lititonto. ON MS 215 katistrimsraide

ANDJ101 THE BANK OF NOY • COTIA resident and_Generd Co uns_el


AND TO* CANADIAN IMPERIAL BANK OF COMMERCE tephen Schultz

199 Bay Street. Commerce Court West. llth_Floot Toronto. ON IVI5L 1A2 ,[email protected]

AND TO TI:_iCANADA TRUST Ellen Patterson

.23451639.11

s11

I.XJCSIOK: 1771712 \ 9

4

Group Head and General Counsel TD Bank Group 12th Floor. TD Tower. TD Centre pO Box 1. Stn. Toronto Dom, Toronto. Ontario M5K 1A2 ellen.pattersoratd.corn

Legal Demands Department

4720 Tahoe Boulevard. 3rd Floor

Mississauga. ON L4W 5P2

Phone: 877-372-3972

Fax: 855-569-1640

ATTN: Rosanna Paolitto

AND TO: J3ANK OF MONTREAL Miguel Mendes Senior counsel & VP. BMO Financial Group I First Canadian Place. 21st Floor Toronto. Ontario M5X 1A1 [email protected]

AND TO: ILSBC BANK CANADA j Mac Bosma Senior Vice-President and General Counsel 1100-885 West Georgia Street Vancouver. BC V6C 3E8 E-mail:

HSBC Branch 1675 The Chase Mississauga. ON L5M 5Y7

HSBC Brand 101-3029 Argentia Rd Mississauga. ON L5N8P7

AND TO: NATIONAL BANK OF CANADA Dominic Paradis

BAGSTAR-N-1-77-1-742-444edel-Reseweah+p-Or-der-R--Reyes)-dee_ _ _ 23451639.11

52o I.XJCSIOK: 1771712 \ 9

4





Phone: 877-372-3972

Fax: 855-569-1640





HSBC Brand 101-3029 Argentia Rd Mississauga. ON L5N8P7



52o I.XJCSIOK: 1771712 \ 9

4





Phone: 877-372-3972

Fax: 855-569-1640





HSBC Brand 101-3029 Argentia Rd IVIississaugg. ON L5N8P7



52o

DUCSTOR: 1771712\9

Sal - 5 -

taa Corporate Secreta 's Office 600De La Gauchetiere Street West,4th Floor Montreal, Quebec_ L1313 4L2 dorninic.paradis@bn_c ca


MsJS=wSj;jmjjaCQrj2J2raCwLyjjcdjapjjawacyjxceL

MILLSA MILLS LLP 2 St,Clair Avenue West —Suite 700 Tor .nto, ON M4V 1L5

Richard Worsfold 40-_682-7113_

Fax; 416-86_ -3997 Riellar&Worafoiti@mill$andrnillssa_

Lawyers fiar the plaintiff in th_e_ab(we-noted proceeding, mdcesson catiada_corptation

AND TO: STIKEMAN ELLIOTT LLP 5300 Commerce Court_West 199 Bay Street lorizata._011M51.,1132

Alex Rose Tel: 416-869-5261 —F.-mail: [email protected]

La_wyersiortheapplicant the above-noted

psoceestiljg, R, Cana

DOCSTOR 41771742 v8 M del_ReceiNership_Order_AT Reyes).doc23451639.11

DUCSTOR: 1771712\9

Sal - 5 -



MsJS=wSj;jmjjaCQrj2J2raCwLyjjcdjapjjawacyjxceL


Richard Worsfold 40-_682-7113_

Fax; 416-86_ -3997 Riellar&Worafoiti@mill$andrnillssa_

Lawyers fiar the plaintiff in th_e_ab(we-noted proceeding, mdcesson catiada_corptation



La_wyersiortheapplicant the above-noted

psoceestiljg, R, Cana


DUCSTOR: 1771712\9

6al - 5 -



MsJS=wCsjmjjaCs2rj2J2raCwLyjjcdjapjjawacyjxc§L


Richard Worsfold I1: 4 0-_682-7111_ Fax; 416-86_ -3997

Riellar&Worafold@mill$andmilissa_

Lawyers fiar the plaintiff in th_e_abPve-noted proceeding, mdcesson catiada_cprptation




PUL:S•I OK: I 77 I 712W

-6

rem Canada Limited v. St. Maharial Pharmacy Inc. et al.

AND TO: BENNETT JONES LLP 100 King Street West. Suite 3400 Toronto. ON M5X 1A4

Dominique T. Hussey

Tel: 416-777-6230

F,-mail: husseydQ.bennettones.com

,awyers for the plaintiff in the above noted proceeding. Teva Canada Limited

AND TO;

7941 Jane Street. Suite 200

Concord. ON L4K 4L6

lio Risceglia

Tel: (905)-695-5200


Lawyers for the plaintiffs in the above-noted proceeding. 170735 Ontario Inc.. JYID Investments Inc. and MD Health Medical Centre Brampton) Inc.

AZiI2 T0;

13AGSTAR4/-1-7-7-1-744-44.4e41-Reeerver-sliv-Afclereyes)-dee_ _ . 73451639 11

PUL:S•I OK: I 77 I 712W

-6



Dominique T. Hussey

Tel: 416-777-6230

F,-mail: husseydQ.bennettones.com


AND TO;


Concord. ON L4K 4L6

lio Risceglia

Tel: (905)-695-5200



AZiI2 T0;


PUL:S• I OK: I 77 I 712W

-6



Dominique T. Hussey

Tel: 416-777-6230

E-mail: husseydQ.bennettones.com


AND TO;


Concord. ON L4K 4L6

Risceglia

Tel: (905)-695-5200



AND TO ELAXEYIILLIMILLIX


625 -7

2 Queen Street East, Suite 1500

1=2Q,_aL\LIA5LIU5=

1, ALBrzezinski

Tel: (416)-594-2952

Faxi (416)-594-5044

E-mail: lbrzeei 'Ms ,g.• II

Varopiari Annan

Tel: (416)-596-2884

Fax. (416)-593-2960

[email protected]

JaYact5 for the dQfendut in_the abovQ7noted

POTFSJ10 LAW 253 Jevlan Drive

ghan.

DUCS1 UR 77171219

AND TO'

Timothy Cindy Dir: (905)-850-2647 L; ost5145Dr154.4

tim@potestiolaw coin

Lawyers for the defendant in the above-noted proceeding, Mg4hat Saad, also...known as Malty Saad_


AND TO

AN II TO,

MAXIUMFINANCIAL SERVICES INC, AND CWB MAXIUM FINANCIAL INC. 30 Vogel) Rd. #1 RichmondEill.ML4331

JJA,RTM&SDNULU„ 2430 S Service Rd W

DQC—S-T-GR-II-1-7-7-1-742-v-8-MeE1eeeeiver-sl+ip—OFE1er—(-T----Reyes-)rE1ee23451639 11

625 -7


1=2Q,_aL\LIA5LIU5=

1, ALBrzezinski

Tel: (416)-594-2952

Faxi (416)-594-5044


Varopiari Annan

Tel: (416)-596-2884

Fax. (416)-593-2960

[email protected]



ghan.

DUCS1 UR 77171219

AND TO'



Lawyers for the defendant in the above-noted proceeding, Mg4hat Saad, also...known as Malty Saad_


AND TO

AN II TO,




625 -7


1=2Q,_aL\LIA5LIU5=

1, ALBrzezinski

Tel: (416)-594-2952

Faxi (416)-594-5044


Varopiari Arman

Tel: (416)-596-2884

F_ax. (416)-593-2960

[email protected]



ghan.

DUCS1 UR 77171219

AND TO'



Lawyers for the defendant in the above-noted proceeding, Mg4hat Saad, also...known as Mary Saad


AND TO

AN II TO,




4.-)01-6)-1(4-4:-14 4444\ 9

524 8

Oakville. ON L6L M59

AND TO: KOHL & FRITSCH LIMITED 7622 Keele Street Concord. ON L4K 2R5

Other

AND TO: SILIEELLINMLGIESIall. 38 Solutions Drive #200 Halifax. NS B3S 1L8

AND TO; CLAIMSECURE INC. 1 City Centre Dr #620 Mississauga. ON L5B 1M2

AND TO; CAMERON STEWART LIFESCIENCE CANADA INC. 3470 Superior Court Oakville. ON L6L 0C4

AND TO: IVIINISTRY OF FINANCE (ONTARIO) IszaLaenkeiltaach 33 King Street West. 6th Floor Oshawa. ON Ll H 8H5


AND TO: DEPARTMENT OF JUSTICE Counsel for the Canada Revenue Agency The Exchange Tpwer 130 King Street West. Suite 3400 po Box 36 Toronto. ON M5X 1K6

Plane Winters. Tel: 416-973-3172 Fax: 416-973-0810

[email protected]

AND TO: ONTARIO COLLEGE OF PHARMACISTS Investigations and Resolutions 483 Huron Street Toronto. ON M5R 2R4

DOGSTOR-4$44;1-74Z-,,,8-Mel—Reseivefship--Afdef—R—Reye*lee234 S1639.11

4.-)01-6)-1(4-4:-14 4444\ 9

524 8



Other








[email protected]



4.-)01-6)-1(4-4:-14 4444\ 9

524 8



Other








[email protected]



DUCSTUR: 1771712\9

5R5 -9

Phone: 1-800-220-1921 flax; 4167:47-84'9

nt ssistaitt [email protected]

ATTN:_Sheliqg Manjidnyestigillor

AND II •

DOCSTOR #1771742 v8 Model_Receivership_OrdeUT Reyes).doc23451639.11

DUCSTUR: 1771712\9

5R5 -9

Phone: 1-800-220-1921 flax; 4167:47-84'9



AND II •


DUCSTUR: 1771712\9

5R5 -9

Phone: 1-800-220-1921 flax; 4167:47-84'9



AND II •


Document comparison by Workshare 9.5 on Monday, September 10, 2018 2:52:31 PM Input:

Document 1 ID file://C:\Users\eri\Desktop\receivership-order-EN.doc Description receivership-order-EN Document 2 ID PowerDocs://TOR_2528/23451639/11 Description TOR 2528-#23451639-v11-Draft Order -_Receiver _ _ _ Rendering set Standard

Legend:

Insertion Deletion

Moved-from-

Moved to

Style change

Format change

Mem -deletion--

Inserted cell

Deleted cell

Moved cell

Split/Merged cell

Padding cell

Statistics:

Count

Insertions 500

Deletions 203

Moved from 4

Moved to 4

Style change 0

Format changed 0

Total changes 711



Legend:

Insertion Deletion

Moved-from-

Moved to

Style change

Format change

Mem -deletion--

Inserted cell

Deleted cell

Moved cell

Split/Merged cell

Padding cell

Statistics:

Count

Insertions 500

Deletions 203

Moved from 4

Moved to 4

Style change 0

Format changed 0

Total changes 711



Legend:

Insertion Deletion

Moved-from-

Moved to

Style change

Format change

Mem -deletion--

Inserted cell

Deleted cell

Moved cell

Split/Merged cell

Padding cell

Statistics:

Count

Insertions 500

Deletions 203

Moved from 4

Moved to 4

Style change 0

Format changed 0

Total changes 711




(COMMERCIAL LIST)


MOTION RECORD TO APPOINT A RECEIVER (Returnable September 11, 2018)

BLAKE, CASSELS & GRAYDON LLP Barristers & Solicitors 199 Bay Street Suite 4000, Commerce Court West Toronto ON M5L 1A9







(COMMERCIAL LIST)



BLAKE, CASSELS & GRAYDON LLP Barristers & Solicitors 199 Bay Street Suite 4000, Commerce Court West Toronto ON M5L 1A9




...NO. ...Mb




(COMMERCIAL LIST)




R. Seumas M. Woods LSO #30169I Tel: 416-863-3876 [email protected]

